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1 INTRODUCTION 
1.1 Photobiomodulation  
 
The use of light for therapeutic purposes dates back to ancient times. However, the 
first major milestone in the field of clinical phototherapy was reached by N. R. Finsen 
in the late 18th century, who succeeded in treating Lupus vulgaris with concentrated 
light radiation1. However, the therapeutic use of visible (VIS) and infrared (IR) light 
was pioneered and became widely recognized as a new treatment modality since the 
invention of lasers in the early 1960s2. Shortly afterwards, in 1967, Endre Mester 
published the first results using low-level laser light. Accompanied by accelerated hair 
growth3, he had proven beneficial effects of red light on wound healing in both, 
preclinical and clinical settings4, 5, introducing the term ‘laser biostimulation’.  
 
Since then, numerous studies and the development of various artificial light sources 
paved the way for the use of low-level phototherapy in modern medicine. As a result, 
new terms were defined in literature involving low-level laser (or light) therapy (LLLT), 
low-intensity laser therapy, low-power laser therapy, cold laser, soft laser as well as 
photobiostimulation complicating a consistent nomenclature6. Although LLLT is the 
most frequently used term, its broad definition is not accurate and outdated due to 
the advanced development of light sources including light-emitting diodes (LEDs), 
introduced in 1962, organic LEDs (OLEDs) or broadband light devices7, 8. Moreover, 
the term impedes an unambiguous differentiation from photodynamic therapy (PDT), 
optogenetics or thermal applications, which are mainly realized with near-infrared 
(NIR) lasers6. Thus, at the joint NAALT and WALT conference in September 2014, 
‘photobiomodulation’ was approved as the term of choice and defined as follows: “A 
form of light therapy that utilizes non-ionizing forms of light sources, including lasers, 
LEDs, and broadband light, in the VIS and IR spectrum. It is a non-thermal process 
involving endogenous chromophores eliciting photophysical (i.e. linear and nonlinear) 
and photochemical events at various biological scales. This process results in 
beneficial therapeutic outcomes including but not limited to the alleviation of pain or 
inflammation, immunomodulation, and promotion of wound healing and tissue 
regeneration”6 (Figure 1).  
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Figure 1: Electromagnetic spectrum differentiating ionizing and non-ionizing radiation with the blue box 
indicating the typical wavelength range used for photobiomodulation [Modified from
9
].  
 
1.1.1 Irradiation parameters  
Besides its inconsistent terminology, significant differences in published study 
designs, applied irradiation parameters and experimental outcomes depreciate light 
therapy to an alternative or complementary treatment modality. The most important 
irradiation parameters represent the wavelength λ [nm], the power [W], the power 
density or irradiance [W/cm2], the energy [J] and the energy density or fluence 
[J/cm2]. The latter is defined as follows: Irradiance [W/cm2] x irradiation time [s], and 
commonly referred to as ‘irradiation dose’10. However, several studies report a non-
linear relationship between those two parameters contradicting the Bunsen-Roscoe 
law of reciprocity, the third law of photobiology11. Therefore, despite of maintaining a 
constant energy input, mutual changes of both parameters often led to different 
biological responses12, 13. Other parameters, which have to be considered, are the 
application mode irradiating either continuously or in pulses/cycles, the number of 
treatments and the treatment interval. In addition, the coherence and polarization of 
light might play a pivotal role for the magnitude of biomodulation10. In total, a vast 
number of irradiation parameters has to be chosen for each treatment, grading the 
use of PBM as largely empirical. Moreover, Jenkins et al.14 underline that irradiation 
parameters are often reported inaccurately or even incompletely impeding the 
reproducibility of published results. 
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1.1.2 Mechanisms of action  
 
Another issue impairing the confidence in light therapy is the ongoing debate about 
molecular mechanisms underlying photobiomodulatory processes. According to the 
first law of photobiology, light effects are based on photon absorption by endogenous 
chromophores, so-called photoacceptors, occurring either in conjugated π-electron 
systems or metal complexes10, 15. Hence, the biological photoresponse depends on 
the wavelength, wave number, frequency, photon energy and action spectrum of the 
respective photoacceptor16. Different chromophores absorbing light throughout the 
ultraviolet (UV), VIS and IR wavebands are for instance chlorophyll, rhodopsin, 
nucleic acids, aromatic amino acids, NADH and NADPH, riboflavin, melanin and 
melanin precursors, bilirubin, hemoglobin, β-carotene, proteins, lipids and water17-20. 
Karu et al.17 postulated four primary mechanisms of photoexcitation resulting in an 
enhanced biochemical activity: (1) Photoexcitation changes the redox properties of 
carriers in the respiratory chain accelerating electron transfer21, (2) excitation energy 
gets partly converted to heat causing a local transient heating of the chromophore22, 
which induces conformational changes triggering biochemical activity, (3) metabolites 
of oxygen like H2O2, OH
• and O2
•- get reabsorbed by mitochondria leading to an 
increased redox activity and therefore to an accelerated respiratory chain23 and (4) 
photoabsorbing chromophores can be converted to photosensitizers24 transferring 
energy to adjacent molecules. Such photosensitizers might be components of the 
respiratory chain like porphyrins, flavins, flavoproteins including cryptochromes, and 
cytochromes25-27. Cytochrome c oxidase, unit 4 of the mitochondrial respiratory chain, 
represents the best characterized chromophore exhibiting absorption bands in the 
red to (N)IR range17, which partly explains the preferred use of red and (N)IR light. 
Secondary responses after light absorption involve the activation of transcription 
factors and signaling pathways regulating various cellular processes. 
 
1.1.3 Medical applications 
 
Although PBM is still not considered as a mainstream therapy, it has emerged as a 
new treatment modality constantly gaining importance for the treatment of various 
injuries and diseases, in acute and chronic conditions8. A literature review showed a 
variety of ailments in different medical fields to benefit from phototherapy (Figure 2).  
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Figure 2: Summary of published LLLT/PBM applications
28, 29
.  
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1.2 Human skin  
1.2.1 Physiology of human skin  
The skin represents the largest organ of the human body, accounting for an area of 
1.6 – 2 m2 and 15% of the total adult body weight with approximately 5 – 10 kg30, 31. 
Besides its main function of forming a protection barrier against environmental insults 
of mechanical, chemical and biological nature, the skin plays an important role in 
thermoregulation, in the prevention of excessive transdermal fluid and electrolyte loss 
as well as in the response to external stimuli including receptors for touch, pain and 
temperature31-35. Basically, the skin can be classified into three distinct layers: the 
epidermis, the dermis and the sub-cutis or hypodermis (Figure 3), which provides an 
essential energy storage to the human body31. Depending on the anatomical location, 
the composition and thickness of the skin varies. In general, the epidermis is quite 
thin with an average depth of 0.04 – 1.6 mm, while the dermis is thicker ranging from 
0.3 mm to 3.0 mm36. Besides of dendritic cells, melanocytes, Langerhans cells and 
Merkel cells, the epidermis consists up to 90 – 95% of keratinocytes, which migrate 
from the stratum basale through different layers towards the stratum corneum at the 
skin surface ending up in flattened, anucleated corneocytes31, 35.  
 
 
 
Figure 3: Anatomy of human skin subdivided into epidermis, dermis and subcutaneous tissue (Image 
reproduced with permission from Reference 
37
).  
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As the multi-layered epidermis has no blood vessels, its nutrient supply needed for a 
continuous renewal is maintained by the underlying dermis comprising numerous 
blood and lymphatic vessels30. In addition, it includes hair follicles, nerve fibers and 
secretory glands38. Furthermore, the dermis comprises the connective tissue, which 
is mainly made up of collagen fibers (> 90%) consisting primarily of interstitial 
collagen type I and III as well as elastic fibers. Similar to the dynamic epidermis, 
matrix components of the dermis undergo constant remodeling, not only in pathologic 
conditions, but also in normal skin38. The connective tissue provides mechanical 
resistance, tensile strength, elasticity and thus a reversible plasticity to the skin31. 
Due to a varying density and arrangement of collagen fibers, the dermis can be 
subdivided into two distinct layers, the stratum papillare and the stratum reticulare. 
Whereas the first is characterized by a relatively thin extracellular matrix (ECM) with 
loosely arranged collagen fiber bundles and a high cell density, the second shows a 
very dense network of organized matrix fibers and a low cell density bordering to the 
fatty tissue of the sub-cutis30, 39. In response to certain stimuli, for instance a skin 
injury, plasma cells, lymphocytes and other leukocytes are able to enter the dermis.  
 
1.2.2 Fibroblasts in human skin  
 
Fibroblasts are a very dynamic and heterogeneous cell population involved in many 
physiological processes. There are several distinct fibroblast lineages populating the 
two-layered dermis: papillary fibroblasts in the superficial layer directly underneath 
the epidermis, reticular cells located in the deep dermis and another subpopulation 
associated with hair follicles40. Besides different spatial locations and morphological 
characteristics with papillary fibroblasts showing a lean, spindle-shaped morphology 
and with reticular ones appearing square and stretched, they exhibit different gene 
expression patterns and therefore functions41-43. In spite of these differences, their 
primary function represents ECM deposition, which gets interspersed between skin’s 
appendages, nerves, vessels, receptors and dermal cells forming the connective 
tissue35, 44. Thus, by providing structural support and maintaining matrix homeostasis, 
fibroblasts are characterized as the main mediators of scar formation, tissue fibrosis 
and wound healing44-46. Moreover, especially during cutaneous tissue repair, growth 
factors, cytokines and chemokines, secreted by fibroblasts, play a crucial role in the 
regulation of epithelial growth and differentiation, and inflammatory processes47, 48. 
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1.2.3 Optical properties of human skin  
 
The skin is naturally exposed to light more than any other organ28, whereby the dose 
of radiation received by the skin is determined by the ozone layer, the position of the 
sun, the geographical location and altitude as well as cloud covers and ground 
reflections. Moreover, the photobiological effects evoked do not only depend on the 
wavelength, frequency and mechanisms of actions induced by UV, VIS or (N)IR 
radiation, but also on skin characteristics like its structure, thickness, vasculature and 
pigmentation49. The wavelengths used for PBM fall into an ‘optical window’ of the 
skin reaching from 650 nm to 1200 nm limited by high absorption bands of principal 
tissue chromophores such as hemoglobin and melanin at < 600 nm and the strong 
absorption of IR light by water at > 1150 nm (Figure 4, (A))10, 16, 49. 
 
(A) (B) 
 
 
 
 
Figure 4: Optical properties of human skin with (A) the ‘optical window’ of tissue
10
 showing absorption 
spectra of different chromophores present in the skin and (B) the optical penetration depth δ of light into 
human skin for a wavelength range from 400 nm to 2000 nm [Modified from 
50
]. 
 
Consequently, the depth of optical penetration δ into human skin highly depends on 
the wavelength of light. Shorter wavelengths with higher energy, such as UV and 
parts of VIS light, do not penetrate into the skin as deep as longer wavelengths like 
IR with less energy even reaching the subcutaneous adipose tissue. Since light 
absorption and optical tissue scattering are more pronounced in the blue region of 
the VIS light spectrum, blue light is able to penetrate up to 0.5 mm into human skin 
(Figure 4, (B))50, 51.  
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1.3 Blue light  
As illustrated in Figure 1, blue light exhibits the highest energy in the VIS part of the 
electromagnetic spectrum ranging from 380 nm to 500 nm. Due to its proximity to UV, 
blue light is often connected to damaging and even cytotoxic effects, especially at 
λ < 450 nm. For instance, overexposure to high-intensity blue light contributes to 
oxidative stress in the retina favoring the onset of age-related macular degeneration52 
or the induction of cataract formation in the eye lens53. Similar to UV light, blue light 
was shown to be antimicrobial exerting bacteriostatic or even bactericidal effects 
against numerous gram-positive as well as gram-negative bacterial strains such as 
Escherichia coli, (methicillin-resistant) Staphylococcus aureus, Pseudomonas 
aeruginosa, Klebsiella pneumoniae, Propionibacterium acnes, and many others54-57. 
Moreover, blue light is well known for its anti-inflammatory properties58, explaining its 
frequent use for inflammatory skin lesions such as psoriasis59 and acne60. Other 
common disorders which were shown to benefit from blue light therapy are for 
instance severe neonatal jaundice61 as well as back and neck pain.  
 
However, in contrast to red and (N)IR light, blue wavelengths are apparently used for 
a limited range of applications, especially when reviewing published in vivo studies. 
This discrepancy can be explained by two reasons: (1) the lower penetration depth of 
blue light (≤ 0.5 mm) restricting its use to rather superficial treatments and (2) less 
insights into light-triggered signaling cascades. With absorption peaks in the range of 
VIS blue light, porphyrin ring structures (~ 410 – 440 nm) and flavins (~ 450 nm), 
which are mainly concentrated in mitochondria, represent the best candidates being 
activated in response to blue light62. Therefore, assessing the effects of blue light on 
mitochondrial function is a logical consequence. Compared to its rare application for 
in vivo studies, many reports described significant blue light effects on different cell 
types including inter alia dermal keratinocytes, fibroblasts and melanocytes as well as 
endothelial cells, stem cells, osteoblasts and several others63-66. Table 1 summarizes 
all reports found describing blue light effects on fibroblast cell types with most of them 
targeting improved wound healing, fibrotic skin diseases or dental treatments. Nearly 
all of the authors observed a decreased mitochondrial activity, cell proliferation and 
viability related to an increased production of reactive oxygen species (ROS) 
probably triggering unbalanced stress responses. In contrast, longer VIS and (N)IR 
wavelengths frequently exert either neutral or stimulatory effects67, 68. 
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Authors Cell type Light source 
Wavelength 
[nm] 
Irradiance 
[mW/cm
2
] 
Time 
[h:min:s] 
Dose 
[J/cm
2
] 
 
#
  
Effects Application 
1 
Akiyama, M. 
et al.
69
  
Human normal neonatal 
dermal fibroblasts  
(NB1RGB) 
LED devices 
405 
471 
1.8 03:00:00 16.2 1 
 Cell growth 
Gene expression profiles, qPCR, 
Immunoblotting:↑ Mic-1, - Tbp, 
 - β2-Microglobulin 
Immune 
regulation 
 
Appetite 
control 
2 
Bonatti, S.  
et al.
70
 
Primary keloid fibroblasts 
Primary adjacent skin 
fibroblasts  
Quasar Esthetique® 
(LED device) 
470 125 
00:01:00 
00:02:00 
00:03:00 
59.9 
122.3 
183.4 
1 
Cell counting: 
 Keloid fibroblasts 
↓ Adjacent skin fibroblasts (183.4 J/cm
2
) 
Keloids 
3 
Fushimi, T. 
et al.
71
 
Normal human dermal 
fibroblasts 
Mignon Belle LT-1 
Crystalline narrow-band 
LED device 
456 0.25 00:20:00 0.3 
1 
PCR: ↑ HGF, - VEGF-A, ↑ KGF, - IL-8,  
- Leptin Wound 
healing 
3 
Growth factor & cytokine levels: ↑ HGF,  
- VEGF-A, ↑ KGF, - IL-8, - Leptin 
4 
Hwang, I. Y. 
et al. 
72
 
Human gingival fibroblasts 
(HGF)  
Plasma lamp 
 
400 – 500 1900 
00:00:01* 
00:00:02* 
00:00:06* 
00:00:13* 
00:00:25* 
2 
4 
12 
24 
48 
1 
↑ DNA synthesis  
↓ Metabolic activity 
↑ Cell viability (≥ 24 J/cm
2
)  
↑ DNA fragmentation 
↓ Cell cycle progression  
↑ Apoptosis (Sub-G0/G1 phase) 
↓ ΔΨm 
↑ Poly (ADP ribose) polymerase cleavage  
Wound 
healing  
 
(Dentistry) 
5 
Krassovka, 
J. et al.
73
  
Normal palmar fibroblasts 
Dupuytren’s fibroblasts  
Narrow-band 
LED device 
453 38 
00:02:22* 
00:04:23* 
00:08:46* 
00:17:33* 
00:26:19* 
00:35:05* 
5 
10 
20 
40 
60 
80 
1 
↓ Metabolic activity (≥ 60 J/cm
2
) 
 α-SMA expression  
↑ ROS  
 Cell viability 
Dupuytren’s 
contracture 
6 
Kushibiki, T. 
et al.
74
  
NIH-3T3 fibroblasts Laser VLM 500®  405 100 
00:01:00 
00:02:00 
6* 
12* 
1 ↑ ROS N/A 
7 
Lee, H. S.  
et al.
75
 
Keloid fibroblasts  Acne photo light (APL®)  410 205 00:00:49 10  2 
 Cell proliferation 
 Cell viability  
PCR (Collagen biosynthesis):  
↓ Collagen I, - TGF-β1, - Smad3, - Smad4  
Western Blot (Collagen biosynthesis):  
↓ Collagen I, - TGF-β1, - Smad3,  -Smad4 
Keloids 
8 
Malcic, A. I. 
et al.
76
 
Lung fibroblasts of the 
Chinese hamster 
(V79 fibroblasts) 
 
Bluephase C8® Light 
Unit (High-performance 
LED polymerization 
light) 
 
Irradiation modes: High 
power (H), low power 
(LP), soft start (S)  
430 – 490 
753.9 (H) 
751.6 (H) 
740.2 (H) 
421.5 (L) 
421.7 (L) 
418.9 (L) 
742.2 (S) 
719.5 (S) 
735.9 (S) 
00:00:20 
00:00:40 
00:00:80 
00:00:20 
00:00:40 
00:00:80 
00:00:20 
00:00:40 
00:00:80 
15.1* 
30.1* 
59.2* 
8.4* 
16.9* 
33.5* 
14.8* 
28.8* 
58.9* 
1 
 Cell viability 
 Colony-forming ability 
↓ Cell proliferation (S, H mode) 
Dentistry 
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Authors Cell type Light source 
Wavelength 
[nm] 
Irradiance 
[mW/cm
2
] 
Time 
[h:min:s] 
Dose 
[J/cm
2
] 
 
#
  
Effects Application 
9 
Mamalis, A.  
et al.
77
 
Primary human skin 
fibroblasts (adult) 
Omnilux Clear-U, 
(LED array) 
415 35 
00:01:55 
00:03:50 
00:05:45 
00:11:30 
00:17:15 
00:30:34 
5 
10 
15 
30 
45 
80 
1 
 Cell viability  
↓ Cell proliferation  
↓ Cell migration  
↑ ROS 
 
Keloids  
 
Other fibrotic 
skin 
diseases 
10 
Masson-
Meyers, D. 
S. et al.
78
  
Primary human dermal 
fibroblasts (adult)  
Dynatron Solaris 708 
(LED device) 
470 30 
00:01:40* 
00:30:33* 
01:01:07* 
02:02:13* 
3 
55 
110 
220 
1 
↓ Metabolic activity  (≥ 55 J/cm
2
)   
↓ Cell viability (≥ 110 J/cm
2
)   
Safety of 
light therapy 
11 
Masson-
Meyers, D. 
S. et al.
79
  
Primary human dermal 
fibroblasts (adult) 
Dynatron Solaris 708 
(LED device) 
470 30 
00:01:40* 
00:02:47* 
00:05:33* 
00:30:33* 
3 
5 
10 
55 
1 
Cell migration: ↑ 5 J/cm
2
, ↓ 55 J/cm
2
 
 Cell viability  
↑ Protein synthesis  
Growth factors: - bFGF, - IL-10, ↓ IL-6  
 Collagen biosynthesis  
Wound 
healing 
12 
Mignon, C.  
et al.
80
 
Primary human reticular 
dermal fibroblasts 
 
Primary human papillary 
dermal fibroblasts  
Proprietary LED-based 
device prototype 
450 30 
00:01:07* 
00:02:47* 
00:04:10* 
00:08:20* 
00:11:07* 
00:16:40* 
00:25:00* 
00:33:20* 
2 
5 
7.5 
15 
20 
30 
45 
60 
3 
↓ Metabolic activity  
↓ Cell viability (> 30 J/cm
2
)  
↑ ROS  
↓ Collagen biosynthesis  
Gene expression profiles, RT-qPCR:  
↓ Proliferation, ↓ Metabolism, ↓ Protein 
synthesis, ↓ Repair (Reticular cells) 
Aging skin 
 
Non-healing 
chronic 
wounds 
13 
Oplander, C.  
et al.
81
 
Primary human dermal 
fibroblasts (adult) 
Prototypes of narrow-
band LED devices 
410 
420 
453 
480 
50 
00:01:40* 
00:03:20* 
00:05:00* 
00:06:40* 
00:10:00* 
00:16:40* 
00:20:00* 
00:26:40* 
00:30:00* 
5 
10 
15 
20 
30 
50 
60 
80 
90 
 
1 
 
Cell viability: ↓ 410 & 420 nm: ≥ 60 J/cm
2
,  
- 453 nm, ↑ 480 nm: ≥ 30 J/cm
2
  
ROS: ↑ 410 & 420 nm: 10 J/cm
2
, - 453 nm,  
- 480 nm  
Antioxidative capacity: ↓ 410 & 420 nm:  
10 J/cm
2
, ↓ 453 nm (30 J/cm
2
), - 480 nm  
Keloids 
 
Hypertrophic 
scars 
 
Fibrotic skin 
diseases 
00:01:40* 
00:05:00* 
00:10:00* 
5 
15 
30 
4 
Cell proliferation: ↓ 410, 420 & 453 nm,  
- 480 nm  
14 
Rotenberg, 
S. et al.
82
 
Mouse lung fibroblasts 
(Balb/c) 
Quartz-tungsten halogen 
(QTH) source  
380 – 500 550 
00:00:10 
00:01:00* 
00:02:00 
00:04:00* 
5 
30 
60 
120 
1 
 
↓ Metabolic activity  
 
Dentistry 
15 
Seo, Y.  
et al.
83
  
Rabbit anterior cruciate 
ligament fibroblasts (ACL) 
Low-intensity LED 
irradiation device  
460 45 00:10:00 27 3 
 Cell proliferation,  Cell migration 
PCR: - EGF, ↑ TGF-β1, ↑ IGF, ↓ Collagen I 
Immunohistochemistry: - CoIlagen I,  
- TGF-β1, - Actin, - αVβ3 Integrin 
N/A 
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Table 1: Summary of LLLT/PBM publications reporting blue light effects on different types of fibroblasts. * Non-reported parameters (Calculated)
 
Authors Cell type Light source 
Wavelength 
[nm] 
Irradiance 
[mW/cm
2
] 
Time 
[h:min:s] 
Dose 
[J/cm
2
] 
 
#
  
Effects Application 
16 
Taflinski, L.  
et al.
84
  
Primary human dermal 
fibroblasts (adult) 
Prototype of a narrow-
band LED device 
420 50 
00:05:00* 
00:10:00* 
00:20:00* 
00:30:00* 
15 
30 
60 
90 
1 
↓ Cell viability (≥ 60 J/cm
2
) 
↑ ROS (15 & 30 J/cm
2
) 
↓ Antioxidative capacity (15 & 30 J/cm
2
) 
↓ Contraction of collagen gels  
Fibrotic skin 
diseases 
00:05:00* 
00:10:00* 
15 
30 
4 
↓ Cell proliferation (15 & 30 J/cm
2 
with 
significant results at 2 days of irradiation ) 
↓ Cell counting  
↓ Number of α-SMA positive cells 
  (15 & 30 J/cm
2
) 
↓ α-SMA expression (15 & 30 J/cm
2
) 
17 
Taoufik, L. 
et al.
85
 
Primary human gingival 
fibroblasts (HGF) 
3M/Trilite, Espe  
(Halogen lamp)  
/ 750 00:04:00 186 
1 
 DNA synthesis  
↓ Cell proliferation  
 Immunofluorescent staining for DNA  
  damage (Double-strand breaks)  
Dentistry The cure, Spring Health 
Products (LED device) 
420 – 600 900 00:03:00 162 
3M Ortholite 
(Plasma arc lamp) 
450 – 500 2000 00:02:00 240 
18 
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NIH/3T3 fibroblasts LEDline2 470 50 00:10:00 30 5 
 Metabolic activity  
↓ Cell migration 
↓ Cell viability  
Wound 
healing 
19 
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Balb/c 3T3 mouse 
fibroblasts   
Optilux (QTH ) 
400 – 500 
556 
00:00:02 
00:00:06 
00:00:12 
1 
3 
6 
1 
Metabolic activity:  
↓ QTH, Laser (≥ 3 J/cm
2
) 
↓ PAC (≥ 1 J/cm
2
) 
 
Dentistry 
PowerPac  
(Plasma arc source) 
1690 
00:00:0.5 
00:00:1.5 
00:00:03 
1 
3 
6 
Accucure (Argon  
laser light source) 
202 
00:00:04 
00:00:12 
00:00:24 
1 
3 
6 
20 
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Diploid human lung 
fibroblasts (WI-38)  
Aneuploid mouse lung 
fibroblasts (Balb/c) 
Human gingival fibroblasts 
(HGF) 
Optilux (QTH ) 
400 – 500 
556 00:02:00 
60 
1 
Metabolic activity: ↓ Balb/c (PAC > QTH),  
↓ HGF (PAC), ↑ WI-38 (PAC) 
TEM micrographs: Structural changes in 
mitochondria for Balb/c fibroblasts 
Modulating 
cell growth 
and survival 
PowerPac  
(Plasma arc source) 
1690 00:00:30 
Accucure (Argon   
laser light source) 
202 00:00:10 5 
Metabolic activity: ↓ Balb/c, ↑ WI-38, ↑HGF 
TEM micrographs: see QTH/PAC  
21 
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Human gingival fibroblasts 
(HGF) 
Techno Light KTL-100 
(LED device)  
Techno Light KTS-150 
(QTH) 
460 250 
00:01:00 
00:03:00 
00:05:00 
 
15 
45 
75 
 
1 
↓ Metabolic activity (LED > QTH)  
↑ ROS (LED > QTH) 
Electron microscopic analysis: Structural 
changes in mitochondria 
Dentistry 
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1.4 MEDILIGHT – Light treatment of chronic wounds  
 
Although fundamental PBM mechanisms are not yet fully understood, numerous LED 
devices were launched to the market with most of them being commercialized for the 
treatment of cutaneous disorders, such as impaired wound healing. Chronic wounds 
appear due to a disruption of the classical healing process resulting in a delayed 
tissue repair beyond the anticipated time, which can take up to several years47, 90. 
Affecting 3 – 6 million patients only in the US with annual costs of approximately 
$10 – 25 billion91, 92, non-healing wounds represent a substantial economic burden to 
public healthcare systems worldwide. With growing prevalence of vascular disorders 
and life-style diseases like obesity and diabetes as well as an increasing aging of the 
population, chronic wounds become a tremendous clinical challenge. According to 
the Wound Healing Society, chronic wounds can be classified into four categories: (1) 
pressure ulcers, (2) diabetic ulcers, (3) venous ulcers and (4) arterial ulcers93. 
Despite their increasing prevalence94, many patients still experience insufficient 
wound care suffering from severe pain and a significantly reduced quality of life often 
ending in amputation of lower extremities and premature death90.  
 
As a new innovation in wound research, the European project 
MEDILIGHT aimed to develop a medical device which uses 
proven therapeutic effects of VIS light to improve the self-
healing process of wounds and monitor their status during 
therapy (co-funded by the European Union’s Horizon 2020 
research and innovation program under Grant Agreement No. 
644267). Driven by URGO RID (France), six other partners 
with different competencies were involved in the consortium: 
TUB Berlin, University of Heidelberg, CSEM, SignalGeneriX 
Ltd., Microsemi Semiconductor Ltd. and AMIRES. The whole 
consortium strived to translate current light technologies, 
which still mainly rely on bulky and stationary devices in 
hospitals, into a wearable, light-weight, low cost, and flexible 
 
 
Figure 5: First prototype 
of the MEDILIGHT device 
fixed to a special shoe for 
diabetic foot ulcer (DFU) 
patients enabling an easy 
as well as a comfortable 
treatment at home. 
solution for personalized treatment at home (Figure 5). Besides target applications 
including DFU and venous leg ulcers (VLU), the device could represent a valuable 
tool for the therapy of fibrotic skin diseases or even PDT of skin cancer.  
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1.5 Aim of the study 
Nowadays, more and more publications arise in PBM research proposing that light 
therapy demonstrates a powerful treatment approach for a wide variety of medical 
conditions. Most in vivo studies testing the efficacy of phototherapy, either in animal 
models or clinical trials, almost exclusively involve red and (N)IR light showing two 
persuasive advantages. On the one hand, longer wavelengths exhibit a deeper tissue 
penetration, while, on the other hand, the underlying mechanism of action is more or 
less elucidated. Consequently, the application of other wavelengths becomes easily 
underappreciated, even though beneficial effects were already proven for numerous 
medical disorders. Especially for blue light, many encouraging results were reported; 
however, its use remains rather controversial, since its higher energy level is often 
linked to suppression of cellular activity and consequently inhibition of proliferation. 
Moreover, primary and secondary mechanisms contributing to local and systemic 
effects remain poorly understood.  
 
Consequently, the main aim of this study was to assess the therapeutic potential of 
different irradiation doses of VIS blue light in an in vitro model of primary normal 
human dermal fibroblasts (NHDF cells). Driven by the European project MEDILIGHT, 
studies were mainly focused on testing the modulatory effect of blue light on cell 
metabolism, proliferation and gene expression profiles. Accordingly, the following 
issues were addressed in this project:  
 
 Do temperature increases, induced by blue light, contribute to an altered cellular 
activity and proliferation of NHDF cells?  
 Which doses of blue light lead to significant changes in the metabolic activity of 
NHDF cells and will be chosen for subsequent studies?  
 Are light-induced metabolic changes also reflected in altered proliferation rates?  
 Does blue light irradiation differentially impact mitochondrial function?  
 Are light treatments, especially with higher irradiation doses, safe with respect to 
cell viability or lead to cytotoxic effects on NHDF cells?  
 Which genes and signaling pathways are commonly or differentially expressed at 
low and/or high dose levels of blue light? 
 Does blue light irradiation using the MEDILIGHT prototype show similar effects on 
the metabolic activity of NHDF cells compared to the BioLight LED Lamp?  
Material and Methods 
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2 MATERIAL AND METHODS  
2.1 Material  
2.1.1 Cell line  
The primary cell line ‘Normal Human Dermal Fibroblasts’ (NHDF), cryopreserved at 
passage 2 (P2), was obtained from PromoCell GmbH (Heidelberg, Germany). The 
company had isolated the cells from the dermis of adult human skin, in detail from the 
temple of a 52-year-old Caucasian female donor. Subsequent quality controls verified 
typical cell morphology as well as common adherence and viability rates. Phenotypic 
characterization was performed by immunohistochemical staining of the fibroblast-
specific surface antigen CD90, which was identified by flow cytometry analysis. With 
a population doubling time of 43.4 hours in the log phase, growth performance was 
tested and guaranteed through multiple passages up to 15 population doublings. The 
morphology of NHDF cells in passage 6 appeared to be elongated with a branched 
cytoplasm surrounding oval nuclei (Figure 6). 
 
 
 
Figure 6: Morphology of normal human dermal fibroblasts (NHDF cells) in passage 6 with mitotic cells. 
Using an inverted Leica DM IRBE microscope (Leica Mikroskopie & Systeme GmbH, Wetzlar, Germany), the 
image was acquired in phase contrast with 5x magnification.  
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2.1.2 Laboratory equipment  
The laboratory equipment is outlined in different subgroups. With the corresponding 
manufacturer specified, the used equipment is listed in subsequent tables as follows: 
consumables in Table 2, substances in Table 3, kits in Table 4, devices in Table 5 as 
well as the software used for data evaluation, which is summarized in Table 6.  
 
2.1.2.1 Consumables, substances and kits 
 
Table 2: Overview of consumables with specification of manufacturer 
Description  Manufacturer  
Cell culture flasks, CELLSTAR® 
75 cm
2
, 175 cm
2
 
Greiner Bio-One GmbH, Frickenhausen, Germany 
Cell culture plates, 96-well, transparent, 
flat bottom, with low evaporation lid 
Costar® by Corning Incorporated, Kennebunk, ME, USA 
Cell culture plates, 96-well, black, clear 
flat bottom, with low evaporation lid 
Costar® by Corning Incorporated, Kennebunk, ME, USA 
Cell culture plates, 96-well, white, flat 
bottom, with low evaporation lid 
BRAND GmbH + Co. KG, Wertheim, Germany  
Conical tubes (15 mL, 50 mL) 
Falcon® by Corning Science México S.A. de C.V., 
Taumalipas, México 
CryoTube™ Vials  Nunc™ by Thermo Fisher Scientific, Roskilde, Denmark 
HuGene-2_0st microarrays (Human) Thermo Fisher Scientific, Waltham, MA, USA 
Luna™ Cell counting slides  Logos Biosystems, Anyang-si, Gyeonggi-do, Korea 
Pipette tips, graduated, with filter STARLAB International GmbH, Hamburg, Germany  
Round-bottom tubes with cell-strainer cap 
(5 mL) 
Falcon® by Corning Science México S.A. de C.V., 
Taumalipas, México 
Safe-lock tubes (1.5 mL, 2.0 mL) Eppendorf AG, Hamburg, Germany 
Serological pipettes (5 mL, 10 mL, 25 mL) SARSTEDT AG & Co., Nümbrecht, Germany  
URGOSTART, Wound dressing E2723 URGO RID, Chenôve, France  
 
Table 3: Overview of substances with specification of manufacturer 
Description  Manufacturer  
Allophycocyanin Annexin V BioLegend, Koblenz, Germany 
Amplex® UltraRed Reagent  
Molecular Probes™
 
by Thermo Fisher Scientific, Life 
Technologies Corporation, Eugene, OR, USA 
Annexin V Binding Buffer  BioLegend, Koblenz, Germany 
Chloroform  Merck, Darmstadt, Germany 
Dimethyl sulfoxide, sterile-filtered  
Hybri-Max™ by Sigma-Aldrich Co. LLC, St. Louis, MO, 
USA 
Dulbecco’s Modified Eagle Medium (1x)  
+ GlutaMAX™ -I, 500 mL 
[+] 4.5 g/L Glucose, [-] Pyruvate  
Gibco™ by Thermo Fisher Scientific, Waltham, MA, USA 
Ethanol, ROTIPURAN®, > 99.8%, p.a. Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Horseradish peroxidase  Pierce™ by Thermo Fisher Scientific, Rockford, IL, USA  
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Hydrogen peroxide solution, 
30% (w/w) in H2O, with stabilizer  
Sigma-Aldrich Chemie, GmbH, Steinheim, Germany  
Nuclease-free water Omega Bio-tek Inc., Norcross, GA, USA 
Penicillin/ Streptomycin  
[+] 10,000 Units/mL Penicillin 
[+] 10,000 µg/mL Streptomycin 
Gibco™ by Thermo Fisher Scientific, Waltham, MA, USA 
Phosphate buffered saline  
(without Mg
2+
/Ca
2+
) 
Gibco™ by Thermo Fisher Scientific, Waltham, MA, USA 
2-Propanol, ROTIPURAN®, > 99.8%, p.a. Carl Roth GmbH & Co. KG, Karlsruhe, Germany 
Propidium Iodide, 1.0 mg/mL 
Invitrogen™
 
by Thermo Fisher Scientific, Life 
Technologies Corporation, Eugene, OR, USA 
Sodium pyruvate (100 mM) Gibco™ by Thermo Fisher Scientific, Waltham, MA, USA 
Staurosporine (Streptomyces staurosporeus) Sigma Aldrich, St. Louis, MO, USA 
SupplementMix, Fibroblast Growth 
Medium 3 
PromoCell GmbH, Heidelberg, Germany 
TRIzol®  
Ambion® by Thermo Fisher Scientific, Life Technologies 
Corporation, Darmstadt, Germany 
Trypan Blue stain (0.4%) Gibco™ by Thermo Fisher Scientific, Waltham, MA, USA 
0.25% Trypsin-EDTA (1x) Gibco™ by Thermo Fisher Scientific, Waltham, MA, USA 
 
Table 4: Overview of kits with specification of manufacturer 
Description  Manufacturer  
Cell Proliferation ELISA, BrdU 
(Colorimetric) 
Roche Diagnostics GmbH, Roche Applied Science, 
Mannheim, Germany 
CellTiter-Glo® Luminescent Cell Viability 
Assay  
Promega Corporation, Madison, WI, USA 
Colorimetric Cell Viability Kit III (XTT) 
PromoKine™ by PromoCell GmbH, Heidelberg, 
Germany 
CyQUANT® Direct Cell Proliferation 
Assay Kit  
Invitrogen™ by Thermo Fisher Scientific, Eugene, OR, 
USA 
FITC BrdU Flow Kit  BD Pharmingen™ by BD GmbH, Heidelberg, Germany 
GeneChip®
 
Hybridization, Wash and 
Stain Kit
 Thermo Fisher Scientific, Waltham, MA, USA 
GeneChip®
 
WT Plus Reagent Kit Thermo Fisher Scientific, Waltham, MA, USA 
Mitochondrial Membrane Potential  
Assay Kit (II) 
Cell Signaling Technology®, Danvers, MA, USA
 
 
 
2.1.2.2 Devices and software  
 
Table 5: Overview of devices with specification of manufacturer 
Description  Manufacturer  
Agilent 2100 Bioanalyzer Agilent Technologies, Santa Clara, CA, USA 
Axio Observer.Z1 with Lamp Module  Carl Zeiss Microscopy GmbH, Göttingen, Germany 
Flow cytometer, BD FACSCanto™
 
II BD Biosciences, Heidelberg, Germany 
Biofuge primo R, Heraeus® Kendro Laboratory Products GmbH, Osterode, Germany 
BioLight LED Lamp with Lumileds 
LUXEON Rebel LXML-PR01-0275 
Philips Electronics Nederland B.V.  
Philips Research, Eindhoven, Netherlands 
Koninklijke Philips N.V., Eindhoven, Netherlands 
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Centrifuge Rotanta 96 RC Hettich GmbH & Co. KG, Tuttlingen, Germany 
CO2 Incubators 
HERAcell™ 240i, HERAcell™ VIOS 160i 
Thermo Electron LED GmbH, Thermo Scientific, 
Langenselbold, Germany  
Diffusor  CSEM, Basel, Switzerland  
Laser Power Meter, 843-R Newport Corporation, Irvine, CA, USA  
GeneChip®
 
Fluidics Station 450 Affymetrix
 
UK Ltd.,
 
High Wycombe, UK 
GeneChip® Hybridization Oven 640 Affymetrix
 
UK Ltd.,
 
High Wycombe, UK 
GeneChip® Scanner 3000 Affymetrix
 
UK Ltd.,
 
High Wycombe, UK 
Laminar flow, Heraeus®, HERAsafe Kendro Laboratory Products GmbH, Hanau, Germany 
Leica DM IRB, IRBE Leica Mikroskopie & Systeme GmbH, Wetzlar, Germany 
Luna™ Automated cell counter  Logos Biosystems, Anyang-si, Gyeonggi-do, Korea 
MEDILIGHT prototypes, 1
st
 generation MEDILIGHT consortium (EU Horizon H2020, # 644267) 
Microplate reader, Spark® 10M  Tecan Austria GmbH, Grödig, Austria  
myFuge™ Mini centrifuge C1008 Benchmark Scientific, Edison, NJ, USA 
Mr. Frosty™ Cryo 1°C Freezing container 
Nalgene® by Thermo Fisher Scientific, Waltham, MA, 
USA 
NanoQuant plate™ Tecan Austria GmbH, Grödig, Austria 
Neutral density filter, D1.0, NG4 Advanced Optics Schott AG, Mainz, Germany  
pH Meter, pH 540 GLP, MultiCal®  WTW, Weilheim, Germany  
Thermocouple Data Logger, USB TC-08  Pico Technology, St. Neots, Cambridgeshire, UK 
Thermocouple, Type K, RS PRO RS Components Ltd., Corby, Northamptonshire, UK 
918 UV-SI Wand detector, 
200 – 1100 nm, OD3 Attenuator, DB15 
Newport Corporation, Irvine, CA, USA 
 
Table 6: Overview of software with specification of manufacturer 
Description  Manufacturer  
BD FACSDiva, version V6.X BD Biosciences, Heidelberg, Germany 
FlowJo™ 10, version 2.5.1  FlowJo LLC, Ashland, OR, USA 
Fiji, Image processing package of ImageJ  Free software for image analysis  
JMP®
 
Genomics, version 7.1 SAS Institute Inc., Cary, NC, USA 
SparkControl, version 1.2 Tecan Austria GmbH, Grödig, Austria  
ZEN 2 pro Carl Zeiss AG, Oberkochen, Germany 
 
2.1.3 Light sources 
Two LED systems were used for the blue light treatment of human dermal fibroblasts. 
For most of the studies, cells were irradiated with the BioLight LED Lamp provided by 
Philips Research (Eindhoven, Netherlands) serving as a benchmark, since the device 
developed by MEDILIGHT was designed and manufactured during the project period. 
In April 2018, the 1st generation of prototypes was provided for in vitro testing.  
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2.1.3.1 BioLight LED Lamp  
 
The BioLight LED Lamp, accompanied by a current modulator, which enabled pulsed 
driving, was set up and calibrated by Philips Electronics Nederland B.V., Philips 
Research (Eindhoven, Netherlands). It was equipped with two power supplies with 
one delivering 1 A at 300 V (direct current) to drive the LEDs via defined presets. The 
second one powered the fan with a fixed voltage of 24 V (direct current) and 0.1 A 
protecting the lamp against overheating, especially when using higher irradiances or 
longer irradiation times (Figure 7, (A)). The illumination field was composed of LEDs 
(Philips Lumileds LUXEON Rebel LXML-PR01-0275 from Koninklijke Philips N.V. 
(Eindhoven, Netherlands)). The latter, showing a royal blue color (Figure 7, (A)) and 
a beam divergence of ±15°, were covered by a set of lenses (Figure 7, (B)).  
 
(A) (B) 
  
 
Figure 7: (A) Experimental set-up of the BioLight LED Lamp with a current modulator and two power 
supplies provided by Philips Electronics Nederland B.V., Philips Research (Eindhoven, Netherlands). (B) 
Lens-covered illumination field (LED aperture). 
 
This set-up provided a homogenous light distribution, which was determined by 
Philips Research using an average central irradiance of 10 mW/cm2 at a distance of 
50 mm from the lamp casing (Figure 8, (A)). The maximum time-averaged emittance 
was given at 100 mW/cm2, corresponding to 15 W for the 10 cm x 15 cm emission 
aperture. Moreover, the maximum peak emittance equaled 350 mW/cm2. According 
to the company’s specification, the LED device was distance and power adjusted to 
deliver a fixed irradiance of 23 mW/cm2 at the surface of irradiated cell culture plates.  
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The peak wavelength, which was measured at a central irradiance of 12 mW/cm2 and 
a distance of 50 mm, was given at λ = 453 nm (Figure 8, (B)). For all experiments the 
irradiation was performed continuously with a duty cycle of 100%. Prior to each light 
treatment, the LEDs were pre-run for a few seconds in order to stabilize their output.  
 
(A)   (B) 
 
 
 
 
Figure 8: Lamp specifications of the BioLight LED lamp with (A) the spatial distribution of irradiance at a 
distance of 50 mm from the lamp casing and (B) the emission spectrum with a peak wavelength at 
453 nm, which was measured at a central irradiance of 12 mW/cm
2
 and a distance of 50 mm. 
 
2.1.3.2 MEDILIGHT system  
 
Seven consortium partners of the European project MEDILIGHT had developed a 
wearable and highly integrated medical device, which was intended to improve the 
impaired healing process of chronic wounds. In respect of hygienic requirements for 
medical devices, the prototype was divided into two parts. The first part consisted of 
a re-usable LED-based illumination and sensing system, which was placed on top of 
a disposable wound dressing and fixed by a customized pocket. Although it sealed 
the wound hermetically, the adhesive and absorbent dressing (E2723), developed by 
URGO RID (Chenôve, France), was still breathable. Besides providing homogenous 
illumination through the dressing, the flat and flexible LED foil was equipped with an 
integrated smart sensing system. This enabled continuous monitoring of temperature 
changes and simultaneous mapping of blood oxygenation levels. The second, also 
re-usable part represented an encasement, which enclosed an electronic module and 
a rechargeable battery with its status indicated by one of the light displays on top of 
the encasement (Figure 9).  
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Figure 9: MEDILIGHT system including a thin and flexible LED foil with integrated temperature and pulse 
oximetry sensors illuminating the wound area through the disposable absorbent wound dressing E2723. 
The rechargeable system was controlled by an electronic module via wireless communication.  
 
Moreover, an application software was developed in order to drive the LED array and 
its integrated sensors as well as to analyze acquired data transmitted via Bluetooth. 
In order to be compliant with hygienic conditions, URGO RID encapsulated the LED 
foil together with a thin-film back-reflector from CSEM (Basel, Switzerland) in silicone. 
The addition of the latter was intended to yield a higher light efficiency (Figure 10).  
 
  
 
Figure 10: Holistical MEDILIGHT prototype from (A) top side and (B) bottom side showing the thin-film 
back-reflector attached to the flexible LED foil, increasing light efficiency within the surrounding silicone 
encapsulation.  
 
Since the prototype missed any optical lenses diffusing the light (Figure 11, (A), (B)), 
the light emission of single LED spots was homogenized by adding another layer, an 
opaque diffusor, which was also provided by CSEM (Figure 11, (C)).  
 
(A) (B) (C) 
   
 
Figure 11: (A) Illumination field of the MEDILIGHT prototype either (B) without diffusor or (C) with diffusor. 
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2.2 Methods 
 
2.2.1 Cell culture  
 
NHDF cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, high 
glucose, GlutaMAX™ Supplement), which was complemented with 100 units/mL 
penicillin/streptomycin as well as 1 mM sodium pyruvate (Gibco™ by Thermo Fisher 
Scientific, Waltham, MA, USA). Moreover, a SupplementMix from PromoCell GmbH 
(Heidelberg, Germany) was added, completing the medium with 0.1 mL/mL fetal calf 
serum (FCS) (10%) (v/v), 1 ng/mL basic fibroblast growth factor and 5 µg/mL insulin. 
Standard culture conditions were maintained in a humidified atmosphere at 37°C and 
5% CO2. In order to ensure logarithmic growth and prevent senescence, the cells 
were only used up to 15 population doublings, which corresponded to about 6 – 8 
passages. At subconfluence (70 – 80%), NHDF cells were re-seeded according to 
the instructions of PromoCell keeping a plating density of 3.500 – 7.000 cells/cm2. 
For cell detachment, 0.25% Trypsin/EDTA (1x) was diluted to 0.04% using phosphate 
buffered saline (PBS) without Mg2+ and Ca2+ (Gibco™ by Thermo Fisher Scientific, 
Waltham, MA, USA) and added for an incubation time of 3 minutes at 37°C and 5% 
CO2. Then, viable cells, determined by Trypan Blue exclusion, were quantified with a 
Luna™ automated cell counter and seeded in new flaks or multiwell plates at the 
suggested plating density. For culture flasks, split ratios of 1:6 – 1:10 were obtained 
with medium renewal twice a week, whereas for 96-well plates the plating density 
was adjusted according to the experiment duration: 5,000 cells/well for 3 culture 
days; 2,500 cells/well for 4 culture days and 1,250 cells/well for 5 days of culturing. 
Unless otherwise specified, NHDF cells were seeded into black 96-well plates, which 
prevented light crosstalk between single wells, and incubated for 24 hours at 37°C 
and 5% CO2 before exposing them to the light treatment. 
  
2.2.2 Light treatment  
 
At 24 hours after seeding, the medium was renewed at 30 minutes prior to irradiation 
in order to provide an appropriate amount of nutrients to the cells. Then, following 
another incubation for 30 minutes at 37°C and 5% CO2, NHDF cells were treated with 
different blue light doses. All light treatments were performed outside the incubator.  
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2.2.2.1 BioLight LED Lamp  
 
As already described in 2.1.3.1, the BioLight LED Lamp provided by Philips Research 
(Eindhoven, Netherlands) operated at a steady irradiance level, yielding 23 mW/cm2 
at the surface of irradiated cell culture plates (50 mm distance from the lamp casing). 
However, since the black plate, the lid and the medium led to a power loss of about 
50% due to light absorption, the irradiance was attenuated to about 12 mW/cm2 95. In 
consequence, the dose resulting from different irradiation times also changed. Blue 
light doses, which were tested in this study, are listed in Table 7.  
 
Table 7: Different irradiation times [min] with corresponding doses [J/cm
2
] at an irradiance level of about 
12 mW/cm
2
. The left column lists irradiation times assigned to low – mid blue light doses, while the right column 
summarizes irradiation times corresponding to mid – high blue light doses. 
 
 
Concerning the experimental set-up, the left 
part of the plate (Col. #1-6) was treated with 
blue light, while the right side (Col. #7-12) 
was dark taped representing the untreated 
control (Figure 12). Hence, apart from blue 
light irradiation, untreated control cells were 
always kept under the same environmental 
conditions, which excluded a plate effect 
between light-treated and untreated groups. 
 
Figure 12: Lid of a black 96-well plate with the 
right side (Col. #7-12) dark taped setting up the 
non-irradiated control. 
Throughout this study, two experimental light schedules were followed involving 
either single treatments with a defined irradiation dose or multiple treatments, with 
the same dose each, summing up in an equivalent irradiation dosage (Figure 13).  
Low – Mid Dose Mid – High Dose
Irradiation time [min] Dose [J/cm2] Irradiation time  [min] Dose [J/cm2]
2.5 1.8 22.5 16.2
5.0 3.6 25.0 18.0
7.5 5.4 30.0 21.6
10.0 7.2 45.0 32.4
12.5 9.0 60.0 43.2
15.0 10.8 90.0 64.8
17.5 12.6 120.0 86.4
20.0 14.4 240.0 172.8
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Using the latter, cells were treated once a day over two or three consecutive days 
with the medium being renewed before each treatment. Following multiple treatments 
long-term effects, for example changes in cell activity and proliferation, were always 
studied at 24 hours after the last irradiation (Figure 13, (B)). In contrast, different time 
points were tested after single blue light exposures to assess fast responses like 
changes in ROS or ATP levels (Figure 13, (A)). To perform direct comparisons, two 
independent methods were often combined on the same test plate, such as the XTT 
assay and time-matched RNA isolation with subsequent gene expression profiles.  
 
(A) (B) 
 
 
 
Figure 13: Experimental light schedules for (A) single and (B) multiple treatments. (A) At 24 hours after 
seeding into black 96-well plates, NHDF cells were irradiated on the second day with assays being performed 
within the next 72 hours after irradiation. (B) Starting at 24 hours after seeding, NHDF cells were treated once a 
day on consecutive days, while the assays were performed at 24 hours after the first, second or third irradiation.  
 
2.2.2.2 MEDILIGHT system  
 
As a prerequisite for subsequent in vivo studies, the efficacy of different MEDILIGHT 
prototypes had to be assessed in vitro. Since its illumination field housing 450 nm 
LEDs was too small to treat half of the multiwell plate, lids with a defined irradiation 
area were prepared (Col. #2-5, Row #C-F). Moreover, irradiation was performed in 
direct contact to the plate. Using an 843-R laser power meter (Newport Corporation, 
Irvine, CA, USA), the irradiance resulting underneath the entire component stack was 
adjusted to 23 mW/cm2, which coincided with the setting of the BioLight LED Lamp. 
Involving the diffusor (CSEM, Basel, Switzerland) or E2723 (URGO RID, Chenôve, 
France), duty cycles (DCs) of respectively 38% and 68% were obtained (Figure 14).  
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(A) (B) 
  
 
Figure 14: Experimental design for in vitro validation of the MEDILIGHT prototype – Plate set-up with (A) 
diffusor (CSEM, Basel, Switzerland) and (B) wound dressing E2723 (URGO RID, Chenôve, France). The red 
rectangle indicates the irradiated area.  
 
To determine whether the illumination field provided a homogenous light distribution, 
NHDF cells were seeded into transparent 96-well plates, which allowed light crosstalk 
between single wells. For these light experiments, the center of the lid (Col. #5-8, 
Row #C-F), adapted to the size of the illumination field, was left untaped, while the 
surrounding was dark taped excluding any light penetration (Figure 15, (A)). Light 
distribution was varied by adding the diffusor or E2723 (Figure 15, (B) & (C)).  
 
(A) (B) (C) 
   
 
Figure 15: Experimental design for light distribution studies with the MEDILIGHT prototype – Plate set-up 
for (A) center irradiation covered with (B) the diffusor or (C) the wound dressing E2723.  
 
2.2.3 Temperature measurements 
 
2.2.3.1 BioLight LED Lamp  
 
In order to exclude thermal effects influencing cellular processes apart from blue light 
treatment, the temperature of cell culture medium was recorded during continuous 
irradiations of 120 minutes. First, the wells of a black 96-well plate were filled with 
100 µL of medium followed by an incubation at 37°C and 5% CO2 for 30 minutes 
before irradiation, imitating experimental conditions.  
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Meanwhile, a pre-run of 15 minutes without light irradiation was performed at room 
temperature (RT) in order to stabilize the measuring system. Afterwards, through 
openings constructed at the side of the cell culture plate, a thermocouple (type K) 
was placed into one of the inner wells and the irradiation was started (Figure 16). 
Connected to a Pico Technology USB TC-08 data logger (RS Components Ltd., 
Corby, Northamptonshire, UK), data were visualized and immediately analyzed. 
 
(A) (B) 
  
 
Figure 16: Experimental design for temperature measurements performed in vitro using the BioLight LED 
Lamp. (A) Black 96-well plate with openings at the side allowing the placement of thermocouples inside the plate 
for in vitro temperature measurements, (B) performed during blue light irradiation.  
 
2.2.3.2 MEDILIGHT system  
 
Owing to the risk of inducing cutaneous hyperalgesia due to significant temperature 
increases (> 40°C), in vitro and in vivo temperature measurements were performed 
to guarantee patient safety. Besides recordings in cell culture plates as described in 
2.2.3.1, temperature changes were followed on a skin-like polymer from URGO RID 
(Chenôve, France) as well as on porcine and human skin. In addition to integrated 
sensors monitoring the temperature on the LED array, external sensors were placed 
at different positions underneath the dressing E2723 to record direct changes on the 
polymer or skin. Due to different wound healing stages requiring either stimulated cell 
responses with 10 mW/cm2 95 or antibacterial effects at 23 mW/cm2 96, the irradiance 
was adjusted accordingly underneath the respective component stacks.  
 
2.2.4 Cell metabolism and proliferation assays 
 
With respect to the interests of MEDILIGHT, blue light effects on cell metabolism and 
proliferation were studied using various methods. Besides metabolic activity assays, 
changes in cell cycle distributions, DNA synthesis rates and cell counts were tested.  
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2.2.4.1 Metabolic activity – XTT reduction  
 
Metabolic activity was assessed using the colorimetric Cell Viability Kit III (XTT) from 
PromoKine (PromoCell GmbH, Heidelberg, Germany). In presence of the activation 
reagent, N-methyl dibenzopyrazine methyl sulfate (PMS), mitochondrial enzymes of 
metabolic active and viable cells reduce the yellow tetrazolium salt XTT to a water-
soluble, orange-colored formazan dye. Therefore, resulting absorbance intensities 
directly correlate with the activity of mitochondrial enzymes of viable and active cells 
metabolizing XTT. Following irradiation, a reaction mixture of XTT and PMS (1:200) 
was added to the medium (50% by volume) and incubated for 1 hour at 37°C and 5% 
CO2. With a Spark® 10M microplate reader (Tecan Austria GmbH, Grödig, Austria) 
absorbance signals were quantified at 450 nm with a reference reading at 690 nm. 
Non-specific signals were identified by adding XTT/PMS only to cell culture medium.  
 
2.2.4.2 Metabolic activity – ATP concentration  
 
The CellTiter-Glo® Luminescent Cell Viability Kit (Promega Corporation, Madison, 
WI, USA) indicates metabolic active cells by ATP quantification. Light and oxyluciferin 
are formed upon the mono-oxygenation of luciferin, which is catalyzed by Ultra-Glo™ 
Recombinant Luciferase in the presence of Mg2+, ATP and molecular oxygen. As 
stated in the enclosed protocol, kit reagents were mixed and added to the cells after 
irradiation (100% by volume). Following cell lysis, induced by shaking for 2 minutes, 
the luminescent signal was allowed to stabilize for 10 minutes at RT. Then, the 
contents of each well were transferred to a white, opaque-walled 96-well plate. With 
an integration time of 500 ms, luminescence was recorded using the Spark® 10M 
microplate reader. Read-outs were supposed to be directly proportional to the ATP 
amount present in culture, representing the count of viable and thus metabolic active 
cells. Background signals were identified by including wells containing only medium.  
 
2.2.4.3 Cell proliferation – Determination of cell cycle distribution  
 
Since the previously described methods depend on metabolic changes and thus only 
represent an indirect measure of proliferation, cell cycle distributions were analyzed 
using the FITC BrdU Flow Kit provided by BD Pharmingen™ (Heidelberg, Germany). 
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5-Bromo-2’-deoxyuridine (BrdU) represents a synthetic thymidine analogue, which is 
incorporated into newly synthesized DNA of cells entering and progressing through 
the S phase of the cell cycle. Therefore, combining immunofluorescent staining of 
BrdU with a total DNA stain allowed the enumeration and characterization of cells 
with respect to their cell cycle position. Following seeding and a 24-hour incubation, 
cells were synchronized by serum starvation (0% FCS) for another day. Afterwards, 
cells were resupplied with full culture medium, treated with blue light and labeled with 
1 mM BrdU for 24 hours at 37°C and 5% CO2, which was repeated for consecutive 
irradiations. At 24 hours after the last treatment, cells were harvested and stained 
according to the manufacturer’s protocol. First, with intermediate washing, NHDF 
cells were fixed and permeabilized in several steps performed on ice. Then, the cells 
were incubated with 300 µg/mL of DNAse for 1 hour at 37°C exposing incorporated 
BrdU. With further washing steps in between, BrdU was stained with fluorescein 
isothiocyanate (FITC)-conjugated antibodies for 20 minutes at RT. Finally, the cells 
were labeled with the total DNA stain 7-Aminoactinomycin D (7-AAD) enabling two-
color flow cytometry analyses using a BD FACSCanto™ II from BD Biosciences 
(Heidelberg, Germany). In total, 10,000 events were recorded for each sample and 
analyzed with the FlowJo software, version 2.5.1 (FlowJo LLC, Ashland, USA).  
 
2.2.4.4 Cell proliferation – DNA synthesis  
 
Similar to the FITC BrdU Flow Kit, the colorimetric Cell Proliferation ELISA from 
Roche Diagnostics (Mannheim, Germany) quantifies cell proliferation based on BrdU 
incorporation. At first, NHDF cells were synchronized by serum depletion (0% FCS) 
for 24 hours. Afterwards, cells were resupplied with full cell culture medium, treated 
with blue light and incubated with 10 µM BrdU for 24 hours at 37°C and 5% CO2, 
which was repeated for consecutive irradiations. At 24 hours after the last blue light 
treatment, the labeling medium was aspirated and cells were fixed for 30 minutes, 
while the DNA was denatured. This enabled an increased accessibility for the anti-
BrdU antibody, which was incubated for 90 minutes, while free, unbound antibodies 
were removed by three subsequent washing steps with 1x PBS. As the antibody was 
conjugated to peroxidase, tetramethyl-benzidine was added for 3 minutes. Then, the 
reaction was stopped with 1 M H2SO4. The Spark® 10M microplate reader was used 
to quantify immune complexes at 450 nm with a reference reading at 690 nm.  
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Thus, measured absorbance values correlated with the extent of BrdU incorporation 
into newly synthesized DNA, indicating changes in the number of actively replicating 
cells. For each test, two controls were included: (1) A blank without cells identifying 
unspecific binding of BrdU and the antibody to the plate and (2) a background control 
assessing unspecific binding of the antibody to cells in the absence of BrdU.  
 
2.2.4.5 Cell proliferation – Nuclei/Cell counting  
 
Besides experiments involving BrdU incorporation, cell counting was used to assess 
light-induced changes in cell proliferation. Instead of using the Luna™ automated cell 
counter yielding highly variable results, NHDF cells were labeled with a nucleic acid 
stain followed by immediate image acquisition of entire wells (Figure 17).  
 
 
 
Figure 17: Stitched fluorescent image acquired and processed using the inverted microscope Axio 
Observer.Z1 (Carl Zeiss Microscopy GmbH, Göttingen, Germany) showing stained nuclei of NHDF cells, 
which were segmented and counted using Fiji, an image processing package of ImageJ.  
 
Therefore, the green fluorescent, live cell-permeable CyQuant® Direct nucleic acid 
stain (Thermo Fisher Scientific, Eugene, OR, USA) was selected, which evaluates 
changes in cell proliferation and viability based on DNA content and membrane 
integrity. At 24 hours after blue light treatment, the nucleic acid stain was mixed with 
a background suppression dye (1:5) using full cell culture medium, added to the cells 
(100% by volume) and incubated for 60 minutes at 37°C and 5% CO2. Using the 
inverted fluorescence microscope Axio Observer.Z1 (Carl Zeiss Microscopy GmbH, 
Göttingen, Germany), 6 wells per condition, treated and untreated, were imaged with 
the GFP filter set (λEx = 489 nm/ λEm = 519 nm), accounting for 1,900 tiles per plate.  
Material and Methods 
29 
After stitching individual tiles with the ZEN 2 pro software, single-color fluorescence 
images were evaluated with a macro written in Fiji analyzing several parameters of 
single particles, respectively cell nuclei. Subsequent to contrast enhancement and 
background subtraction, images were converted into binary masks and holes were 
filled. Using a watershed algorithm, individual cell nuclei were segmented based on 
minimum and maximum threshold values (Figure 17). Besides total cell nuclei counts, 
the area (in pixels) and shape of single particles were analyzed. Finally, processed 
images and corresponding results were saved automatically (.jpeg and .txt format).  
 
2.2.5 Functional assays  
 
Since photosensitization processes activated by blue light are said to occur mainly in 
mitochondria, cell metabolism tests were substantiated with assays further studying 
mitochondrial function. Furthermore, cell viability was determined following different 
doses of blue light irradiation.  
 
2.2.5.1 Mitochondrial function – Generation of hydrogen peroxide (H2O2)  
 
The generation of H2O2 induced by blue light irradiation was assessed using the 
Amplex® UltraRed Reagent (AUR) from Molecular Probes™ (Life Technologies™ by 
Thermo Fisher Scientific, Carlsbad, CA, USA). It represents a fluorogenic substrate 
for horseradish peroxidase (HRP) reacting with H2O2 in a stoichiometric ratio of 1:1, 
which forms brightly fluorescent Amplex® UltroxRed. After light treatment, a solution 
of 100 µM AUR and 0.2 U/mL HRP was prepared with a 0.1 M potassium phosphate 
buffer (pH 6.0) and added to the cells (100% by volume) for 20 minutes in the dark at 
RT. Several controls were included identifying unspecific signals (Table 8). 
 
Table 8: Amplex® UltraRed assay – Selected controls identifying non-specific fluorescence signals. 
 Medium Cells Irradiation AUR 
Control 1 ✓ X X X 
Control 2 ✓ X ✓ X 
Control 3 ✓ X X ✓ 
Control 4 ✓ X ✓ ✓ 
Control 5 ✓ ✓ X X 
Control 6 ✓ ✓ ✓ X 
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The Spark® 10M microplate reader was used to read-out fluorescence signals from 
the bottom at λEx = 490 nm/ λEm = 581 nm. 
 
2.2.5.2 Mitochondrial function – Mitochondrial membrane potential ΔΨm 
 
Changes in the mitochondrial membrane potential (ΔΨm) were quantified using the 
cell membrane-permeable cationic dye tetramethylrhodamine ethyl ester perchlorate 
(TMRE). Upon its addition, TMRE accumulates in active mitochondria of living cells 
and indicates them by an orange fluorescent signal at λEx = 550 nm/ λEm = 575 nm. 
Consequently, cells showing a decrease of ΔΨm due to mitochondrial depolarization 
or inactivation are characterized by less TMRE accumulation. After light treatment, 
NHDF cells were incubated with a 200 nM TMRE labeling solution for 20 minutes at 
37°C and 5% CO2. Following three washing steps, cells were kept in 1x PBS for later 
analyses using the Spark® 10M microplate reader and the fluorescence microscope 
Axio Observer.Z1. Prior to TMRE labeling of cells, controls were treated with 50 µM 
of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) for 15 minutes at 37°C and 
5% CO2. The ionophore blocks the formation of an electrochemical proton gradient 
and thus uncouples oxidative phosphorylation, which finally leads to ΔΨm disruption.  
 
2.2.5.3 Cell viability – Flow cytometry analysis  
 
To assess whether blue light treatment induces cell death, the supernatant of treated 
and untreated cells was collected at 24 hours after irradiation. Remaining adherent 
cells were harvested by trypsinization and combined with the respective supernatants 
collected before. Viable (negative) and dead (positive) control samples were obtained 
according to the same procedure. Cytotoxicity was induced with 1 µM staurosporine 
(Streptomyces staurosporeus by Sigma Aldrich, St. Louis, MO, USA), which was 
incubated for 24 hours at 37°C and 5% CO2 prior to cell harvesting. The samples 
were centrifuged (2,000×g, 3 minutes, RT) and supernatants were discarded. First, 
the negative control was washed with a Hank’s Balanced Salt Solution including 2% 
FCS, 2 mM EDTA as well as 10 mM HEPES (Staining buffer (SB)). After a second 
centrifugation (2,000×g, 3 minutes, RT), NHDF cells were dissolved in 500 µL of SB 
in order to pre-adjust the flow cytometer BD FACSCanto™ II (Heidelberg, Germany) 
by defining appropriate voltage settings for the required fluorescence channels. 
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Table 9 shows that light-treated, untreated and dead cell populations were, according 
to the number of tests, dissolved using different SB volumes. Then, 200 µL of each 
sample was added to one well of a 96-well plate with U-bottom, which was thereafter 
centrifuged (2,000×g, 3 minutes, RT). The supernatant was discarded, while the 
samples were washed with 200 µL SB each and centrifuged again. Adding 100 µL of 
Annexin Binding Buffer (ABB), samples were either single stained, double stained or 
left unstained in order to identify autofluorescence (Table 9). Annexin V (BioLegend, 
San Diego, CA, USA), which was conjugated to the fluorophore allophycocyanin (AV-
APC), and Propidium Iodide (PI) (Invitrogen™, Life Technologies™ by Thermo Fisher 
Scientific, Carlsbad, CA, USA) were used to mark apoptotic and necrotic cells. With 
3 µL and 2 µL respectively, both stains were added and incubated simultaneously for 
15 minutes in the dark at RT. Finally, 100 µL of ABB was added and cell viability was 
examined using the pre-adjusted BD FACSCanto™ II. In total, 20,000 events were 
recorded per sample and analyzed with the FlowJo software, version 2.5.1. 
 
Table 9: Cell viability testing using flow cytometry – Summary of test conditions including the negative 
control, the positive control as well as untreated and light-treated samples. Besides the staining buffer 
volume, in which the cells were dissolved, the resulting sample number and type of stainings are indicated.  
 Test condition Buffer volume [µL] Sample Staining 
1 Negative control 500 1 Unstained 
2 
Positive control 
(Staurosporine-treated) 
800 
1 Unstained 
2 Single stained: AV-APC+ 
3 Single stained: PI+ 
4 Double stained: AV-APC+/PI+ 
3 Test samples (Blue Light) 400 
1 Unstained 
2 Double stained: AV-APC+/PI+ 
4 Test samples (No Light) 400 
1 Unstained 
2 Double stained: AV-APC+/PI+ 
 
2.2.6 Gene expression analysis  
 
2.2.6.1 RNA isolation  
 
At different time points after irradiation, NHDF cells were harvested and lysed with 
TRIzol (Ambion®, Life Technologies™ by Thermo Fisher Scientific, Carlsbad, CA, 
USA). Lysates of untreated and blue light-treated cells were pooled from 15 wells of a 
96-well plate (Figure 12), with three replicates each, and shortly after stored at -80°C.  
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To isolate the RNA, 200 µL of chloroform was added for 1 mL TRIzol and incubated 
for 3 minutes at RT. Then, the samples were vortexed and centrifuged (12,000×g, 
15 minutes, 4°C) yielding three different phases: a lower organic phase with proteins 
and lipids, an interphase with DNA and an upper aqueous phase containing the 
desired RNA. The upper phase was transferred to a new tube and precipitated by the 
addition of 500 µL isopropanol for 1 mL TRIzol. Afterwards, the tubes were inverted, 
incubated for 10 minutes at RT and centrifuged (12,000xg, 10 minutes, 4°C). The 
supernatant was discarded and two washing steps followed adding 1 mL of 80% 
ethanol each. After centrifugation (12,000×g, 5 minutes, 4°C), the RNA pellet was air-
dried and dissolved in 20 µL of RNAse-free water.  
 
2.2.6.2 RNA quantification and quality control  
 
Extracted RNA was quantified by spectrophotometric analysis using the Spark® 10M 
microplate reader. In addition to the concentration, RNA purity was determined by 
measuring the absorbance ratio at A260/280 with acceptable values of 1.7 – 2.1. 
Moreover, the RNA integrity was assessed by capillary electrophoresis on an Agilent 
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) revealing the RNA 
Integrity Number (RIN), with RIN > 7 indicating sufficient RNA quality. Following the 
standard labeling protocol from Affymetrix, a total amount of 100 ng RNA was used to 
prepare biotinylated antisense cDNA using the GeneChip® WT Plus Reagent Kit and 
the GeneChip® Hybridization, Wash and Stain Kit (both kits from Thermo Fisher 
Scientific, Waltham, MA, USA). Then, using a GeneChip Hybridization Oven 640, 
fragmented and labeled cDNA was hybridized into Affymetrix HuGene-2_0-st 
microarrays for 16 hours at 45°C. Finally, the arrays were dyed and washed on a 
GeneChip Fluidics Station 450 and scanned with a GeneChip Scanner 3000. All 
equipment was provided by Affymetrix UK Ltd. (High Wycombe, UK).  
 
For bioinformatic evaluation of microarray data, a Custom CDF, version 21, including 
ENTREZ based gene definitions was used for annotation97. Fluorescence intensity 
values were processed by quantile normalization and Robust Multi-Array Average 
(RMA) background correction. Using the commercial software package JMP10® 
Genomics, version 7.1 (SAS, SAS Institute Inc., Cary, NC, USA), one-way analysis of 
variance (ANOVA) was performed to identify differentially expressed genes.  
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Corresponding plots like 3D scatter plots, correlation heat maps and Venn diagrams 
were prepared with JMP10® Genomics, version 7.1. Gene Set Enrichment Analysis 
(GSEA) was performed to determine whether defined lists or sets of genes exhibited 
a statistically significant bias in their distribution within a ranked gene list using the 
software GSEA (see http://www.broadinstitute.org/gsea/)98. With the public external 
database Kyoto Encyclopedia of Genes and Genomes (KEGG), which combines 
expression patterns of selected genes, differentially regulated pathways for various 
cell functions were obtained. The latter are grouped in seven main categories, which 
are further classified into subcategories (https://www.genome.jp/kegg/pathway.html). 
Whereas pathway analysis was considered significant at a nominal p-value of < 0.05, 
statistical significance for differentially expressed genes was specified at a false 
discovery rate (FDR) of < 0.05 corresponding to the adjusted p-value (q-value). 
 
2.2.7 Statistical analysis  
 
Depending on the type and size of data sets, numerical data were either represented 
as points showing means ± standard deviation (SD) or box-and-whisker plots. For the 
latter, the lower quartile (1st quartile) and upper quartile (3rd quartile) were depicted 
with their difference specified as the interquartile range (IQR). The whiskers were set 
at the 3rd quartile +1.5 (IQR) for the maximum and at the 1st quartile -1.5 (IQR) for the 
minimum. In addition, the median was represented as a white band in the middle of 
the boxes. Fold changes were obtained by normalizing the data to time-matched, 
non-irradiated controls. Statistical analyses were performed using JMP® Genomics, 
version 7.1. After confirming a normal data distribution (Shapiro-Wilk normality test), 
one-way ANOVA and a Student’s t-test for pairwise comparisons were applied. If the 
null hypothesis H0 assuming a normal data distribution was rejected, nonparametric 
statistics were employed using the Wilcoxon test for pairwise comparisons. For all 
statistical tests, differences were considered statistically significant at a false positive 
rate of α = 0.05. Unless otherwise specified, the number of repetitions and replicates 
performed for each test method is indicated as follows: N (# repetitions, # replicates).  
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3 RESULTS 
3.1 BioLight LED Lamp  
3.1.1 Temperature measurements  
In order to exclude biological effects induced by high temperatures during irradiation, 
thermal changes of the cell culture medium were monitored during continuous blue 
light treatment. After stabilizing the measuring system with a pre-run of 15 minutes at 
RT, a thermocouple (type K) was placed into one of the inner wells of a pre-warmed 
black 96-well plate, which was filled with 100 µL of medium. At the same time, blue 
light irradiation was started for 120 minutes. Initially, a fast temperature rise was 
observed since the 96-well plate was directly taken from the incubator. However, in 
the following time course, the temperature remained constant in a range between 
32°C to 35°C (Figure 18). As NHDF cells were cultivated in a humidified atmosphere 
at 37°C, light-generated heat stress could be excluded. Therefore, biological effects 
shown below were caused by blue light treatment instead of thermal (de-)activation.  
 
 
 
Figure 18: Temperature measurements performed during 120 minutes of continuous blue light irradiation 
using the BioLight LED Lamp from Philips Research (Eindhoven, Netherlands). First, the measurement was 
started with a pre-run of 15 minutes without irradiation at RT in order to stabilize the system. Afterwards, a 
thermocouple (type K) was placed into one of the inner wells of a pre-warmed black 96-well plate, which was filled 
with 100 µL of cell culture medium, and the irradiation was started for 120 minutes. Experiments were performed 
in three independent test runs (N = 3 repetitions). 
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3.1.2 Cell metabolism assays  
 
At first, changes in the metabolism of NHDF cells following blue light irradiation were 
determined based on the activity of mitochondrial enzymes and the quantification of 
ATP present in cell culture.  
 
3.1.2.1 Assessment of XTT linearity revealed an optimal incubation time of 1 hour 
 
Since the color change, XTT undergoes upon reduction by viable cells, and thus the 
resulting absorbance read-out increases over time, the optimal incubation time had to 
be determined in order to verify signal linearity. For this purpose, a range of different 
NHDF cell numbers including 1,500; 1,750; 2,000; 2,500; 4,000; 5,000; 6,000; 7,500; 
7,750 and 8,000 cells/well was seeded into black 96-well plates. At 48 hours after 
seeding, imitating an experiment duration of three days, activated XTT was added 
and incubated for 30 minutes up to 2.5 hours (Figure 19).  
 
Figure 19 shows a linear increase in absorbance values, which directly correlate to 
an increasing number of viable and metabolic active cells as well as to a longer 
incubation time of activated XTT. With R2 = 0.98, which indicates the goodness-of-fit 
of linear regression, excellent linearity was obtained for incubation times ranging from 
1 hour to 2 hours. In contrast, a shorter (30 minutes) or longer (2.5 hours) incubation 
period showed lower R2 values. Especially for an incubation time of 2.5 hours, 
absorbance values for higher plated cell numbers, particularly from 4,000 cells/well 
on, reached a plateau, recommending a shorter incubation time of XTT (Figure 19). 
Nevertheless, the signal seemed to be proportional over a wide range of different cell 
numbers and incubation times, demonstrating that the XTT assay provided a reliable 
quantification of viable and metabolic active cells in unknown samples.  
 
Although the Spark® 10M microplate reader from Tecan Austria GmbH (Grödig, 
Austria) is said to provide signal linearity for optical densities from 0 – 3 OD, an 
incubation time of activated XTT for 1 hour was chosen, showing about 0.7 – 0.8 AU 
for a seeded cell number of 5,000 cells/well (Figure 19). While meeting the Lambert-
Beer law, this cell number yielded about 80% confluence on the third culture day in 
96-well plates, excluding any impact of contact inhibition on cellular activity.  
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Figure 19: XTT results for varying NHDF cell concentrations seeded into black 96-well plates (1,500; 
1,750; 2,000; 2,500; 4,000; 5,000; 6,000; 7,500; 7,750 and 8,000 cells/well) and different XTT incubation 
times of 30 minutes, 1 hour, 1.5 hour, 2 hours and 2.5 hours (N = 1 repetition, 3 replicates). Linear 
relationships between increasing absorbance values, cell numbers and XTT incubation times were verified by R
2
. 
 
3.1.2.2 Different blue light irradiation times showed a biphasic dose-response curve 
of cellular metabolism  
 
First, NHDF cells were exposed to different irradiation times or respectively doses of 
blue light (Table 7), while the XTT assay was constantly performed at 24 hours after 
continuous irradiation. For lower light doses (< 9.0 J/cm2), the mitochondrial activity 
was slightly increased with a maximum effect of 7.10% (p<0.0001) after blue light 
treatment with 5.4 J/cm2. However, exposing the cells to higher blue light doses and 
respectively longer irradiation times, an inflection point to inhibitory effects was found 
after 10.8 J/cm2 of blue light, corresponding to 15 minutes of irradiation. With an 
attenuation by 25.09% (p<0.0001) in comparison to the non-irradiated control, the 
metabolic activity of NHDF cells was constantly decreasing up to a mid irradiation 
dose of 21.6 J/cm2. For subsequent, even higher, doses (> 21.6 J/cm2), the inhibition 
of cellular activity was further enhanced by 6.04% (p<0.0001) following blue light 
irradiation using 86.4 J/cm2 (Figure 20). Therefore, blue light-triggered changes in 
cell metabolism were characterized by a biphasic dose-response curve showing an 
accelerated metabolic activity after lower blue light doses (< 10.8 J/cm2), whereas 
cell activity was slowed down using higher irradiation doses (> 10.8 J/cm2).  
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Figure 20: Changes in the metabolic activity of NHDF cells following different blue light doses with a 
constant time point of XTT testing at 24 hours after irradiation. Single blue light treatments were performed in 
continuous mode. Fold changes were evaluated versus time-matched, non-irradiated controls. Data are 
presented as box plots with means displayed as + (N = 3 repetitions, 3 replicates). Corresponding statistics are 
summarized in Table 17 (Appendix).  
 
To study both, stimulatory and inhibitory light effects, blue light doses of 5.4 J/cm2 
and 21.6 J/cm2 were chosen for subsequent analyses investigating cellular processes 
following either single or multiple light treatments.  
 
3.1.2.3 Changes in metabolic activity after single blue light treatments with 5.4 J/cm2 
and 21.6 J/cm2 were time-dependent 
 
Furthermore, changes in the mitochondrial activity of NHDF cells were assessed at 
different time points after continuous exposure to either 5.4 J/cm2 or 21.6 J/cm2 of 
blue light (Figure 21). In direct comparison to the non-irradiated control, light-treated 
cells showed an increased metabolic activity by 6.09% (p<0.0001) at 1 hour following 
5.4 J/cm2 of blue light, which slowly attenuated within the next 11 hours. During this 
time period, a significant difference of 2.39% (p<0.0001) was observed at 3 hours 
after irradiation, while no significant effects were found after 6 hours with 0.24% 
(p=0.5560) and after 12 hours with 0.17% (p=0.2366).  
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Nonetheless, a second increase in cellular metabolism of NHDF cells was present at 
24 hours (6.86%, p<0.0001), which corresponds to the time-matched result depicted 
in Figure 20. In the further time course, mitochondrial activity decreased down to 
2.42% (p<0.0001) at 48 hours after irradiation reaching a non-significant difference of 
0.26% (p=0.4001) after 72 hours (Figure 21).  
 
 
 
Figure 21: Changes in the metabolic activity of NHDF cells at different time points following a single blue 
light exposure to either 5.4 J/cm
2
 or 21.6 J/cm
2
. Blue light treatments were performed in continuous mode. 
Fold changes were evaluated versus time-matched, non-irradiated controls. Data are presented as mean ± SD 
(N = 3 repetitions, 3 replicates). Corresponding statistics are summarized in Table 18 (Appendix).  
  
When using a higher irradiation dose of 21.6 J/cm2, changes in cellular metabolism 
showed a delayed onset, which started to be significantly different after 6 hours with 
a decrease by 6.53% (p<0.0001). Subsequently, a continuous decline in cell activity 
was noted with 16.62% (p<0.0001) less active cells after 12 hours. With a reduction 
by 25.31% (p<0.0001), the inhibition of metabolic activity was even more enhanced 
after 24 hours. This finding was in line with the outcome obtained for the first set of 
experiments (25.09% (p<0.0001)), in which cell metabolism was tested at 24 hours 
following different doses of continuous blue light treatment (Figure 20). Nevertheless, 
in the course of progressing metabolic inhibition, NHDF cells were able to recover 
already at 48 hours after light exposure, which was similar to the trend seen for the 
lower blue light dose of 5.4 J/cm2 (Figure 21).  
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3.1.2.4 Consecutive single irradiations of 21.6 J/cm2 enhanced metabolic inhibition, 
while multiple treatments with 5.4 J/cm2 did not increase cell stimulation 
 
Subsequent to studies testing blue light effects on cell metabolism at various time 
points after single irradiations with different doses, NHDF cells were treated multiple 
times. To test whether the differential effects of 5.4 J/cm2 and 21.6 J/cm2 could be 
maintained or even enhanced, consecutive blue light irradiations were performed 
every 24 hours, applying both blue light doses in separate experiments. The XTT test 
was performed at 24 hours after the last blue light treatment. For this purpose, the 
seeded cell number was adjusted preventing the occurrence of cell confluency and 
therefore contact inhibition since metabolic activity greatly varies with cell density. At 
the same time, the increasing cell density limited the experimental duration to five 
days allowing three days of blue light irradiation with 24-hour time intervals.  
 
Treating NHDF cells twice using a single irradiation dose of 5.4 J/cm2 each (2x (24), 
10.8 J/cm2) could not enhance the stimulatory effect on cellular metabolism found at 
24 hours after a single light treatment (0.30%, p=0.5359). However, the acceleration 
of mitochondrial activity following a single irradiation was reproducible in comparison 
to the outcomes depicted in Figure 20 and Figure 21. Compared to one irradiation 
(1x (24)), three consecutive light treatments (3x (24), 16.2 J/cm2) slightly decreased 
the metabolic activity of NHDF cells by 1.89% (p<0.0001) (Figure 22).  
 
In contrast, a second irradiation with the higher blue light dose of 21.6 J/cm2 (2x (24), 
43.2 J/cm2) revealed an even stronger decrease in mitochondrial activity (Figure 22). 
Numerically speaking, the difference between a two-fold irradiation returning a 
decrease by 35.69% compared to a reduction of metabolically active cells by 25.54% 
after one treatment resembled to approximately 10% (p<0.0001). Again, the latter 
outcome confirmed the effects previously found (Figure 20, Figure 21). Moreover, it 
was possible to maintain the inhibitory effect, which was lost at 48 hours following a 
single blue light treatment (Figure 21). However, the difference between two (2x (24), 
43.2 J/cm2) and three consecutive blue light treatments (3x (24), 64.8 J/cm2) was not 
significant (p=0.9727) (Figure 22). 
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Figure 22: Changes in the metabolic activity of NHDF cells following single (1x (24)) and consecutive 
(2x (24), 3x (24)) treatments with either 5.4 J/cm
2
 or 21.6 J/cm
2
 of blue light. Consecutive irradiations were 
performed every 24 hours in continuous mode. XTT tests were carried out at 24 hours after the last light 
treatment. Fold changes were evaluated versus time-matched, non-irradiated controls. Data are presented as 
mean ± SD (N = 3 repetitions, 3 replicates). Corresponding statistics are summarized in Table 19 (Appendix).  
 
3.1.2.5 Multiple daily treatments with 5.4 J/cm2 of blue light enhanced the stimulatory 
effect on cell metabolism  
 
Since the metabolic stimulation of NHDF cells could not be enhanced with single 
irradiations of 5.4 J/cm2 over consecutive days, two and three daily exposures were 
performed with 3-hour time intervals. The XTT test was carried out at 24 hours after 
the last irradiation. Compared to a single irradiation per day (1x), two irradiations (2x) 
revealed a continuous increase in cell metabolism. While the respective differences 
on the first (3.76%, p<0.0001) and second day of irradiation (2.13%, p<0.0001) were 
hardly distinct, a significant difference of 9.71% (p<0.0001) was reached after the 
third treatment day (differences between single groups were evaluated with the non-
parametric Wilcoxon method). Thus, compared to the control, two irradiations per day 
showed the highest effect of 14.88% (p<0.0001) following three consecutive days of 
blue light treatment. In contrast, three irradiations per day (3x) reduced the metabolic 
activity by 17.10% (p<0.0001) already after the first treatment day.  
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However, mitochondrial activity seemed to recover slowly decreasing the difference 
to the first day of irradiation by 6.16% (p<0.0001) on day 2 and by additional 2.86% 
(p<0.0001) on day 3 (Figure 23). 
 
 
 
 
Figure 23: Changes in the metabolic activity of NHDF cells following single (1x) and multiple blue light 
treatments (2x, 3x) of 5.4 J/cm
2
 per day with a time interval of 3 hours in between. Irradiations were 
performed in continuous mode. XTT tests were carried out at 24 hours after the last light treatment. Fold changes 
were evaluated versus time-matched, non-irradiated controls. Data are presented as mean ± SD (N = 
3 repetitions, 3 replicates). Corresponding statistics are summarized in Table 20 (Appendix). 
 
3.1.2.6 Energy metabolism increased using an irradiation dose of 5.4 J/cm2, while 
21.6 J/cm2 of blue light decreased the ATP concentration 
 
The amount of viable and metabolic active cells was further determined based on 
cellular ATP quantification. As changes in ATP levels represent a fast response, the 
assay was performed at different time points following single irradiations with either 
5.4 J/cm2 or 21.6 J/cm2 of blue light. As shown in Figure 24, at 30 minutes after 
irradiation, the energy metabolism of NHDF cells slightly decreased with significant 
differences of 1.58% (p=0.0169) for 5.4 J/cm2 and 3.29% (p<0.0001) for 21.6 J/cm2 of 
blue light. However, in comparison to the untreated controls, the ATP levels found at 
1 hour following light exposure were contrasting for both irradiation doses.  
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While it increased to 3.20% (p<0.0001) after 5.4 J/cm2 of blue light, the higher dose 
led to a reduction by additional 1.19% (p=0.0055) (Figure 24). Then, both curves 
converged each other reaching a difference of 2.88% (p<0.0001) at 6 hours after 
irradiation. Subsequently, the effect for 21.6 J/cm2 of blue light remained constant 
within the next 18 hours (0.25%, p=0.6599), while another peak of 4.69% (p<0.0001) 
was present at 24 hours following irradiation with 5.4 J/cm2, which indicated a higher 
ATP concentration compared to the control (Figure 24).  
 
 
 
Figure 24: Changes in the ATP concentration of NHDF cells present at different time points following a 
single blue light exposure to either 5.4 J/cm
2
 or 21.6 J/cm
2
. Blue light treatments were performed in 
continuous mode. Fold changes were evaluated versus time-matched, non-irradiated controls. Data are 
presented as mean ± SD (N = 3 repetitions, 3 replicates). Corresponding statistics are summarized in Table 21 
(Appendix). 
 
3.1.3 Cell proliferation assays  
 
Since the colorimetric XTT Cell Viability Kit and the luminescent ATP Cell Viability 
Assay evaluate changes in cell metabolism, they only represent an indirect measure 
of cell proliferation. Consequently, proliferation rates may not be reflected accurately. 
Therefore, various strategies were used to quantify proliferative activity of NHDF cells 
following blue light irradiation with different doses, involving analyses of cell cycle 
distribution, DNA synthesis and cell count.  
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3.1.3.1 Consecutive irradiations using a blue light dose of 5.4 J/cm2 each led to an 
accumulation of S-phase cells, while multiple treatments with 21.6 J/cm2 of 
blue light increased the amount of G0/G1-phase and G2/M-phase cells 
 
The first experimental approach chosen was based on the determination of cell cycle 
distribution following single and consecutive irradiations with flow cytometry analysis. 
The proportion of NHDF cells in each cell cycle phase was quantified by staining their 
total DNA content with 7-AAD and combining it with an immunofluorescent staining of 
BrdU, detecting active DNA synthesis. Thus, cell populations staying in different cell 
cycle phases could be clearly differentiated depending on their staining intensities. 
Figure 25 shows representative density plots with the populations of interest being 
marked in terms of their cell cycle position – Region 1: Sub-G0/G1 phase, Region 2: 
G0/G1 phase, Region 3: early and late S phase as well as Region 4: G2/M phase.  
  
 
 
Figure 25: Representative pseudocolor density plots of NHDF cells stained by the total DNA dye 7-AAD 
and an anti-BrdU antibody, conjugated to FITC. In each plot 8,000 events are depicted.  
 
Cell populations showing 7-AAD fluorescence intensities in the range of ~100 – 150 
exhibited low DNA contents, with R2 representing cells in the G0/G1 phase, while 
cells in R3 could be assigned to the early S phase, since they were positive for BrdU. 
Equally, cells with higher DNA contents either stayed in the late S phase (R3, BrdU+) 
or the G2/M phase (R4, BrdU-). R1, specified at 7-AAD fluorescence intensities < 50, 
identified apoptotic, fragmented cells characterized by degraded DNA (Figure 25). 
After synchronization, cells were resupplied with full medium and treated with single 
or consecutive irradiations of 5.4 J/cm2 and 21.6 J/cm2, followed by BrdU addition. 
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The staining protocol was started at 24 hours after the last light treatment. For both 
doses, time-matched controls showed a similar cell cycle distribution with ~ 4.67% in 
Sub-G0/G1, ~ 25.90% in G0/G1, ~ 66.55% in S and ~ 2.52% in G2/M (Figure 26).  
 
 
 
Figure 26: Changes in the cell cycle distribution of NHDF cells following single (1x (24)) and consecutive 
(2x (24), 3x (24)) treatments with either 5.4 J/cm
2
 or 21.6 J/cm
2
 of blue light. Consecutive irradiations were 
performed every 24 hours in continuous mode. Flow cytometry analyses were carried out at 24 hours after the 
last light treatment and subsequent addition of BrdU. Bars display mean values ± SD (N = 3 repetitions, 
3 replicates). Corresponding statistics for each cell cycle phase are summarized in Table 22 (Appendix). 
 
A single treatment with 5.4 J/cm2 of blue light elevated the number of S-phase cells 
by 5.20% (p=0.0017) accompanied by a decrease of G0/G1-phase cells by 6.00% 
(p<0.0001). This effect was slightly enhanced with a second irradiation on the next 
day, with 75.10% of the entire cell population showing an active DNA replication, 
while 14.70% of NHDF cells stayed in G0/G1. However, three exposures reset the 
cell cycle distribution close to control values along with an increase of the Sub-G0/G1 
phase to 8.02% and the G2/M proportion to 8.51%. In contrast, consecutive blue light 
irradiations with 21.6 J/cm2 each led to a continuous decrease of NHDF cells present 
in the S phase from 66.30% after a single light exposure down to 34.70% (p<0.0001) 
following three irradiations. The reduction in S-phase cells after one irradiation was 
accompanied by an increase of the G0/G1 phase by 8.20% (p<0.0001), which was 
not enhanced with additional light treatments. In contrast, two (2x (24), 43.2 J/cm2) 
and three (3x (24), 64.8 J/cm2) irradiations showed a higher frequency of cells 
staying in Sub-G0/G1 and G2/M (Figure 26). 
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3.1.3.2 Two consecutive blue light irradiations using 5.4 J/cm2 each stimulated DNA 
replication, whereas proliferation was blocked with 21.6 J/cm2 of blue light 
 
Besides flow cytometry analyses, a colorimetric ELISA based on BrdU incorporation 
was performed in order to confirm changes in the number of actively replicating cells 
following blue light treatment. After synchronization by serum starvation, NHDF cells 
were resupplied with full cell culture medium and treated with single or consecutive 
irradiations of 5.4 J/cm2 and 21.6 J/cm2, while multiple treatments were performed 
every 24 hours. The ELISA was carried out at 24 hours after the last irradiation and 
subsequent addition of BrdU. Compared to the untreated control, DNA synthesis 
increased by 3.34% (p=0.0007) following one irradiation with 5.4 J/cm2 of blue light 
(1x (24)). This effect was enhanced to 5.40% (p<0.0001) with two consecutive light 
treatments accounting for 10.8 J/cm2 (2x (24)), whereas a third irradiation, yielding a 
dosage of 16.2 J/cm2 (3x (24)), led to a reduction by 3.36% (p=0.0073) (Figure 27).  
 
 
 
Figure 27: Changes in the DNA synthesis of NHDF cells following single (1x (24)) and consecutive 
(2x (24), 3x (24)) treatments with either 5.4 J/cm
2
 or 21.6 J/cm
2
 of blue light. Consecutive irradiations were 
performed every 24 hours in continuous mode. BrdU-ELISAs were carried out at 24 hours after the last light 
treatment and subsequent addition of BrdU. Fold changes were evaluated versus time-matched, non-irradiated 
controls. Data are presented as mean ± SD (N = 3 repetitions, 3 replicates). Corresponding statistics are 
summarized in Table 23 (Appendix). 
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When exposing NHDF cells to the higher blue light dose of 21.6 J/cm2, active DNA 
synthesis was reduced down to 92.32% (p<0.0001) following a single light treatment 
(1x (24)). After two treatments (2x (24)), accounting for a total dosage of 43.2 J/cm2, 
it was further blocked by another 3.73% (p=0.0197). Moreover, three irradiations 
(3x (24), 64.8 J/cm2) decreased BrdU incorporation by actively replicating cells to 
78.49% (p<0.0001) indicating an enhanced inhibition of cell proliferation (Figure 27).  
 
3.1.3.3 Blue light treatment with either 5.4 J/cm2 or 21.6 J/cm2 differentially 
modulated nuclei counts, respectively cell counts, and nuclei sizes  
 
In addition to experiments involving BrdU incorporation to evaluate DNA synthesis, 
stained nuclei of living cells were counted after single and consecutive treatments 
with either 5.4 J/cm2 or 21.6 J/cm2 of blue light. At 24 hours after the last irradiation, 
cell nuclei were stained with the fluorescent dye CyQuant® in order to assess 
changes in total cell numbers and therefore proliferation. Analyzing the acquired 
fluorescence images with a macro written in Fiji, nuclei counts were evaluated for 
entire wells representing a measure for the total cell count. In addition, the area of 
single nuclei and different shape descriptors were determined.  
 
Treating NHDF cells either once or twice with 5.4 J/cm2 of blue light led to increased 
cell counts compared to the control. Numerically speaking, 1.99% (p<0.0001) more 
cells were found following a single irradiation (1x (24)), which was enhanced up to 
8.39% (p<0.0001) following two treatments performed on consecutive days (2x (24), 
10.8 J/cm2). However, three light treatments (3x (24), 16.2 J/cm2) revealed a reduced 
cell count by 5.94% (p<0.0001) compared to the non-irradiated control (Figure 28). In 
contrast, with a single blue light irradiation using 21.6 J/cm2 (1x (24)), the cell count 
decreased by 6.59% (p<0.0001) intensifying to 10.89% (p<0.0001) less cells after 
two light treatments (2x (24), 43.2 J/cm2). A third irradiation (3x (24)), yielding a total 
dosage of 64.8 J/cm2, showed a reduced cell count by 32.51% (p<0.0001) revealing 
a stronger inhibition of cell proliferation with an increasing number of light treatments 
using 21.6 J/cm2 (Figure 28).  
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Figure 28: Changes in nuclei or respectively NHDF cell counts following single (1x (24)) and consecutive 
(2x (24), 3x (24)) treatments with either 5.4 J/cm
2
 or 21.6 J/cm
2
 of blue light. Consecutive irradiations were 
performed every 24 hours in continuous mode. Staining of cell nuclei was carried out at 24 hours after the last 
light treatment. Fold changes were evaluated versus time-matched, non-irradiated controls. Data are presented 
as mean ± SD (N = 4 repetitions, 3 replicates). Corresponding statistics are summarized in Table 24 (Appendix). 
 
In addition to the count, the area of single nuclei was analyzed. Figure 29 illustrates 
slight changes found after consecutive irradiations with single doses of 5.4 J/cm2 of 
blue light. With two light treatments (2x (24), 10.8 J/cm2), smaller nuclei sizes were 
indicated by a decrease of 2.01% (p=0.0005), while after three irradiations (3x (24), 
16.2 J/cm2) a minor trend to bigger cell nuclei was observed (1.57%, p=0.0047). In 
contrast, consecutive irradiations with 21.6 J/cm2 of blue light, which were performed 
every 24 hours, yielded more pronounced effects showing a continuous rise of nuclei 
sizes with an increasing dose. Whereas one (1x (24), 21.6 J/cm2) and two (2x (24), 
43.2 J/cm2) treatments revealed similar increases by 4.59% and 6.13% (p<0.0001), a 
third one (3x (24)), yielding a dosage of 64.8 J/cm2, increased the average size of cell 
nuclei by additional 5.19% adding up to 11.32% (p<0.0001) (Figure 29).  
 
The determination of different shape descriptors, like circularity, roundness as well as 
aspect ratio did not reveal statistically significant differences.  
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Figure 29: Changes in the average area of NHDF cell nuclei following single (1x (24)) and consecutive 
(2x (24), 3x (24)) treatments with either 5.4 J/cm
2
 or 21.6 J/cm
2
 of blue light. Consecutive irradiations were 
performed every 24 hours in continuous mode. Staining of cell nuclei was carried out at 24 hours after the last 
light treatment. Fold changes were evaluated versus time-matched, non-irradiated controls. Data are presented 
as mean ± SD (N = 4 repetitions, 3 replicates). Corresponding statistics are summarized in Table 25 (Appendix). 
 
3.1.4 Functional assays 
 
3.1.4.1 Blue light irradiation triggered immediate generation of H2O2  
 
The formation of ROS, which play a crucial role as second messengers in numerous 
signaling pathways, is known to be modulated by blue light irradiation. Since ROS 
production represents a fast response, the generation of H2O2 was investigated at 
different time points following single irradiations with 5.4 J/cm2 or 21.6 J/cm2 of blue 
light (Figure 30). Directly after irradiation, corresponding to 30 minutes due to the 
incubation time of Amplex® UltraRed, the fluorescent signal was highly elevated for 
both irradiation doses. Using 5.4 J/cm2, an initial rise in H2O2 by 193.26% (p<0.0001) 
was observed, whereas the level of H2O2 following the higher dose of 21.6 J/cm
2 was 
increased approximately two-fold by 114.49% (p<0.0001). However, increased H2O2 
concentrations were normalized to the control level within 1 hour following a single 
irradiation with 21.6 J/cm2 of blue light, while it took about 3 hours for the lower dose. 
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Figure 30: Changes in H2O2 levels of NHDF cells measured at different time points following a single blue 
light exposure to either 5.4 J/cm
2
 or 21.6 J/cm
2
. Blue light treatments were performed in continuous mode. 
Amplex® UltroxRed was excited at λEx = 490 nm, while its fluorescence emission was measured at λEm = 581 nm. 
Fold changes were evaluated versus time-matched, non-irradiated controls. Data are presented as mean ± SD 
(N = 3 repetitions, 3 replicates). Corresponding statistics are summarized in Table 26 (Appendix).  
 
In contrast, the formation of H2O2 was again elevated to 6.28% (p<0.0001) at 3 hours 
following irradiation with 21.6 J/cm2 of blue light. At 6 hours and 24 hours afterwards, 
the amount of H2O2 fluctuated in comparison to preceding time points. Numerically 
speaking, slight reductions in H2O2 concentrations by 3.28% (p=0.1243) for 5.4 J/cm
2 
and by 12.46% (p<0.0001) for 21.6 J/cm2 at 6 hours were turned back to respective 
increases by 17.76% (p<0.0001) and 18.45% (p<0.0001) at the last time point. Thus, 
NHDF cells seemed to balance sudden H2O2 bursts within 24 hours (Figure 30).  
 
3.1.4.2 TMRE staining revealed an impairment of mitochondrial function directly after 
blue light irradiation  
 
Since Figure 30 indicates a sharp rise in H2O2 shortly after irradiation of NHDF cells, 
the question was whether light-triggered ROS generation exceeds physiological 
levels, which in turn may impair mitochondrial function. Thus, ΔΨm was measured at 
different time points following single irradiations with 5.4 J/cm2 and 21.6 J/cm2 of blue 
light using the fluorescent probe TMRE, which concentrates in active mitochondria.  
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At 30 minutes after exposing NHDF cells to 21.6 J/cm2 of blue light, the fluorescence 
signal was significantly attenuated by 12.36% (p<0.0001), which demonstrated less 
accumulation of TMRE and therefore a higher number of depolarized mitochondria. 
In the further time course, the initial decrease slowly turned back to the control level 
with significant differences of 6.67% at 1 hour (p<0.0001) and 4.99% (p<0.0001) at 
3 hours after blue light treatment. Thereafter, the inhibitory effect on ΔΨm was 
balanced with non-significant changes by 1.10% (p=0.3604) at 6 hours and 1.14% 
(p=0.1222) at 24 hours (Figure 31).  
 
Following a single treatment with 5.4 J/cm2 of blue light, a similar trend was found at 
30 minutes after irradiation, except that the lower decrease in ΔΨm by 4.31% 
(p<0.0001) was compensated within 1 hour. At later time points, up to 24 hours, no 
significant differences were found compared to the untreated control (Figure 31). 
CCCP, an uncoupler of mitochondrial oxidative phosphorylation, suppressed TMRE 
staining intensities by 67.5% on average, which revealed not only a successful 
depolarization control, but also validated the staining characteristics of TMRE.  
 
 
 
Figure 31: Changes in the mitochondrial membrane potential ΔΨm of NHDF cells at different time points 
following a single blue light exposure to either 5.4 J/cm
2
 or 21.6 J/cm
2
. Blue light treatments were performed 
in continuous mode. TMRE was excited at λEx = 550 nm, while its fluorescence emission was measured at 
λEm = 580 nm. Fold changes were evaluated versus time-matched, non-irradiated controls. Data are presented as 
mean ± SD (N = 2 repetitions, 3 replicates). Corresponding statistics are summarized in Table 27 (Appendix). 
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In addition to spectrophotometric measurements, TMRE intensities were verified with 
fluorescence microscopy. Figure 32 displays exemplary images acquired immediately 
after microplate readings with (A) showing the positive control with ΔΨm disruption 
induced by CCCP as well as (B) the untreated sample and treated samples at (C) 
30 minutes and (D) 3 hours following irradiation with a blue light dose of 21.6 J/cm2. 
While the positive control showed low fluorescence intensities as a consequence of 
mitochondrial depolarization (Figure 32, (A)), the untreated control displayed brightly 
fluorescent cells with TMRE accumulated in active mitochondria (Figure 32, (B)). In 
contrast, blue light irradiation led to a reduction of the signal indicating changes of the 
mitochondrial polarization status. Viewing the corresponding images (Figure 32, (C) 
& (D)), a slight difference was observed, while the fluorescence intensity of TMRE 
seemed to be slightly higher at 3 hours following 21.6 J/cm2 of blue light.  
 
(A) (B) 
  
(C) (D) 
  
 
Figure 32: Representative fluorescence images showing the extent of TMRE accumulation in NHDF cells 
following different treatments. (A) The positive control sample, in which ΔΨm disruption was induced with 
50 µM of CCCP, (B) the untreated sample receiving no light and the treated sample at (C) 30 minutes and (D) 
3 hours after irradiation with 21.6 J/cm
2
 of blue light. 
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3.1.4.3 Single blue light treatments did not induce cell death up to an irradiation dose 
of 172.8 J/cm2 
 
To elucidate whether the found reductions in cellular activity and proliferation resulted 
from growth inhibition instead of cell death, flow cytometry analyses were performed 
at 24 hours following single blue light treatments. Besides using prechosen blue light 
doses of 5.4 J/cm2 and 21.6 J/cm2, NHDF cells were treated with up to 172.8 J/cm2 in 
order to guarantee safety of high-energy light treatments. For the positive control, 
cytotoxic effects were induced by exposing NHDF cells to 1 µM of staurosporine 
(Streptomyces staurospores), a non-selective protein kinase inhibitor, for 24 hours at 
37°C and 5% CO2. At different time points following staurosporine administration, 
respectively at 2 hours, 6 hours and 24 hours, cell morphology was documented by 
acquiring phase contrast images using an inverted Leica DM IRBE microscope (Leica 
Mikroskopie & Systeme GmbH, Wetzlar, Germany) (Figure 33, (B) – (D)). Already 
after 2 hours of incubation at 37°C and 5% CO2 (Figure 33, (B)), the apoptotic 
stimulus exerted by staurosporine revealed a remarkable induction of cell shrinkage 
compared to untreated control cells (Figure 33, (A)). In the following time course, cell 
shrinkage was enhanced (Figure 33, (C)), and finally, at 24 hours of incubation, a lot 
of NHDF cells were found to be detached from the adherent surface (Figure 33, (D)), 
showing a time-dependent cytotoxic effect.  
 
(A) (B) 
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Figure 33: NHDF morphology before treatment with staurosporine (A) and following incubation with 1 µM 
of staurosporine for (B) 2 hours, (C) 6 hours and (D) 24 hours. Images were acquired using an inverted Leica 
DM IRBE microscope (Leica Mikroskopie & Systeme GmbH, Wetzlar, Germany) in phase contrast with 5x 
magnification.  
 
Single cells were analyzed with respect to their scatter parameters and their light 
emission properties generated by two different fluorescent stains. The measurement 
of forward scatter (FSC) allowed to discriminate cell populations by size, whereas the 
intensity of side scatter (SSC) provided information about the granularity and thus 
internal complexity of cells. In contrast to living cells (Figure 34, (A)), dead cells were 
characterized by forward and side scatters of low intensities indicating smaller cell 
sizes and a lower degree of internal complexity or granularity (Figure 34, (B)).  
 
(A) (B) 
  
 
Figure 34: Representative pseudocolor density plots of NHDF cells either (A) untreated or (B) exposed to 
1 µM of staurosporine for 24 hours inducing cytotoxicity. In each plot 8,000 events are depicted. 
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In Figure 35 exemplary forward vs. side scatter plots are represented for untreated 
and treated fibroblasts, either irradiated with 5.4 J/cm2 or 21.6 J/cm2 of blue light, as 
well as for the respective positive controls. For a better comparison of the individual 
dot plots, overlays were compiled. Comparing the dot plots of untreated and treated 
cells with the ones for the positive control, they represented a rather healthy cell 
population with forward and side scatters of higher intensities. However, the 
difference between untreated and light-treated samples was negligible, since their 
measured scatter intensities were similar, which can be easily inferred from the 
overlays shown in Figure 35. This observation applied for both blue light doses. 
Therefore, the discrimination of dead and living NHDF cells based on their scatter 
parameters suggested that samples, treated with 5.4 J/cm2 and 21.6 J/cm2 of blue 
light, exhibited a similar amount of dead cells compared to untreated samples. 
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Figure 35: Representative two-parameter dot plots showing scatter parameters (forward scatter (FSC), side scatter (SSC)) of NHDF cells following different treatments. 
From left to right: The positive control sample, in which cytotoxicity was induced with 1 µM of staurosporine for 24 hours, the untreated sample receiving no light, the blue light-
treated sample and finally the overlay of all three conditions. Flow cytometry analysis was performed at 24 hours following staurosporine treatment of the positive control as well as 
continuous blue light treatment of irradiated samples with either 5.4 J/cm
2
 or 21.6 J/cm
2
. In each plot 8,000 events are depicted. 
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To mark apoptotic and necrotic cells, Allophycocyanin (APC)-conjugated Annexin V 
(AV-APC) and Propidium Iodide (PI) were chosen. Unstained samples were prepared 
to determine background autofluorescence in order to set appropriate PMT voltages 
and derive proper gating strategies (Figure 36, (A)). AV-APC identifies cells in which 
phosphatidylserine gets exposed at the outer leaflet of the plasma membrane, which 
is typical of early apoptotic cells (AV-APC+/PI-) shown in the lower right quadrant Q3 
of the dot plot (Figure 36, (B)). In contrast, necrotic cells are characterized by a loss 
of their membrane integrity resulting in an increased permeability. Therefore, the 
second stain PI, a fluorescent DNA intercalating dye, detects necrotic cells, which 
accumulate in the upper left quadrant Q1 of the plot (Figure 36, (C)). However, it has 
to be noted that AV-APC also binds to internal phosphatidylserine following complete 
cell rupture indicating late apoptotic/necrotic cells. Consequently, double labeling 
shows a complete representation of dead cells and allows the distinction of early 
apoptotic cells (AV-APC+/PI-) from necrotic cells (AV-APC+/PI+) (Figure 36, (D)).  
 
 
(A) Unstained (B) Single stained (AV-APC+) 
  
(C) Single stained (PI+) (D) Double stained (AV-APC+/PI+) 
  
 
Figure 36: Representative pseudocolor density plots of NHDF cells exposed to 1 µM of staurosporine for 
24 hours inducing cytotoxicity. (A) Unstained, (B) Single stained with AV-APC, (C) Single stained with PI and 
(D) Double stained with AV-APC and PI. In each plot 8,000 events are depicted.  
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In the following figures, representative two-parameter dot plots and single-parameter 
histograms are shown for double stained samples containing positive control cells as 
well as untreated and blue light-treated cells. Latter were either treated with a blue 
light dose of 5.4 J/cm2 depicted in Figure 37 or 21.6 J/cm2 displayed in Figure 38. For 
the positive control, fluorescence intensities of AV-APC and PI were increased, which 
was visualized by definite shifts in both graphics, the dot plots and the histograms. In 
contrast, untreated and light-treated samples showed lower fluorescence intensities 
accounting for higher numbers of living cells in the respective cell populations, which 
was clearly illustrated by the overlays for AV-APV and PI (Figure 37, Figure 38). 
Therefore, the exemplary dot plots and histograms shown for both irradiation doses, 
5.4 J/cm2 and 21.6 J/cm2, gave a first indication that blue light does not induce cell 
death up to a mid irradiation dose. In addition, the observation of irradiated NHDF 
cells during experiments did not reveal rounding or other stress signs after exposure 
to different blue light doses.  
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Figure 37: Exemplary two-parameter dot plots and single-parameter histograms showing fluorescence intensities of NHDF cells stained with AV-APC and PI following 
different treatments. From left to right: The positive control sample, in which cytotoxicity was induced with 1 µM of staurosporine for 24 hours, the untreated sample receiving no 
light, the treated sample with 5.4 J/cm
2
 of blue light and finally the overlay of all three conditions. Flow cytometry analysis was performed at 24 hours following staurosporine 
treatment of the positive control as well as continuous blue light treatment of irradiated samples. The dot plots are subdivided by four quadrants with living cells being located in the 
lower left quadrant (Q4). Cells in early apoptosis, stained by AV-APC, can be assigned to the lower right quadrant (Q3), whereas the upper right quadrant depicts the percentage of 
cells staying in late apoptosis (Q2). Necrotic cells, stained by PI, can be found in the upper left quadrant (Q1). In each plot 8,000 events are depicted.  
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Figure 38: Exemplary two-parameter dot plots and single-parameter histograms showing fluorescence intensities of NHDF cells stained with AV-APC and PI following 
different treatments. From left to right: The positive control sample, in which cytotoxicity was induced with 1 µM of staurosporine for 24 hours, the untreated sample receiving no 
light, the treated sample with 21.6 J/cm
2
 of blue light and finally the overlay of all three conditions. Flow cytometry analysis was performed at 24 hours following staurosporine 
treatment of the positive control as well as continuous blue light treatment of irradiated samples. The dot plots are subdivided by four quadrants with living cells being located in the 
lower left quadrant (Q4). Cells in early apoptosis, stained by AV-APC, can be assigned to the lower right quadrant (Q3), whereas the upper right quadrant depicts the percentage of 
cells staying in late apoptosis (Q2). Necrotic cells, stained by PI, can be found in the upper left quadrant (Q1). In each plot 8,000 events are depicted. 
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However, for quantitative data analysis, counts of living cells were inferred from the 
lower left quadrant Q4, whereas the overall number of dead cells was added up by 
summarizing Q1, Q2 and Q3. Whereas the positive control showed an overall rate of 
cell death by approximately 50% ranging from 42.1% to 53.8% for the individual 
samples, untreated and blue light-treated samples yielded about 90% living cells and 
10% dead cells. Comparing the respective event numbers of living and dead cells for 
untreated and blue light-treated samples, no significant differences were observed up 
to a light dose of 86.4 J/cm2, corresponding to an irradiation time of 120 minutes. 
However, a significant change of 3.5% (p=0.0160) was noted for the highest dose of 
172.8 J/cm2 (Figure 39), which was negligible with respect to the questioned safety of 
high-energy light treatments. Hence, flow cytometry results obtained for increasing 
doses, did not reveal an energy-density dependent induction of cell death by blue 
light irradiation.  
 
 
 
Figure 39: Number of events [%] for living and dead NHDF cells inferred from two-parameter dot plots 
showing fluorescence intensities of AV-APC and PI following different treatments. From left to right: The 
positive control samples, in which cytotoxicity was induced with 1 µM of staurosporine for 24 hours, the untreated 
samples receiving no light, and the blue light-treated samples, which were irradiated with different blue light 
doses. Flow cytometry analyses were performed at 24 hours following staurosporine treatment of the positive 
control as well as continuous blue light treatment of irradiated samples. Living cell counts were inferred from the 
lower left quadrant (Q4), whereas the total amount of dead cells was added up by summarizing the number of 
events in Q1, Q2 and Q3. Bars display mean values ± SD (N = 1 repetition, 3 replicates). Corresponding statistics 
are summarized in Table 28 (Appendix). 
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3.1.5 Gene expression analysis  
 
Subsequent to cell harvesting at different time points (1 hour, 3 hours and 24 hours) 
following irradiation, RNA extraction and respective quality controls (RIN = 10 for all 
samples), time-dependent changes in gene expression of NHDF cells were studied 
using transcriptome analysis. As single blue light treatments using either 5.4 J/cm2 or 
21.6 J/cm2 revealed contrary effects on metabolism, proliferation and mitochondrial 
function, it was examined whether both irradiation doses differentially impact gene 
expression. For the respective time points after single treatments with different blue 
light doses, gene expression analyses were performed once with three replicates for 
each condition tested, light-treated and untreated (see 2.2.6.1). Following distribution 
analysis and batch normalization for separate experiments, correlation heatmaps and 
principal component analyses showed an unambiguous differentiation of irradiated 
and non-irradiated samples into distinct clusters. Figure 40 depicts a representative 
correlation matrix compiled for 24 hours of harvesting after 5.4 J/cm2 of blue light with 
the Pearson’s correlation coefficient r indicating negative correlations between blue 
light and control samples. Moreover, the similarity dendogram illustrates dissimilar 
relations between light-treated and untreated data sets (Figure 40).  
 
 
 
Figure 40: Representative Pearson correlation heatmap showing cluster analysis of untreated (control, 
N = 1 repetition, 3 replicates) and treated (light, N = 1 repetition, 3 replicates) samples following a single 
blue light treatment of NHDF cells with 5.4 J/cm
2
 and cell harvesting at 24 hours afterwards. Red indicates 
positive linear correlations (r = 1), while blue shows negative linear correlations (r = -1). The matrix reveals strong 
correlations between light-treated samples, which can be clearly differentiated from untreated samples.  
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Out of 24,733 genes, screened with the Affymetrix HuGene-2_0-st microarrays, on 
average 1,300 significant genes (FDR < 0.05) were differentially expressed in each 
experiment corresponding to approximately 5% of the complete array. Since previous 
test methods revealed dose-dependent effects of blue light, it was reviewed whether 
both irradiation doses used, 5.4 J/cm2 and 21.6 J/cm2, triggered commonly and/or 
rather differentially expressed genes. Figure 41 illustrates that only a few genes 
shared in common were affected, while the amount increased for longer time points 
following irradiation. Whereas at 1 hour after exposure to blue light of either 5.4 J/cm2 
or 21.6 J/cm2, only 47 genes were found in common, the number of shared genes at 
24 hours after irradiation accounted for 139 in total. Nevertheless, the proportion of 
commonly shared genes stayed below 5%, as their increasing number over time was 
accompanied by a cumulative amount of overall differentially expressed genes. 
Apparently, most of the genes were differentially affected when comparing both blue 
light doses, 5.4 J/cm2 and 21.6 J/cm2 (Figure 41). 
 
(A) Harvesting at 1 hour after irradiation (B) Harvesting at 3 hours after irradiation 
  
(C) Harvesting at 24 hours after irradiation 
 
 
Figure 41: Venn diagrams showing the number of significantly (FDR < 0.05) commonly or differentially 
expressed genes in NHDF cells at (A) 1 hour, (B) 3 hours and (C) 24 hours following a single blue light 
treatment with either 5.4 J/cm
2
 shown in green and 21.6 J/cm
2
 displayed in red.  
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While the total amount of differentially expressed genes alternated for increasing 
harvesting times after 5.4 J/cm2 of blue light, the number constantly accumulated for 
the higher dose of 21.6 J/cm2. Nevertheless, for both blue light doses, the highest 
amount of de-regulated genes was given at 24 hours of cell harvesting (Figure 41). 
Table 10 lists the counts of significantly up- and down-regulated genes for each 
treatment group. At 1 hour following irradiation, the number of down-regulated genes 
prevailed for both irradiation doses, while the lower blue light dose of 5.4 J/cm2 
affected a higher number of genes. In the following, at 3 hours of harvesting, the 
opposite occurred, as 21.6 J/cm2 of blue light affected more genes with the majority 
being up-regulated. In contrast, the overall number of differentially expressed genes 
was reduced for 5.4 J/cm2 of blue light with a similar ratio of up- and down-regulated 
genes compared to 1 hour of harvesting. At 24 hours after irradiation, the number of 
up-regulated genes was nearly equal for both irradiation doses, while the data sets 
showed a difference of 57 significantly down-regulated genes (Table 10). However, 
differential changes induced by varying blue light doses rather emerged in the early 
phase after irradiation, which might lead to different cell fates in the long run. 
 
Table 10: Number of significantly up- and down-regulated genes differentially expressed in NHDF cells at 
different harvesting time points following a single blue light treatment with either 5.4 J/cm
2
 or 21.6 J/cm
2
. 
Treatment group Significantly differentially expressed genes 
Dose [J/cm
2
] Time Point [h] Up-regulated genes Down-regulated genes 
5.4 1 567 676 
21.6 1 489 567 
5.4 3 444 595 
21.6 3 789 662 
5.4 24 754 736 
21.6 24 757 793 
 
Using ranked lists of differentially expressed genes, GSEA was performed to identify 
differences in genes sets predefined by KEGG. Hence, higher (or lower) normalized 
enrichment scores (NES) indicate a shift of genes towards the top (or the bottom) of 
the ranked list representing up-regulated pathways with positive values (or down-
regulated pathways with negative values). Table 11 lists the numbers of de-regulated 
KEGG pathways at different time points following single blue light treatments with 
either 5.4 J/cm2 or 21.6 J/cm2.  
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With 146 and 134 gene sets, the total number of up- and down-regulated pathways 
was comparable at 1 hour following irradiation with the lower blue light dose of 
5.4 J/cm2, while 21 pathways containing mainly up-regulated genes were significantly 
enriched at a nominal p-value < 0.05. In the further time course, respectively at 
3 hours and 24 hours of harvesting, the counts of up- and down-regulated pathways 
were characterized by contrary trends. Whereas the amount of down-regulated 
pathways peaked at 3 hours with 183 gene sets in total (16 pathways at a nominal p-
value < 0.05), the number of pathways prevailed by up-regulated genes reached its 
maximum at 24 hours with 165 gene sets (22 pathways at a nominal p-value < 0.05) 
(Table 11). Using 21.6 J/cm2 of blue light, the total number of up- and down-regulated 
pathways remained nearly constant. The highest amount of up-regulated gene sets 
was given at 3 hours of cell harvesting with 117 sets in total, of which 14 pathways 
were significantly enriched at a nominal p-value < 0.05. In contrast, down-regulated 
pathways emerged predominantly after 24 hours with 180 sets in total, while 38 of 
them were significantly enriched at a nominal p-value < 0.05 (Table 11).  
 
Table 11: Number of differentially expressed KEGG pathways at different time points following a single 
blue light treatment of NHDF cells with either 5.4 J/cm
2 
or 21.6 J/cm
2
. Starting from an overall gene set 
number of 280, total numbers of up-regulated and down-regulated pathways are shown. In addition, the number 
of significantly enriched pathways is listed for different significance levels: at a nominal p-value of < 0.05, at a 
nominal p-value of < 0.01 and at an adjusted p-value (FDR) < 0.25.  
Time Point of Harvesting [h] 1 3 24 
Dose [J/cm
2
] 5.4 21.6 5.4 21.6 5.4 21.6 
De-regulated pathways in total  280 280 280 280 280 280 
Up-regulated pathways in total 146 103 97 117 165 100 
With nominal p-value < 0.05 21 1 5 14 22 10 
With nominal p-value < 0.01 7 1 1 6 10 5 
With adjusted p-value (FDR) < 0.25 11 0 1 5 19 6 
Down-regulated pathways in total 134 177 183 163 115 180 
With nominal p-value < 0.05 12 8 16 17 7 38 
With nominal p-value < 0.01 1 2 6 9 1 15 
With adjusted p-value (FDR) < 0.25 0 2 7 9 0 16 
 
Comparing the number of up- and down-regulated gene sets, significantly enriched at  
a nominal p-value < 0.05, between both light doses, they showed contrary counts, 
especially with respect to the time course of up-regulated pathways. For 5.4 J/cm2 of 
blue light, a similar amount of about 20 pathways was given at 1 hour and 24 hours 
of harvesting, whereas the highest number arose at 3 hours after 21.6 J/cm2.  
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In contrast to alternating counts of down-regulated pathways after 5.4 J/cm2 of blue 
light, their number constantly increased over time following a single treatment using 
the higher irradiation dose of 21.6 J/cm2 (Figure 42).   
 
 
Figure 42: Total counts of up-regulated and down-regulated KEGG pathways, significantly enriched at a 
nominal p-value < 0.05, at different time points following a single blue light treatment of NHDF cells with 
either 5.4 J/cm
2
 or 21.6 J/cm
2
.  
 
In order to assess which molecular interactions, reactions and networks were mainly 
affected when using two different irradiation doses, Figure 43 and Figure 44 illustrate 
the classification of significantly enriched pathways (nominal p-value < 0.05) into 
KEGG main categories. For 5.4 J/cm2 of blue light, up-regulated pathways could be 
mainly assigned to the main category of metabolism with 11 de-regulated genes sets 
at 1 hour and 24 hours after irradiation. However, only 4 up-regulated gene sets were 
found to be in common between those time points, with 2 of them belonging to the 
main category of metabolism, galactose metabolism and oxidative phosphorylation. 
In contrast, down-regulated gene sets rather belonged to other main categories of 
genetic information processing, environmental information processing and cellular 
processes mainly involving protein processing, signal transduction as well as cellular 
community. The corresponding Venn diagrams for different harvesting time points 
hardly showed any commonly shared gene sets de-regulated over time. However, 
the lower dose of 5.4 J/cm2 mainly affected metabolic processes (Figure 43). 
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 (A) 
 
 
(B) 
 
 
(C) 
 
 
 
Figure 43: (A) Distribution of significantly enriched pathways (nominal p-value < 0.05), either up-regulated 
(NES > 0) or down-regulated (NES < 0), within the KEGG main categories and comparison of significant 
pathway lists with (B) NES < 0 and (C) NES > 0 at different harvesting time points following a single 
continuous blue light treatment of NHDF cells with 5.4 J/cm
2
.  
 
Compared to 5.4 J/cm2, the higher blue light dose of 21.6 J/cm2 yielded less changes 
in metabolic processes showing a constant number of significantly down-regulated 
pathways throughout the different harvesting time points. Moreover, from 3 hours 
after irradiation, down-regulated gene sets were found in all KEGG categories, with 
the highest number of significantly enriched pathways belonging to the main category 
of human diseases. Contrary to down-regulated gene sets, up-regulated pathways 
affected less categories, while they still revealed a greater variety compared to the 
lower light dose of 5.4 J/cm2 (Figure 43). Corresponding Venn diagrams indicated 
only two significantly down-regulated gene sets shared in common at 3 hours and 
24 hours after blue light irradiation, with one of them representing the ECM-receptor 
interaction of the main category ‘environmental information processing’ (Figure 44).  
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 (A) 
 
 
(B) 
 
 
(C) 
 
 
 
Figure 44: (A) Distribution of significantly enriched pathways (nominal p-value < 0.05), either up-regulated 
(NES > 0) or down-regulated (NES < 0), within the KEGG main categories and comparison of significant 
pathway lists with (B) NES < 0 and (C) NES > 0 at different harvesting time points following a single 
continuous blue light treatment of NHDF cells with 21.6 J/cm
2
.  
 
In addition, Venn diagrams were used in order to determine relations between both 
irradiation doses at each respective harvesting time. Thereby, de-regulated pathways 
equally modulated by both irradiation doses were found at 3 hours and 24 hours of 
harvesting. However, no commonly affected up- and down-regulated pathways were 
observed at 1 hour after blue light treatment. Significantly enriched gene sets shared 
in common are listed in Table 12 subdivided by the harvesting time point and the type 
of regulation. 
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Table 12: Up- and down-regulated pathways (nominal p-value < 0.05) commonly affected at different 
harvesting time points after continuous blue light treatment of NHDF cells with 5.4 J/cm
2
 or 21.6 J/cm
2
. 
 
 
At 3 hours after irradiation, several pathways belonging to the main category ‘human 
diseases’ like Alzheimer’s disease, Parkinson’s disease or Huntington’s disease were 
down-regulated. Despite their link to certain diseases, all of these gene sets involve a 
mitochondrial pathway related to changes in ROS and ATP production as well as 
modulations of ΔΨm indicating mitochondrial function. In this context, also oxidative 
phosphorylation was found to be down-regulated after treatment with both irradiation 
doses. In contrast, several up-regulated pathways were equally affected at 24 hours 
following irradiation including glycolysis/gluconeogenesis, ovarian steroidogenesis, 
chemical carcinogenesis, the arylhydrocarbon receptor (AhR) signaling pathway as 
well as the metabolism of xenobiotics by cytochrome P450. The last three signaling 
pathways involve a number of oxidative stress-dependent nuclear factor erythroid 2- 
related factor 2 (Nrf2)-transcribed genes encoding phase II detoxification enzymes, 
such as glutathione S-transferases (GST) and UDP-glucuronosyltransferases (UGT). 
Moreover, several genes encoding phase I xenobiotic-metabolizing enzymes (XMEs), 
for instance cytochrome P450 (CYP) monooxygenases, were up-regulated. Besides 
GST and UGT gene families, gene expression analyses performed for different 
harvesting time points after irradiation with either 5.4 J/cm2 or 21.6 J/cm2 revealed 
also other Nrf2-transcribed genes, which were significantly de-regulated (Figure 45). 
Besides ALDH3A1 and NQO1, respectively encoding the phase II XMEs aldehyde 
dehydrogenase 3 family member A1 as well as NAD(P)H quinone dehydrogenase 1, 
Time 
Point [h]
Pathway NES
Nom. 
p-val
Adj. 
p-val.
NES
Nom. 
p-val
Adj. 
p-val.
Alzheimer’s disease -1.46 0.018 0.418 -1.88 0.000 0.014
Complement and coagulation cascades -1.48 0.026 0.430 -1.37 0.026 0.445
Huntington’s disease -1.72 0.000 0.091 -1.83 0.000 0.017
Non-alcoholic fatty liver disease (NAFLD) -1.36 0.020 0.614 -1.52 0.004 0.237
Oxidative phosphorylation -1.74 0.000 0.102 -2.10 0.000 0.001
Parkinson's disease -1.94 0.000 0.033 -2.10 0.000 0.001
Ribosome -1.84 0.000 0.065 -1.89 0.000 0.014
? MicroRNAs in cancer 1.80 0.000 0.100 1.74 0.000 0.062
? Adherens junction -1.34 0.049 0.733 -1.40 0.031 0.260
Arylhydrocarbon receptor (AhR) signaling pathway 1.81 0.002 0.041 1.80 0.000 0.057
Chemical carcinogenesis 1.81 0.000 0.031 1.92 0.000 0.024
Glycolysis/ Gluconeogenesis 1.67 0.000 0.118 1.49 0.018 0.311
Metabolism of xenobiotics by cytochrome P450 2.04 0.000 0.006 1.72 0.002 0.086
Ovarian steroidogenesis 1.50 0.035 0.206 1.44 0.047 0.347
24
?
Dose [J/cm 2] 5.4 21.6
3
?
↑
↓
↑
↓
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GCLC, GCLM, HMOX1, TXNRD1, TXNRD2 and SRXN1 represent important genes, 
which promote antioxidant defense, while the latter mainly detoxify peroxides like 
H2O2. Whereas at 1 hour following blue light treatment with both doses, only a few 
genes were found significantly up-regulated, most of them showed an increased 
expression after 3 hours and 24 hours of harvesting. Especially after irradiation with 
21.6 J/cm2, ALDH3A1, NQO1, GCLM, HMOX1 and TXNRD1 were highly expressed, 
whereas expression levels remained rather constant using 5.4 J/cm2 of blue light 
(Figure 45). Nonetheless, some of these genes were commonly affected (Figure 41).  
 
 
 
Figure 45: Expression changes of a selection of Nrf2-transcribed genes for different harvesting time 
points following a single continuous blue light treatment of NHDF cells with either 5.4 J/cm
2
 or 21.6 J/cm
2
.  
 
Besides metabolic processes involving genes dedicated to detoxification and thus 
cell protection, many pathways belonging to the KEGG main category ‘metabolism’ 
were highly affected by light irradiation, especially at 1 hour and 24 hours following 
blue light treatment with 5.4 J/cm2 (Figure 43). With respect to KEGG subcategories, 
the metabolism of various molecules like carbohydrates, amino acids, glycans, lipids 
and terpenoids was modulated. However, the only significantly enriched gene set, 
which was continuously expressed at all harvesting time points following 5.4 J/cm2 of 
blue light was oxidative phosphorylation. Although it was enhanced at 1 hour and 
24 hours following irradiation, it was down-regulated at 3 hours of cell harvesting.  
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Table 13 depicts metabolic pathways significantly enriched (nominal p-value < 0.05) 
at different time points after blue light treatment using (A) 5.4 J/cm2 or (B) 21.6 J/cm2.  
 
Table 13: Significantly de-regulated KEGG pathways (nominal p-value < 0.05) of the main category 
‘metabolism’ at different time points after continuous blue light treatment of NHDF cells with (A) 5.4 J/cm
2
 
or (B) 21.6 J/cm
2
. Up-regulated pathways are indicated by NES > 0; down-regulated pathways show NES < 0.  
(A) 
 
(B) 
 
Time 
Point [h]
Sub Category Pathway NES
Nom. 
p-val. 
Adj.
p-val.
1 1.8 Metabolism of cofactors and vitamins Nicotinate and nicotinamide metabolism 1.83 0.006 0.116
1 1.9 Metabolism of terpenoids and polyketides Terpenoid backbone biosynthesis 1.69 0.008 0.169
1 1.7 Glycan biosynthesis and metabolism Glycosaminoglycan biosynthesis - HS/Hep 1.67 0.010 0.149
1 1.3 Lipid metabolism Glycerophospholipid metabolism 1.60 0.002 0.190
1 1.7 Glycan biosynthesis and metabolism Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 1.58 0.024 0.171
1 1.5 Amino acid metabolism Glycine, serine and threonine metabolism 1.56 0.023 0.185
1 1.1 Carbohydrate metabolism Glyoxylate and dicarboxylate metabolism 1.55 0.031 0.183
1 1.1 Carbohydrate metabolism Galactose metabolism 1.54 0.026 0.174
1 1.5 Amino acid metabolism Alanine, aspartate and glutamate metabolism 1.44 0.037 0.313
1 1.7 Glycan biosynthesis and metabolism N-Glycan biosynthesis 1.43 0.040 0.337
1 1.2 Energy metabolism Oxidative phosphorylation 1.39 0.033 0.362
3 1.5 Amino acid metabolism Arginine Biosynthesis 1.64 0.014 0.271
3 1.1 Carbohydrate metabolism Propanoate metabolism 1.52 0.039 0.533
3 1.7 Glycan biosynthesis and metabolism Glycosphingolipid biosynthesis - lacto and neolacto series 1.48 0.039 0.540
3 1.7 Glycan biosynthesis and metabolism Mucin type O-Glycan biosynthesis -1.53 0.034 0.352
3 1.7 Glycan biosynthesis and metabolism Glycosaminoglycan biosynthesis - KS -1.70 0.010 0.093
3 1.2 Energy metabolism Oxidative phosphorylation -1.74 0.000 0.102
24 1.11 Xenobiotics biodegradation and metabolism Metabolism of xenobiotics by cytochrome P450 2.04 0.000 0.006
24 1.1 Carbohydrate metabolism Galactose metabolism 1.98 0.000 0.007
24 1.11 Xenobiotics biodegradation and metabolism Arylhydrocarbon receptor (AhR) signaling pathway 1.81 0.002 0.041
24 1.1 Carbohydrate metabolism Glycolysis / Gluconeogenesis 1.67 0.000 0.118
24 1.5 Amino acid metabolism Histidine metabolism 1.59 0.010 0.173
24 1.11 Xenobiotics biodegradation and metabolism Drug metabolism - cytochrome P450 1.59 0.006 0.157
24 1.6 Metabolism of other amino acids beta-Alanine metabolism 1.56 0.014 0.166
24 1.5 Amino acid metabolism Phenylalanine metabolism 1.55 0.030 0.167
24 1.1 Carbohydrate metabolism Fructose and mannose metabolism 1.49 0.041 0.203
24 1.1 Carbohydrate metabolism Amino sugar and nucleotide sugar metabolism 1.46 0.022 0.211
24 1.2 Energy metabolism Oxidative phosphorylation 1.33 0.040 0.423
24 1.7 Glycan biosynthesis and metabolism Mucin type O-Glycan biosynthesis -1.58 0.019 0.502
24 1.5 Amino acid metabolism Valine, leucine and isoleucine degradation -1.66 0.011 0.480
Time 
Point [h]
Sub Category Pathway NES
Nom.
 p-val.
Adj.
 p-val.
1 1.5 Amino acid metabolism Tyrosine metabolism -1.40 0.045 0.917
1 1.5 Amino acid metabolism Valine, leucine and isoleucine degradation -1.51 0.022 0.600
1 1.6 Metabolism of other amino acids Selenocompound metabolism -1.52 0.045 0.709
3 1.3 Lipid metabolism Linoleic acid metabolism 1.68 0.010 0.088
3 1.3 Lipid metabolism alpha-Linolenic acid metabolism 1.51 0.045 0.304
3 1.4 Nucleotide metabolism Purine metabolism -1.40 0.011 0.398
3 1.1 Carbohydrate metabolism Galactose metabolism -1.52 0.015 0.252
3 1.2 Energy metabolism Oxidative phosphorylation -2.10 0.000 0.001
24 1.11 Xenobiotics biodegradation and metabolism Arylhydrocarbon receptor (AhR) signaling pathway 1.80 0.000 0.057
24 1.11 Xenobiotics biodegradation and metabolism Metabolism of xenobiotics by cytochrome P450 1.72 0.002 0.086
24 1.9 Metabolism of terpenoids and polyketides Terpenoid backbone biosynthesis 1.63 0.015 0.122
24 1.1 Carbohydrate metabolism Glycolysis / Gluconeogenesis 1.49 0.018 0.311
24 1.6 Metabolism of other amino acids Glutathione metabolism 1.48 0.031 0.284
24 1.7 Glycan biosynthesis and metabolism N-Glycan biosynthesis -1.49 0.028 0.291
24 1.7 Glycan biosynthesis and metabolism Glycosaminoglycan degradation -1.54 0.038 0.323
24 1.0 Global and overview maps 2-Oxocarboxylic acid metabolism -1.84 0.004 0.051
24 1.7 Glycan biosynthesis and metabolism Glycosaminoglycan biosynthesis - HS/Hep -1.93 0.000 0.027
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Whereas a remarkable number of metabolic pathways was differentially expressed 
by blue light, gene sets related to cell growth, replication, proliferation, cell survival 
and signal transduction were hardly found to be significantly enriched. However, with 
respect to the KEGG subcategory 2.4 involving replication and repair processes, the 
base excision repair pathway was continuously up-regulated following blue light 
irradiation with 5.4 J/cm2, which was significant at 1 hour of harvesting. In contrast, 
homologous recombination was found to be significantly down-regulated at 1 hour 
after irradiation (Table 14, (A)). When using the higher blue light dose of 21.6 J/cm2, 
two repair processes, homologous recombination and the Fanconi anemia pathway, 
showed constant up-regulation, with significant effects at 3 hours after blue light 
treatment (Table 14, (B)). Other DNA repair mechanisms such as mismatch and 
nucleotide excision repair were not significantly modulated by blue light. 
 
Table 14: KEGG pathways belonging to the main category: 2. Genetic Information Processing, and 
subcategory: 2.4 Replication and repair de-regulated at different time points after continuous blue light 
treatment of NHDF cells with either (A) 5.4 J/cm
2
 or (B) 21.6 J/cm
2
. Significantly enriched pathways are 
indicated by a nominal p-value < 0.05.  
 
(A) 5.4 J/cm
2 
of blue light 
 
 
(B) 21.6 J/cm
2
 of blue light  
 
 
 
Pathway NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
DNA replication 0.73 0.860 1.000 -0.65 0.970 1.000 1.1 0.300 0.729
Mismatch repair -0.75 0.832 1.000 0.68 0.907 1.000 -0.86 0.643 1.000
Base excision repair 1.6 0.020 0.170 0.71 0.907 1.000 1.05 0.396 0.761
Nucleotide excision repair -0.88 0.678 1.000 0.77 0.829 1.000 -1.25 0.149 0.812
Homologous recombination -1.52 0.034 1.000 0.67 0.925 1.000 -1.25 0.139 0.835
Fanconi anemia pathway -1.11 0.275 1.000 1.18 0.206 1.000 -1.43 0.051 0.742
Time Point of Harvesting [h]
1 3 24
Pathway NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
DNA replication 1.03 0.393 1.000 1.06 0.350 0.868 -0.86 0.685 0.909
Mismatch repair -1.04 0.416 1.000 0.74 0.852 0.989 -0.75 0.834 0.980
Base excision repair -0.95 0.531 1.000 -1.15 0.233 0.715 -1.03 0.409 0.728
Nucleotide excision repair 0.64 0.968 1.000 1.08 0.344 0.870 -0.66 0.967 0.993
Homologous recombination 1.18 0.233 1.000 1.49 0.038 0.330 0.84 0.728 1.000
Fanconi anemia pathway 1.12 0.277 1.000 1.81 0.000 0.040 1.22 0.141 0.633
Time Point of Harvesting [h]
1 3 24
Results 
72 
In addition, contrary effects on DNA replication were noted at 24 hours of harvesting, 
with 5.4 J/cm2 of blue light stimulating DNA replication, while the higher irradiation 
dose of 21.6 J/cm2 blocked new DNA synthesis (Table 14). Dose-dependent blue 
light effects on cell growth and proliferation were further confirmed by the cell cycle 
pathway. While the lower dose of 5.4 J/cm2 revealed a continuous but non-significant 
up-regulation of the cell cycle, the gene set was down-regulated for the higher dose 
of 21.6 J/cm2, apart from 3 hours of cell harvesting showing significant up-regulation 
(Table 15). Apparently, the higher expression of the cell cycle pathway following 
21.6 J/cm2 of blue light was accompanied by a significantly up-regulated p53 
signaling pathway, which was conversely found to be significantly down-regulated at 
24 hours following blue light treatment with 5.4 J/cm2. Furthermore, two apoptosis 
pathways were found up-regulated in most cases for both blue light doses, although 
statistical significance was hardly achieved. However, shortly after treating NHDF 
cells with 5.4 J/cm2, the apoptosis pathway for mammals (multiple species) was 
significantly down-regulated at 3 hours of harvesting, rather involving genes linked to 
the intrinsic apoptosis pathway affecting mitochondria (Table 15, (A)).  
 
Table 15: KEGG pathways belonging to the main category: 4. Cellular processes, and subcategory: 4.3 
Cell growth and death de-regulated at different time points after continuous blue light treatment of NHDF 
cells with either (A) 5.4 J/cm
2
 or (B) 21.6 J/cm
2
. Significantly enriched pathways are indicated by a nominal p-
value < 0.05.  
 
(A) 5.4 J/cm
2 
of blue light 
 
 
(B) 21.6 J/cm
2 
of blue light 
 
Pathway NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
Cell cycle 0.93 0.654 0.927 0.92 0.649 1.000 0.85 0.848 0.990
p53 signaling pathway 1.18 0.190 0.639 0.89 0.648 1.000 -1.4 0.039 0.780
Apoptosis 0.86 0.807 0.927 0.64 1.000 1.000 0.94 0.583 0.944
Apoptosis - multiple species 1.32 0.112 0.467 -1.46 0.043 0.453 0.82 0.765 1.000
Time Point of Harvesting [h]
1 3 24
Pathway NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
Cell cycle -0.78 0.924 1.000 1.43 0.011 0.359 -0.80 0.897 0.953
p53 signaling pathway 0.87 0.709 1.000 2.03 0.000 0.002 -1.00 0.434 0.735
Apoptosis 0.87 0.780 1.000 1.16 0.169 0.786 -1.21 0.118 0.448
Apoptosis - multiple species 1.01 0.431 1.000 1.12 0.309 0.845 1.00 0.440 0.998
Time Point of Harvesting [h]
1 3 24
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In addition, the regulation of several signal transduction pathways such as the AMPK, 
MAPK, NF-kappa B (NF-κB), PI3K-Akt, TGF-β and the TNF signaling pathway, which 
are known to be involved in the regulation of cell metabolism, growth, proliferation, 
apoptosis, survival, immune cell recruitment and cell interactions, were compared for 
both blue light doses. Similar expression changes over time were observed for the 
FoxO and Jak-STAT signaling pathways showing alternating regulation as well as for 
the mTOR and PI3K-Akt signaling pathways, which were characterized by constant 
down-regulation. For the TGF-β signaling pathway, time-dependent changes were 
contrary for both blue light doses, 5.4 J/cm2 and 21.6 J/cm2 (Table 16). Furthermore, 
the NF-κB signaling pathway was activated directly after irradiation with both doses, 
with a significant up-regulation at 3 hours following continuous blue light treatment 
using 21.6 J/cm2 (Table 16, (B)). However, in the following time course, at 24 hours of 
harvesting, the pathway was down-regulated for both irradiation doses. Moreover, the 
TNF signaling pathway was continuously up-regulated after irradiation with 5.4 J/cm2. 
However, the latter was found significantly up-regulated at 24 hours after blue light 
treatment with 21.6 J/cm2, whereas the Wnt signaling pathway was constantly down-
regulated (Table 16).  
 
Table 16: KEGG pathways belonging to the main category: 3. Environmental Information Processing, and 
subcategory: 3.2 Signal transduction de-regulated at different time points after continuous blue light 
treatment of NHDF cells with either (A) 5.4 J/cm
2
 or (B) 21.6 J/cm
2
. Significantly enriched pathways are 
indicated by a nominal p-value < 0.05.  
 
(A) 5.4 J/cm
2 
of blue light 
 
 
 
 
Pathway NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
AMPK signaling pathway -1.28 0.056 0.676 -1.03 0.369 0.963 1.14 0.202 0.736
ErbB signaling pathway -0.74 0.943 1.000 -0.98 0.490 0.967 1.19 0.173 0.641
FoxO signaling pathway -0.99 0.462 1.000 0.92 0.641 1.000 -0.85 0.814 1.000
Jak-STAT signaling pathway -0.75 0.968 1.000 0.84 0.830 1.000 -1.09 0.265 1.000
MAPK signaling pathway 0.83 0.907 0.962 -1.03 0.345 0.946 -0.85 0.905 1.000
mTOR signaling pathway -1.51 0.021 1.000 -0.97 0.524 0.952 -0.81 0.823 1.000
NF-kappa B signaling pathway 0.96 0.535 0.901 1.19 0.153 1.000 -0.79 0.886 1.000
PI3K-Akt signaling pathway -1.03 0.360 1.000 -0.93 0.733 1.000 -1.02 0.390 1.000
TGF-β signaling pathway 0.72 0.970 1.000 -1.21 0.137 0.798 0.85 0.801 0.984
TNF signaling pathway 1.09 0.292 0.673 0.86 0.751 1.000 1.11 0.231 0.749
VEGF signaling pathway 0.85 0.716 0.938 0.68 0.965 1.000 1.08 0.313 0.742
Wnt signaling pathway 0.93 0.614 0.921 -0.86 0.816 1.000 1.22 0.100 0.599
Time Point of Harvesting [h]
1 3 24
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(B) 21.6 J/cm
2 
of blue light 
 
 
Although listed KEGG pathways hardly showed significant expression, especially with 
respect to signal transduction processes, trends in gene expression changes will be 
discussed with particular focus on metabolic control, proliferation, stress response 
and cell survival.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pathway NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
NES
Nom.
 p-val.
Adj.
 p-val.
AMPK signaling pathway 0.74 0.971 1.000 -1.13 0.195 0.737 -0.96 0.545 0.784
ErbB signaling pathway -0.96 0.526 1.000 1.33 0.065 0.478 -0.73 0.937 0.986
FoxO signaling pathway -0.95 0.592 1.000 1.43 0.011 0.338 -0.90 0.698 0.857
Jak-STAT signaling pathway -1.39 0.013 0.915 0.93 0.634 0.885 -1.06 0.306 0.680
MAPK signaling pathway -1.01 0.417 1.000 0.98 0.499 0.833 -0.96 0.582 0.789
mTOR signaling pathway -1.04 0.375 1.000 -1.18 0.177 0.640 -0.81 0.815 0.948
NF-kappa B signaling pathway 0.86 0.740 1.000 1.45 0.020 0.336 -0.90 0.647 0.851
PI3K-Akt signaling pathway -1.06 0.270 1.000 -1.05 0.296 0.734 -1.47 0.000 0.237
TGF-β signaling pathway -0.78 0.889 1.000 1.00 0.433 0.889 -0.94 0.545 0.799
TNF signaling pathway -1.09 0.286 1.000 1.02 0.410 0.912 1.34 0.037 0.452
VEGF signaling pathway -0.75 0.893 1.000 0.91 0.627 0.924 0.86 0.727 1.000
Wnt signaling pathway -0.84 0.871 1.000 -1.19 0.101 0.633 -1.23 0.099 0.452
Time Point of Harvesting [h]
1 3 24
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3.2 MEDILIGHT system  
 
In April 2018, the first generation of prototypes was finalized and distributed to the 
consortium partners. To prove their efficacy and validate their use for subsequent in 
vivo studies, blue light effects on metabolic activity, found after irradiation with the 
BioLight LED Lamp, had to be confirmed. Since the system was still a first prototype, 
many issues were occurring, especially in the early period of testing, necessitating a 
few modifications and optimizations, in particular with respect to thermal properties.  
 
3.2.1 Temperature measurements  
 
As heat management represents an important issue for patient safety, temperature 
measurements were performed with integrated as well as external sensors using two 
different irradiance values. The latter were based on different blue light applications 
throughout single wound healing stages. Whereas an irradiance of 12 mW/cm2 was 
intended to accelerate granulation and epidermization by promoting the activity of 
different skin cell types, 23 mW/cm2 were identified to induce antibacterial effects. 
However, operating the flexible LED foil in continuous mode yielding 23 mW/cm2 
underneath the entire component stack resulted in a fast temperature rise on human 
skin, which finally induced thermal hyperalgesia. Thus, worst case scenarios were 
subsequently tested on a skin-like polymer from URGO RID (Chenôve, France).  
 
The required irradiance values of 10 mW/cm2 and 23 mW/cm2, resulting underneath 
the entire component stack including back-reflector, diffusor and the wound dressing 
E2723, were given at DCs of 25% and 78%. With an irradiance of 10 mW/cm2 the 
maximum temperature reached at the center of the flexible LED foil and external 
sensor #2 was approximately 39°C, while external sensor #1 showed a rise up to 
41°C at the polymer surface. Whereas these values were close to the set threshold 
of 40°C, the higher irradiance of 23 mW/cm2 resembled a maximum temperature of 
52°C on the LED array and about 51°C at the polymer (Figure 46, (A)). Therefore, in 
order to prevent the risk of thermal hyperalgesia, irradiation had to be fractionated in 
cycles to enable the LED foil and consequently the patient’s skin to cool down. By 
pausing irradiation with cycles of 1 minute at 10 mW/cm2, temperature maxima of all 
sensors were reduced to a range between 35°C and 37°C (Figure 46, (B)).  
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(A) 
 
 
(B) 
 
 
 
Figure 46: Temperature measurements using the flexible LED foil equipped with back-reflector on a skin-
like polymer with 10 mW/cm
2
 (25% DC) or 23 mW/cm
2
 (78% DC) in (A) continuous or (B) cycled mode 
(cycles of 1 minute). Irradiances were adjusted underneath the complete stack involving the diffusor and the 
wound dressing E2723. In total, three sensors are shown: The safety temperature sensor integrated onto the LED 
array (Flex Foil Center) and two external sensors #1 and #2 placed underneath E2723 on the polymer surface.  
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With the higher irradiance of 23 mW/cm2, the safety temperature sensor on the LED 
foil showed a temperature increase up to 48°C, while both external sensors recorded 
approximately 46°C at maximum (Figure 46, (B)). Although cooling rates of the LED 
array and the polymer seemed to be fast, the recorded temperature maxima reached 
were still highly above the threshold set at 40°C. Moving to a more realistic set-up 
enabling heat transfer by blood circulation, temperature profiles at 23 mW/cm2 were 
tested on porcine skin. In Figure 47, the maximum skin temperature measured by 
both external sensors was limited to 37°C leading to a temperature rise of 45°C on 
the LED array. While the sensors located at the periphery of the LED foil showed 
constant values of 32°C – 34°C, the recordings of the central safety sensor revealed 
cycles of 30 seconds. The LED foil was still able to cool down fast (Figure 47).  
 
 
 
Figure 47: Temperature measurement using the flexible LED foil equipped with back-reflector on porcine 
skin with 23 mW/cm
2
 (62% DC). Irradiance was adjusted underneath the complete stack involving the wound 
dressing E2723, but excluding the diffusor. Five different sensors are shown: One sensor in the center of the 
flexible LED foil (dark blue) and 4 different sensors at the borders of the foil (light blue, orange, red and green).  
 
Coming back to in vitro validation tests, the irradiance underneath the complete stack 
was adjusted to 23 mW/cm2 given at the plate surface. Due to light absorption by the 
set-up (black plate, lid, etc.), NHDF cells received about 12 mW/cm2 (see 2.2.2.1). 
With a 68% DC and cycles of 30 seconds, the safety sensor on the LED foil showed 
a maximum temperature of 35°C measured at the plate surface, which stayed below 
the incubation temperature of 37°C. Thus, induction of heat stress could be excluded.  
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3.2.2 In vitro validation of prototypes  
 
In order to validate the prototype’s use for subsequent in vivo studies, several blue 
light doses with a maximum value of 43.2 J/cm2, previously applied with the BioLight 
LED Lamp, were investigated once again with the MEDILIGHT system. Similar to 
Figure 20, blue light effects on cell metabolism were evaluated at 24 hours after light 
treatment using the colorimetric XTT Cell Viability Kit. As described in 2.2.2.2, blue 
light irradiation was either performed through the wound dressing E2723 at 68% DC 
or the diffusor at 38% DC with 23 mW/cm2 adjusted underneath each respective 
component stack. In comparison to Figure 20, Figure 48 depicts a less pronounced 
increase in metabolic activity following a single irradiation with 5.4 J/cm2 of 450 nm 
blue light (2.50% (p<0.0001) with diffusor and 1.95% (p=0.0032) with E2723).  
 
 
 
Figure 48: Changes in the metabolic activity of NHDF cells following different blue light doses with a 
constant time point of XTT testing at 24 hours after irradiation. Continuous irradiation using the silicone-
encapsulated flexible LED foil was either performed through the diffusor or the wound dressing E2723 providing a 
homogenous illumination field. Irradiance was adjusted to 23 mW/cm
2
 underneath the respective component 
stacks yielding a DC of 38% with the diffusor and 68% with E2723. Fold changes were evaluated versus time-
matched, non-irradiated controls. Data are presented as mean ± SD (N = 3 repetitions, 3 replicates). 
Corresponding statistics are summarized in Table 29 (Appendix). 
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Moreover, for both conditions, the mitochondrial activity of NHDF cells was hardly 
affected by 10.8 J/cm2 of blue light, although this dose represented the inflection 
point from stimulatory to inhibitory effects in Figure 20. However, using an irradiation 
dose of 21.6 J/cm2, blue light treatment through the diffusor decreased the cellular 
metabolism by 28.21% (p<0.0001), whereas through the dressing E2723 a reduction 
by 3.42% (p=0.0001) was found compared to the non-irradiated control. Blue light 
irradiation with 43.2 J/cm2 compensated the effect at around 70% – 75% (p<0.0001) 
of cell activity being left after light treatment (Figure 48), which agrees to the outcome 
displayed in Figure 20. Thereby, the maximum temperature reached throughout blue 
light treatment through the diffusor was about 36°C. However, continuous irradiation 
through E2723 could no longer be performed since a predefined temperature safety 
threshold of 50°C was exceeded multiple times during operation resulting in a 
temporary shutdown of the LEDs. Moreover, NHDF cells were probably exposed to 
high temperatures (> 37°C). In order to prevent temperature effects on cell activity 
and growth, defined irradiation schemes, derived from temperature profiles tested on 
the skin-like polymer and porcine skin (Figure 46, Figure 47), were evaluated in vitro 
using the XTT Cell Viability Kit.  
 
Figure 49 depicts the XTT test results for NHDF cells, which were treated with the 
irradiation scheme specified in Figure 47, and a direct comparison to the outcomes, 
which had been obtained with the BioLight LED Lamp. However, it has to be noted 
that the light treatment with the BioLight LED Lamp was performed in continuous 
mode and without wound dressing, while the MEDILIGHT prototype was run in cycled 
mode (30-second cycles) irradiating the cells through E2723. Though, equal doses 
were applied by doubling the irradiation time for the latter. Moreover, the distance of 
the light sources to the surface of the 96-well plates was different. Nevertheless, both 
light sources provided an irradiance level of about 23 mW/cm2 at the plate surface. 
Compared to continuous light treatment, cycled irradiation yielded stimulatory effects 
on cell metabolism at higher doses. Using the BioLight LED Lamp, the highest cell 
activity was given at a dose of 5.4 J/cm2 (7.10%, p<0.0001), whereas an increase of 
4.71% (p<0.0001) was found at 10.8 J/cm2 with the MEDILIGHT prototype. Also, the 
stimulatory range was broadened from 3.6 J/cm2 to 12.6 J/cm2. In the following, cell 
metabolism was reduced with a difference of about 10.0% (p<0.0001) at 21.6 J/cm2 
of blue light, which was narrowed at higher doses of 32.4 J/cm2 and 43.2 J/cm2.  
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With a maximum inhibition of mitochondrial activity by 25% – 30% (p<0.0001), both 
curves showed a biphasic dose-response validating the functionality and efficacy of 
MEDILIGHT prototypes.  
 
 
 
Figure 49: Changes in the metabolic activity of NHDF cells following different blue light doses with a 
constant time point of XTT testing at 24 hours after irradiation. Single blue light treatments were either 
performed with the BioLight LED Lamp (Philips Research, Eindhoven, Netherlands) in continuous mode or with 
the MEDILIGHT prototype through the wound dressing E2723 in cycled mode (cycles of 30 seconds). For the 
latter, the irradiance was adjusted to 23 mW/cm
2
 underneath the respective component stack (68% DC), which 
complied with the irradiance value of the Philips device. Fold changes were evaluated versus time-matched, non-
irradiated controls. Data are presented as mean ± SD (N = 3 repetitions, 3 replicates for the BioLight LED Lamp; 
N = 2 repetitions, 3 replicates for the MEDILIGHT prototype). Corresponding statistics are summarized in 
Table 30 (Appendix). 
 
3.2.3 Light distribution studies  
  
A homogenous light distribution is indispensable to induce stable photobiological 
effects. In consequence, light, which is emitted by single LED spots, needs to be 
distributed uniformly. Using the in vitro model described in 2.2.2.2, light homogeneity 
was investigated based on the biological activity of NHDF cells tested with the XTT 
Cell Viability Kit. Adding only the diffusor between the illumination field of the 
MEDILIGHT prototype and the transparent 96-well plate, color coding of absorbance 
intensities clearly showed that the reduction in cell metabolism of NHDF cells was 
carried over to two adjacent columns and rows (Figure 50).  
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Figure 50: Changes in the metabolic activity of NHDF cells following continuous irradiation in transparent 
96-well plates using a blue light dose of 21.6 J/cm
2
 – Color coding of absorbance intensities. The black 
rectangle shows the area in which the irradiation took place through the diffusor.  
 
Since the diffusor represents an additional layer in the component stack leading to an 
increase in DCs and the resulting energy input, it was tested whether only the wound 
dressing E2723 provided by URGO RID (Chenôve, France) could homogenize the 
light sufficiently. Absorbance intensities obtained following light treatment through 
E2723, either with or without the diffusor, did not indicate a clear difference in light 
distribution within the transparent plate. Moreover, the metabolic inhibition of NHDF 
cells induced by 21.6 J/cm2 of blue light was still carried over to at least two adjacent 
columns and rows (Figure 51). Thus, the diffusor did not improve light distribution 
when using it with the dressing E2723. In addition, with respect to heat management, 
the exclusion of the diffusor could benefit to a DC reduction and thus to a decrease of 
temperature increases within the irradiation system.  
 
Without 
diffusor 
 
With 
diffusor 
 
 
Figure 51: Changes in the metabolic activity of NHDF cells following continuous irradiation in transparent 
96-well plates using a blue light dose of 21.6 J/cm
2
 – Color coding of absorbance intensities. The black 
rectangle shows the area in which the irradiation took place through E2723. The addition of the diffusor was 
optional: (A) without diffusor, (B) with diffusor. 
 
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.65 0.66 0.66 0.60 0.51 0.51 0.51 0.53 0.63 0.68 0.71 0.69
B 0.66 0.67 0.63 0.51 0.47 0.47 0.46 0.48 0.49 0.62 0.67 0.68
C 0.67 0.65 0.53 0.47 0.43 0.41 0.42 0.44 0.46 0.52 0.67 0.68
D 0.66 0.65 0.50 0.45 0.42 0.39 0.41 0.41 0.45 0.49 0.63 0.66
E 0.65 0.63 0.49 0.45 0.40 0.39 0.40 0.41 0.47 0.51 0.64 0.65
F 0.67 0.70 0.54 0.48 0.44 0.42 0.42 0.45 0.51 0.54 0.68 0.68
G 0.66 0.66 0.62 0.49 0.46 0.46 0.46 0.47 0.49 0.65 0.65 0.64
H 0.67 0.67 0.66 0.63 0.53 0.51 0.51 0.55 0.61 0.68 0.70 0.68
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.69 0.69 0.68 0.62 0.53 0.52 0.51 0.54 0.60 0.68 0.70 0.67
B 0.69 0.68 0.62 0.52 0.48 0.47 0.47 0.49 0.49 0.63 0.69 0.68
C 0.69 0.68 0.51 0.51 0.45 0.43 0.43 0.46 0.49 0.51 0.67 0.69
D 0.73 0.68 0.51 0.49 0.45 0.43 0.44 0.45 0.51 0.52 0.70 0.68
E 0.67 0.67 0.52 0.48 0.44 0.41 0.42 0.44 0.48 0.52 0.68 0.69
F 0.72 0.67 0.53 0.50 0.47 0.45 0.43 0.45 0.50 0.52 0.69 0.69
G 0.67 0.68 0.63 0.51 0.50 0.48 0.47 0.49 0.50 0.64 0.72 0.67
H 0.69 0.67 0.68 0.63 0.54 0.52 0.50 0.52 0.61 0.68 0.68 0.68
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4 DISCUSSION 
 
Throughout the past decade, PBM has gained more and more attention as a new 
treatment modality for a wide range of medical applications. Nevertheless, it is still 
considered as an alternative treatment approach due to a vast inconsistency of 
published outcomes and a lack of understanding the underlying molecular cascades 
triggered by irradiation. In contrast to red and (N)IR light, predominantly used in PBM 
studies, the application of blue light is rather connected to inhibitory effects and 
therefore only suitable for a few ailments. Thus, this study aimed at characterizing the 
response of primary human dermal fibroblasts to 453 nm light. Appropriate irradiation 
doses were inferred from XTT cell metabolism studies. Then, photobiomodulatory 
effects were investigated at different time points following light treatment monitoring 
short-term and long-term changes. In addition, the number of treatments was varied 
to set up a preliminary light schedule on cellular level for subsequent in vivo tests. 
Using various cell proliferation assays like cell cycle distribution studies, BrdU-ELISA 
and cell counting, it was tested whether metabolic changes are also reflected in 
altered proliferation rates. Furthermore, dose-dependent effects of blue light on 
mitochondria of NHDF cells were analyzed by measuring H2O2 concentrations and 
the mitochondrial membrane potential ΔΨm at different time points after irradiation. 
Moreover, for safety reasons, cell viability was assessed after treating NHDF cells 
with high blue light doses. To elucidate which genes and signaling pathways were 
commonly or differentially expressed after different irradiation doses, comprehensive 
gene expression analyses were performed at several time points following blue light 
treatment. All results were contributed to the European project MEDILIGHT, which 
developed a medical device facilitating personalized light therapy for chronic wound 
patients. Examining the mitochondrial activity of NHDF cells following treatment with 
selected light doses, the efficacy of the MEDILIGHT prototype was compared to the 
BioLight LED Lamp and finally validated for upcoming in vivo tests.  
 
A broad analysis of studies already published in the PBM research field showed that 
metabolic activity is one of the most common measures evaluated as an indicator of 
cell viability and proliferation. Since reports investigating blue light effects on a variety 
of fibroblast cell types showed different experimental outcomes using varying sets of 
irradiation parameters (Table 1), NHDF cells were at first exposed to different doses. 
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Therefore, the irradiation time was adjusted keeping a constant irradiance value of 
12 mW/cm2 at the plate surface (see 2.2.2.1, Table 7). Using the XTT Cell Viability 
Kit, changes in mitochondrial activity were investigated at 24 hours after irradiation. 
Over a range from 0.0 J/cm2 to 86.4 J/cm2 a biphasic dose-response curve was 
obtained with a maximum acceleration of cell metabolism by 7.10% using 5.4 J/cm2 
of blue light, while lower doses induced less significant effects. In contrast, higher 
irradiation doses suppressed the activity of mitochondrial enzymes to a maximum of 
about 30% (Figure 20). The phenomenon of dose-dependent effects has often been 
described in literature and is thus well-known in PBM research99. These biphasic 
dose-response curves are frequently linked to a common model dating back to 1887, 
the Arndt-Schulz law100, 101, which is nowadays defined by the term ‘hormesis’, first 
referenced by Stebbing in 1982102 and followed up by Calabrese103, 104. The law 
specifies that a certain energy threshold has to be crossed to evoke stimulation 
reaching its maximum following even stronger stimuli; instead, applying too much 
energy results in inhibitory effects (Figure 52).  
 
 
 
Figure 52: Three-dimensional surface plot illustrating the influence of an increasing irradiance [W/cm
2
] or 
irradiation time [s] on dose-dependent PBM effects
8
.  
 
In order to study both phases of the biphasic response curve, two irradiation doses 
were selected for subsequent experiments: 5.4 J/cm2 corresponding to 7.5 minutes of 
blue light and 21.6 J/cm2 resulting from an irradiation time of 30 minutes. In addition 
to the observed dose-dependency of metabolic activity, it was also shown to be time-
dependent (Figure 21). Both, stimulatory and inhibitory effects were long-lasting up to 
24 hours after a single treatment with respectively 5.4 J/cm2 and 21.6 J/cm2 of blue 
light, whereas at 48 hours and 72 hours the effects could not be maintained.  
Discussion  
84 
In a similar manner, Wataha et al.88 measured the mitochondrial activity of different 
types of fibroblasts at 24-hour intervals for 72 hours following exposure to different 
blue light sources. Whereas aneuploid mouse lung fibroblasts (Balb/c) revealed a 
constant suppression of succinate dehydrogenase activity for 72 hours, slower-
growing human gingival fibroblasts (HGF) and diploid human fibroblasts (WI-38) 
reacted differently. Blue light exposure of human gingival fibroblasts resulted in a 
transient suppression of succinate dehydrogenase activity by 30% at 24 hours, which 
was attenuated by 10% within the next 48 hours. Based on these cell type-specific 
responses, the authors claim that differential effects might depend on varying 
population doubling times and related energy consumption levels suggesting rapidly 
dividing cells to be more sensitive to irradiation88. With a population doubling time of 
43.3 hours, NHDF cells used in this study are rather classified as a slowly growing 
cell line reasoning the fast recovery of mitochondrial activity within 48 hours after 
irradiation (Figure 21), which is in line with the findings described by Wataha et al.88.  
 
Since a steady up- or down-regulation of cellular activity would benefit respectively 
the impaired healing process of chronic wounds or hypertrophic scaring, NHDF cells 
were treated once per day on two and three consecutive days. Hence, multiple light 
treatments were carried out in order to come up with a potential irradiation regimen 
for subsequent in vivo wound healing studies. In line with Oplander et al.81 and 
Taflinski et al.84, consecutive exposures to 21.6 J/cm2 of blue light revealed a further 
decrease in metabolic activity, while consecutive irradiations with 5.4 J/cm2 did not 
enhance the stimulatory effect found after a single treatment (Figure 22). However, 
two irradiations per day using 5.4 J/cm2 each with a 3-hour interval, accounting for a 
daily dosage of 10.8 J/cm2, caused a higher increase in metabolic activity compared 
to only one or even three treatments per day (Figure 23). Similarly, Brondon et al.105 
evaluated the effect of different treatment frequencies on the metabolic activity and 
proliferative capacity of human HEP-2 carcinoma cells and murine L-929 fibroblasts. 
Using red light of 670 nm, cells were treated either once, twice or four times a day 
receiving 5.0 J/cm2 per treatment. For both cell lines, the authors observed the 
highest stimulation with two irradiations per day, while four daily treatments led to 
reduced proliferation rates, which correlates to the results obtained for NHDF cells 
treated three times a day (Figure 23). Thus, besides determining favorable irradiation 
parameters, an appropriate light regimen has to be identified for each cell line.  
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To elucidate whether changed cellular activities are accompanied by a modulation of 
mitochondrial function and thus oxidative phosphorylation, overall differences in ATP 
concentration of untreated and light-treated cells were assessed. Whereas cellular 
ATP contents were diminished following irradiation with the higher blue light dose of 
21.6 J/cm2, mitochondrial respiration was stimulated at 1 hour and 24 hours after light 
treatment using 5.4 J/cm2 (Figure 24). Consequently, using indirect and direct assays 
examining the cellular energy status confirmed that blue light irradiation was capable 
of regulating mitochondrial respiration. In contrast to that, Liebmann et al.63 reported 
opposing trends when comparing the metabolic activity and ATP synthesis rates of 
keratinocytes and endothelial cells irradiated with 453 nm light, which were traced 
back to the onset of cellular differentiation. However, differentiation markers such as 
Thy-1, encoding the CD90 surface antigen106, and transforming growth factor beta 
(TGF-β), which is particularly related to an increased mitochondrial function107, were 
not significantly expressed in this study.  
 
Most notably, XTT and ATP assays, performed at matching time points following blue 
light treatment, showed correlating changes in the metabolic rate of NHDF cells when 
using different irradiation doses. However, since cell metabolism can be affected by a 
lot of different factors, its quantification cannot be directly translated into changes in 
cell proliferation108. Using different test strategies, including the analysis of cell cycle 
distribution, determination of new DNA synthesis and cell counting, proliferation was 
studied after single and consecutive irradiations with either 5.4 J/cm2 or 21.6 J/cm2. 
Flow cytometry analyses revealed a higher proportion of S-phase cells after a single 
and two consecutive light treatments with 5.4 J/cm2, which was accompanied by a 
lower cell fraction staying in G0/G1 (Figure 26). Hence, low doses of blue light 
seemed to result in a higher proliferative capacity, which was confirmed by an 
increased synthesis of cellular DNA (Figure 27) and elevated cell counts (Figure 28). 
However, three consecutive light treatments slightly reversed the stimulatory effect, 
which might be explained by a nearly confluent cell monolayer yielding contact 
inhibition and therefore limited proliferation. Although the seeded cell number was 
adjusted according to the respective experiment duration, it could not be further 
reduced since low plating densities favor differentiation into myofibroblasts109. In 
addition, three irradiations delivering 5.4 J/cm2 each (16.2 J/cm2) seemed to evoke 
replication stress, indicated by a slightly higher amount of apoptotic cells (Figure 26).  
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The latter observation was even more enhanced with an increasing number of light 
treatments using 21.6 J/cm2 each leading to deleterious effects. A single irradiation 
revealed a higher proportion of G0/G1-phase cells accompanied by a reduction in S-
phase cells, which was exactly the opposite compared to the cell cycle distribution 
obtained after one treatment with 5.4 J/cm2. Two and three treatments rather resulted 
in a shift to increasing percentages of G2/M-phase cells (Figure 26). At 72 hours and 
96 hours after exposure to 470 nm light, Ohara et al.110 observed similar effects in 
B16 melanoma cells, suggesting an inhibited G1/S transition as well as a prolonged 
M phase as possible reasons for slower cell growth. In accordance with Li et al.111 the 
increased amount of G2/M-phase cells after multiple exposures might be explained 
by several bursts in H2O2, since they had reported that H2O2 evoked G2 cell cycle 
arrest and therefore inhibited cell proliferation of murine and human osteoblasts. The 
continuous decline in S-phase cells was confirmed by BrdU-ELISA results, showing a 
persistent slow-down of DNA synthesis (Figure 27), and lower cell counts (Figure 28). 
  
A delayed ability to enter mitosis from G2 might be also inferred from an increased 
size of cell nuclei, which was constantly enhanced following multiple exposures of 
NHDF cells to 21.6 J/cm2 (Figure 29). According to Gregory et al.112 and Cavalier-
Smith et al.113 describing the ‘nucleoskeletal theory’, a larger nuclear size might be 
related to a higher DNA content as well as a lower extent of chromatin condensation 
giving rise to a larger cell volume. In contrast, several other studies propose different 
mechanisms affecting nuclear size and shape involving either the re-organization of 
the endoplasmic reticulum114 or the activation of nuclear lamina proteins115. However, 
cell nuclei staining following consecutive irradiations using 5.4 J/cm2 revealed only 
slight, negligible changes in nuclear size (Figure 29).  
 
Assuming that blue light mediates cellular processes to some extent via stimulation 
or inhibition of mitochondrial respiration, further tests were carried out investigating 
mitochondrial function following blue light exposure. Moreover, the latter were mainly 
justified by the fact that photosensitizers absorbing wavelengths of the visible blue 
range, namely porphyrin ring structures and flavins, are supposed to be concentrated 
in mitochondria. Upon blue light absorption, they are known to generate ROS, which 
represent key secondary messengers mediating downstream effects116. Therefore, 
ROS generation is another widely used test variable in PBM research (Table 1).  
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As a result of normal mitochondrial metabolism, ROS are produced in physiological 
concentrations acting as beneficial signaling molecules in metabolic control, cellular 
proliferation, stress responses, cell survival, death and inflammatory processes117. In 
contrast, high ROS levels or sustained ROS generation promote oxidative damage, 
particularly to DNA, proteins as well as lipids, finally leading to cell death, which 
characterizes ROS as so-called ‘Janus-type’ mediators99. Since H2O2 represents a 
major component of ROS species in cells118 and is relatively stable119, its production 
was analyzed at different time points following single blue light exposures to either 
5.4 J/cm2 or 21.6 J/cm2 (Figure 30). In line with the study performed by Zeng et al.120, 
who assessed intracellular ROS generation in mouse dermal fibroblasts after UVB 
irradiation, the H2O2 concentration reached its maximum at 30 minutes and was 
normalized at 1 hour after irradiation. Thus, the well-known effect of increased ROS 
levels by blue light was confirmed77, 85, 89. However, contrary to the assumption that 
higher irradiation doses correlate with elevated ROS levels121, a higher H2O2 peak 
was found directly after blue light treatment with the lower dose of 5.4 J/cm2. Similar 
outcomes were reported by Huang et al.10, who observed a biphasic response of 
intracellular ROS levels in mouse embryonic fibroblasts, measured at 5 minutes 
following irradiation with different doses of 810 nm laser light. This observation might 
be connected to the higher metabolic activity found when using the lower blue light 
dose of 5.4 J/cm2, generating even higher concentrations of mitochondrial ROS.  
 
Since both blue light doses resulted in a rapid depolarization of ΔΨm, reflected by 
decreased TMRE fluorescence intensities (Figure 31, Figure 32), and a subsequent 
impairment of oxidative phosphorylation and therefore ATP synthesis at 3 hours after 
irradiation (Table 12, Figure 24), increased ROS levels were considered to induce 
oxidative stress. However, in contrast to Zeng et al.120, who showed a progressive 
decline in ΔΨm of mouse dermal fibroblasts after 4x 120 mJ/cm2 of UVB irradiation, 
leading to premature senescence and apoptosis, ΔΨm was found to recover within 
6 hours (Figure 31). Besides highly increased ROS levels, also repair mechanisms 
were found significantly up-regulated shortly after irradiation with both doses, which 
reinforces the hypothesis of oxidative stress induction. For the lower blue light dose 
of 5.4 J/cm2, the KEGG gene set ‘base excision repair’ was significantly enriched 
representing the predominant DNA repair pathway for small base lesions most likely 
induced by oxidative stress122 (Table 14, (A)).  
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In contrast, using 21.6 J/cm2 of blue light revealed a significant up-regulation of 
homologous recombination as well as of the Fanconi anemia pathway (Table 14, (B)) 
probably indicating the occurrence of DNA double-strand breaks or interstrand cross-
links, which are rather ascribed to high-energy X-ray radiation instead of VIS or even 
UV irradiation123, 124. Moreover, this assumption is contrary to the findings of Taoufik 
et al.85, who did not observe formation of DNA double-strand breaks following blue 
light treatment of primary human gingival fibroblasts, although they used even higher 
irradiation doses. Mignon et al.80 even observed several repair pathways to be down-
regulated after exposing primary reticular fibroblasts to 30 J/cm2 of 450 nm light. 
However, a single blue light treatment using 21.6 J/cm2 seemed to harm NHDF cells 
to a higher extent than the lower irradiation dose of 5.4 J/cm2, although the H2O2 
concentration, measured at 30 minutes after irradiation, was less (Figure 30). As 
suggested by Huang et al.99, this observation might be explained by the generation of 
different kind of ROS species hypothesizing superoxides as good ROS, whereas 
hydroxyl radicals and peroxynitrite represent bad ROS showing a higher damaging 
potential. Consequently, apart from testing H2O2, additional studies examining other 
ROS species might be necessary to broaden the investigation of redox regulation. 
  
However, single blue light treatments up to 172.8 J/cm2 did not show any signs of cell 
death induction (Figure 39), which was similarly observed by Liebmann et al.63 
claiming cytotoxic effects on human keratinocytes and endothelial cells only for high 
doses of 453 nm light (> 500 J/cm2). In addition, cell viability tests performed by 
Masson-Meyers at el.78 showed that doses < 110 J/cm2 of 470 nm light were safe 
when irradiating human dermal fibroblasts.  
 
Based on gene expression levels, KEGG pathways related to cell growth and death 
were not significantly regulated in most cases (Table 15). However, shortly after 
irradiation with 5.4 J/cm2, TP53 coding for p53 was slightly up-regulated inducing the 
expression of genes like GADDA45A, CDKN1A (p21), BID and CASP3, which 
indicates the onset of DNA repair and damage prevention by promoting cell cycle 
arrest and apoptosis125. Chen et al.126 have observed similar changes in H2O2-treated 
fetal lung fibroblasts, suggesting that oxidant exposure induces cell recovery via p53 
activation. Accordingly, Smith et al.127 figured out that mouse embryonic fibroblasts 
lacking p53 or GADD45 genes exhibited a higher sensitivity to DNA damage.  
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In the following time course, TP53 transcription was suppressed by the activation of 
its antagonist MDM2, which encodes a nuclear-localized E3 ubiquitin ligase. This 
observation might reflect a decrease in cellular stress, which was accompanied by 
significantly down-regulated genes involved in the caspase cascade like APAF-1, 
CASP8 and CASP3. In comparison, the higher blue light dose of 21.6 J/cm2 induced 
a time-shifted up-regulation of stress response genes at 3 hours after irradiation 
accounting for statistical enrichment of the entire pathway (Table 15, (B)). However, 
at 24 hours of harvesting apoptotic genes were found down-regulated, whereas the 
activity of CCND1/CDK4 and CCNE1/CDK2 complexes were inhibited promoting G1 
arrest128, which was also reflected by time-matched cell cycle analyses (Figure 26).  
 
Although apoptosis pathways were rather up-regulated following blue light treatment 
of NHDF cells with 5.4 J/cm2 (Table 15, (A)), single gene expression indicated a 
continuous up-regulation of BCL2 encoding a homonymous, anti-apoptotic protein, 
which antagonizes BID activity within the intrinsic apoptosis pathway. Thereby, 
Bak/Bax-mediated mitochondrial outer membrane permeabilization (MOMP) yielding 
cytochrome c release and subsequent caspase activation involving inter alia CASP3, 
CASP7 and CASP9 might be counteracted preventing the translation of stress 
responses into apoptosis. Also, Naik et al.129 observed that overexpression of Bcl-2 in 
mouse embryonic fibroblasts promoted cell survival by the inhibition of apoptotic 
signaling thereby enhancing their resistance to UV radiation. Besides the intrinsic 
apoptosis pathway, genes encoding death ligands of the extrinsic pathway such as 
FASLG or TNSF10 were found significantly up-regulated at 3 hours after blue light 
treatment; nevertheless, the caspase cascade executing programmed cell death still 
remained slightly down-regulated since respective adaptors were not significantly 
expressed. In contrast, when using the higher blue light dose of 21.6 J/cm2, the 
interplay between BCL2 and BID was reversed at 1 hour of cell harvesting, followed 
by a significant up-regulation of genes encoding extrinsic death receptors like FAS 
and TNFRSF10D as well as cytoplasmic proteins like APAF-1 promoting caspase 
activation at 3 hours after irradiation. Though, gene transcription levels of single 
caspases were not significantly modulated, which strongly correlated with the results 
of cell viability analyses using flow cytometry (Figure 39). Therefore, oxidative stress 
induced by blue light seemed to be reversible preventing the cells from undergoing 
persistent damage and death, particularly for 5.4 J/cm2 of blue light.  
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This was also indicated by the fast alleviation of immediate H2O2 bursts shortly after 
irradiation (Figure 30). Since mitochondria represent the primary source of ROS 
contributing up to 95% of intracellular levels130 and contain classical blue light 
photosensitizers62, the fast recovery to physiological ROS levels might be explained 
as a result of mitochondrial hormesis (‘mitohormesis’). Under conditions of metabolic 
stress, inter alia indicated by a reduction of ΔΨm directly after irradiation (Figure 31), 
unbalanced AMP/ATP ratios are likely to arise. In this context, several disease 
pathways like Alzheimer’s disease, Parkinson’s disease and Huntington’s disease, in 
which mitochondria play a critical role, were found significantly down-regulated at 
3 hours after blue light treatment with both irradiation doses (Table 12). In detail, the 
expression of genes like NDUFA1, SDHB, CYC1, COX4I1 and ATP5A1 encoding 
subunits of respiratory chain complexes I – V was significantly lower when compared 
to the control. Hence, the activity of mitochondrial complexes might be impaired, 
which leads to a compromised energy metabolism by blocking electron transfer within 
the respiratory chain. The latter was confirmed by an accompanying down-regulation 
of oxidative phosphorylation for both blue light doses (Table 12), which may result in 
a decreased susceptibility to apoptosis131. Moreover, SLC25A4, encoding the subunit 
of an ADP/ATP carrier across the mitochondrial membrane was found significantly 
down-regulated, favoring an unbalanced energy status.  
 
Consequently, AMP-activated protein kinase (AMPK), an important cellular energy 
sensor, might be activated restoring ATP homeostasis by stimulating catabolic 
energy-releasing pathways and inhibiting anabolic energy-consuming processes132. 
This assumption was supported by gene expression profiles showing a significant up-
regulation of PRKAA1 at 1 hour and 3 hours after blue light treatment with 5.4 J/cm2, 
coding for the catalytic subunit of AMPK. As a result, mitochondrial activity was 
increased, which was proven by XTT assays (Figure 21) as well as the significant up-
regulation of oxidative phosphorylation at 1 hour and 24 hours following irradiation 
(Table 13), which coincided with elevated ATP concentrations at the respective time 
points (Figure 24). Inevitably, mitochondrial ROS levels were probably increased, 
which might also trigger AMPK activation leading to adaptive changes in cellular 
metabolism133. In addition, several other metabolic pathways were significantly up-
regulated, which provides further evidence of metabolic reprogramming (Figure 43, 
Table 13).  
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Thereupon, several redox-sensitive transcription factors might be activated, which 
translocate from the cytoplasm to the nucleus affecting gene transcription in a 
retrograde response134, 135, mainly mediating cytoprotective responses to oxidative 
stress. Hence, recurrent and mild activations of defense mechanisms may contribute 
to the development of a long-term resistance against oxidative stress136.  
 
In contrast, at 1 hour and 24 hours following blue light treatment with 21.6 J/cm2, 
PRKAA1 was slightly down-regulated or left unaffected, explaining the emerging lack 
of metabolic and energy homeostasis in NHDF cells, which was represented by a 
continuous suppression of mitochondrial activity (Figure 21, Figure 24). Nonetheless, 
affirming the assumption of counteracting oxidative stress, the metabolism of 
xenobiotics by cytochrome P450 was significantly up-regulated at 24 hours after 
irradiation with both blue light doses involving several genes coding for XMEs 
(Table 12). Those, encoding phase II detoxification enzymes like GSTs and UGTs, 
belong to a group of stress-dependent genes activated by Nrf2. The latter represents 
a key transcription factor inducing cytoprotective responses to oxidative stress as 
well as a potential target of AMPK137. Upon inactivation of kelch like ECH associating 
protein 1 (Keap1), Nrf2 translocates to the nucleus, binds to the antioxidant response 
element (ARE) and finally triggers the transcription of genes involved in xenobiotic 
metabolism and disposition, antioxidant defense and redox signaling138, 139.  
 
Moreover, at 1 hour after irradiation, both light doses resulted in an up-regulation of 
other Nrf2-transcribed genes140, while in most cases their expression was enhanced 
over time, especially for 21.6 J/cm2 of blue light (Figure 45). Similarly, Didier et al.141 
as well as Meewes et al.142 proposed that UVA irradiation was found to increase 
superoxide dismutase (SOD) and thioredoxin (TRX) activity in human skin fibroblasts 
preventing phototoxicity mediated by oxidative stress. As a result, resistance against 
repeated ROS exposure might be induced by developing an adaptive antioxidant 
response, which is commonly known as ‘preconditioning’. However, after consecutive 
exposures to 21.6 J/cm2 of blue light, excessive ROS accumulation may not have 
been compensated by antioxidant defense mechanisms showing exhausted buffering 
capacity, which gave rise to long-term defects and finally cell death (Figure 26)143.  
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Besides AMPK, the aryl hydrocarbon receptor (AhR) was suggested as a possible 
target of blue light irradiation activating downstream processes involved in antioxidant 
defense mechanisms. Becker et al.144 reported that blue light irradiation of human 
keratinocytes for 7.5 minutes did not show significant changes in oxidative stress-
dependent Nrf2-transcribed genes, while an exposure time of 30 minutes revealed a 
continuous up-regulation of phase I and II XMEs. In comparison, NHDF cells seemed 
to show a higher sensitivity in response to oxidative stress, since Nrf2 and its target 
genes were even up-regulated using the lower blue light dose. Moreover, at 24 hours 
after treating NHDF cells with both blue light doses, the AhR signaling pathway was 
found significantly up-regulated (Table 12). Consequently, the differential modulation 
of oxidative stress response genes shows cell-type specific changes, which might be 
explained by two possible reasons. First, the studies of Becker et al. were performed 
using immortalized human keratinocytes. Increasing evidence suggests that these 
cells are transcriptomically and functionally different from primary cells resulting in 
different sensitivity levels145, 146. Second, fibroblasts are less amenable to blue light 
irradiation compared to keratinocytes, since they are located in deeper skin layers 
showing a higher sensitivity. Similar effects were reported by Marionnet et al.147, who 
tested 24 markers involved in various antioxidant defense systems following UV 
radiation of a reconstructed skin model including keratinocytes and fibroblasts. In the 
latter, a higher number of genes was found to be significantly modulated shortly after 
UV treatment, which correlates with the results obtained for light-treated NHDF cells.  
 
In addition, consistent with Tigges et al.’s observations148, it was found that the AhR 
repressor gene AHRR was expressed twice as high in NHDF cells when compared to 
keratinocytes. This might be linked to a less pronounced up-regulation of CYP1A1 
and CYP1B1, coding for phase I detoxification enzymes, which was denied by Tigges 
et al. Though, in addition to xenobiotic metabolism, CYP enzymes are also reported 
to play a crucial role in steroid hormone biosynthesis149, accounting for the anti-
inflammatory effects found after blue light irradiation of human keratinocytes144. 
Treating NHDF cells with both blue light doses showed no significant changes in the 
steroid hormone biosynthesis pathway, while the ovarian steroidogenesis was found 
to be significantly up-regulated at 24 hours following blue light treatment (Table 12). 
Nonetheless, in direct comparison to the effects described for human keratinocytes, 
blue light irradiation revealed less anti-inflammatory potential exerted in NHDF cells. 
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Inflammatory processes, stress-induced responses as well as cell survival can be 
also mediated via the nuclear factor kappa B (NF-κB), a redox-sensitive transcription 
factor, which can be equally activated by AMPK and AhR, while it is still controversial 
for the latter16, 150, 151. Known from a study performed by Liu et al.150, activated AMPK 
facilitates the transcriptional activity of NF-κB by enhancing the ubiquitination and 
therefore degradation of κB inhibitors (IκBs). Thus, AMPK is capable of triggering the 
expression of anti-apoptotic genes via the canonical NF-κB pathway, promoting cell 
survival. Shortly after irradiation, the NF-κB signaling pathway was up-regulated for 
both irradiation doses reaching statistical significance at 3 hours following light 
treatment with 21.6 J/cm2 (Table 16). Indeed, especially the latter condition showed 
many anti-apoptotic genes being up-regulated involving inter alia BCL2, BCL2A1, 
BIRC2, XIAP and GADD45B, which correlates to the findings made by Liu and 
colleagues150. Moreover, inflammatory processes seemed to be enhanced, which 
matched with a nearly continuous up-regulation of the TNF signaling pathway defined 
by KEGG (Table 16). Although blue light is said to be anti-inflammatory29, 58, genes 
encoding pro-inflammatory chemokines and cytokines were also significantly up-
regulated favoring the recruitment and activation of various immune cells to the site 
of injury. With respect to acute and chronic wound healing by blue light treatment, 
this might be particularly helpful in accelerating the entire repairing process.  
 
Moreover, the up-regulation of PRKAA1 shortly after irradiation with 5.4 J/cm2 of blue 
light might have led to the phosphorylation and thus activation of FOXO1 encoding 
the forkhead box protein O1136, 152, which represents an important transcription factor 
involved in cell cycle progression, stress tolerance and cell survival. At 1 hour of 
harvesting, FOXO1 was significantly up-regulated inducing the transcription of genes 
encoding CDK inhibitors such as p15 (CDKN2B) and p21 (CDKN1A) as well as the 
growth arrest and DNA-damage-inducible protein GADDA45 alpha promoting cell 
cycle arrest. In addition, FOXO1-dependent transcription of antioxidant genes was 
increased, which matches to the modified expression of TP53 and Nrf2-transcribed 
genes. Hence, cell cycle progression might be halted allowing cells to recover from 
oxidative stress and to repair potential damage before resuming normal proliferation. 
However, at 3 hours after irradiation, the regulation of FOXO-transcribed genes lost 
statistical significance turning to down-regulation at 24 hours following blue light 
treatment (Table 16, (A)).  
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In addition to AMPK, serine/threonine kinase 1 (AKT), encoded by AKT1, acts as a 
primary effector in response to metabolic stress, while their interplay is characterized 
by antagonistic roles. Thus, at 24 hours following irradiation using 5.4 J/cm2 of blue 
light, FOXO1 was significantly down-regulated by its inhibitor AKT1, which surpasses 
AMPK activation by phosphorylation153. Therefore, genes enhancing growth arrest 
were significantly down-regulated favoring an unimpaired cell cycle progression of 
light-treated NHDF cells, which was shown by an increased accumulation of cells in 
the S phase (Figure 26) and higher DNA replication rates (Figure 27, Table 14 (A)). 
In line with a lower expression of TP53, cell cycle regulation turned from inhibition in 
the short-term to stimulation in the long-term. In contrast, with the higher blue light 
dose of 21.6 J/cm2 PRKAA1 was slightly up-regulated at 3 hours of harvesting, while 
AKT1 was not significantly enriched. Consequently, FOXO1 was equally up-regulated 
promoting cell growth arrest as well as oxidative stress resistance and DNA repair. In 
addition to an accompanying up-regulation of the p53 signaling pathway, correlating 
changes were followed within the significantly enriched NF-κB gene set, revealing 
higher expression levels of anti-apoptotic genes. Just like AMPK, AKT is also known 
to be involved in the regulation of NF-κB154; however, this relation could not be 
inferred in this study. The differential expression of AKT1 by both irradiation doses 
also indicated a divergent trend in the regulation of cell survival, showing significant 
down-regulation of the PI3K-Akt signaling pathway at 24 hours after 21.6 J/cm2 of 
blue light (Table 16, (B)).  
 
In addition to the FoxO signaling pathway, the antagonistic crosstalk between AMPK 
and AKT plays an important role in the mTOR signaling pathway153. While AMPK 
stimulation inhibits the mechanistic target of rapamycin (mTOR), AKT is known to 
activate its expression leading to changes in protein synthesis, cellular growth and 
metabolism155. In line with the significant up-regulation of PRKAA1 at 1 hour and 
3 hours following irradiation using 5.4 J/cm2, MTOR was found down-regulated. The 
opposing regulation of cell metabolism and growth was also confirmed at 24 hours of 
harvesting, while MTOR got significantly up-regulated probably yielding an increased 
protein synthesis, which might enhance cell growth and therefore proliferation. In 
direct comparison, the higher light dose of 21.6 J/cm2 showed a contrary regulation 
over time: Directly following irradiation MTOR was slightly up-regulated going along 
with an inhibition of PRKAA1, while their regulation was inversed at 24 hours.  
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Consequently, blue light irradiation with the lower dose of 5.4 J/cm2 resulted in a 
higher growth capacity over time, which matched to the results of various proliferation 
assays (Figure 26 - Figure 28).  
 
Time-dependent changes in cell proliferation after blue light irradiation could also be 
inferred from cell cycle-related genes. In addition to an early up-regulation of p21 at 
1 hour after blue light treatment with 5.4 J/cm2 promoting cell cycle arrest, CDK9 was 
found significantly enriched maintaining cell cycle recovery and thus genome integrity 
in response to replication stress or spontaneous DNA damage156. However, CCND2 
encoding cyclin D2 was highly expressed at 3 hours of harvesting promoting G1/S 
phase transition and thus cell cycle progression. At 24 hours after irradiation, CDK2 
was found significantly up-regulated encoding a cyclin-dependent serine/threonine 
protein kinase with maximum activity during S and G2 phase. Throughout cell cycle 
progression, CDK2, which interacts with cyclin A, B1, B3, D and E, phosphorylates 
retinoblastoma proteins and thereby releases the transcription factor E2F1. Upon 
activation, the latter promotes the expression of genes involved in G1/S transition, 
DNA replication and mitosis, such as FOXM1, which was highly expressed after 
24 hours. Moreover, genes playing a crucial role in the formation of the anaphase 
promoting complex like ANAPC1, ANAPC4 and ANAPC5 were highly up-regulated, 
revealing an increased proliferative activity. In comparison to the lower blue light 
dose, which induced a continuous up-regulation of the cell cycle pathway, it was 
inhibited after irradiation with 21.6 J/cm2 of blue light, apart from showing significant 
up-regulation at 3 hours of harvesting (Table 16). The latter might be explained by an 
increased expression of DNA-damage response genes, like PRKDC as well as ATM, 
without significantly affecting genes, which are responsible for cell cycle progression. 
PRKDC and ATM can be activated upon double-strand breaks157 matching to the up-
regulation of the repair mechanism ‘homologous recombination’ (Table 14, (B)). ATM 
can directly activate p53 by phosphorylation, with the respective pathway shown to 
be highly up-regulated at 3 hours of harvesting (Table 15, (B)), inducing the activation 
of DNA repair proteins and cell growth arrest. At 24 hours after irradiation, all CDKs 
were down-regulated indicating a slowed-down cell cycle progression. Moreover, the 
proliferation stop was confirmed by a significantly decreased expression of PRKCA, 
coding for protein kinase C (PKC), which was reported to promote irradiation-induced 
apoptosis in human lung fibroblasts by down-regulating anti-apoptotic markers158.  
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However, coming back to the increasing proportion of G2/M-phase cells following 
consecutive light treatments with 21.6 J/cm2 each (Figure 26), G2 cell cycle arrest 
was suggested as a possible explanation. Since the G2 phase provides time for 
proofreading and packaging of replicated DNA prior to cell division, its increasing 
prolongation might indicate an accumulation of replication errors, which retains NHDF 
cells at the G2/M checkpoint and thus prevents them from passing through the cell 
cycle159. Though, the mismatch repair pathway, which is activated in response to 
replication errors122, was not significantly enriched. According to Ianzini et al.160, 
another explanation for the growing emergence of G2/M-phase cells could be an 
excessive accumulation of cyclin B in cells arrested in the late cell cycle due to a lack 
of p53 signaling. Contrary to the expectation that a higher blue light dose, a potential 
stress signal, triggers an increase of p53, TP53 was slightly down-regulated at 1 hour 
and 3 hours after irradiation reaching statistical significance at 24 hours. Moreover, at 
24 hours of harvesting, a significant up-regulation of CCNB1 encoding cyclin B arose 
indicating elevated cyclin B1 protein levels. Therefore, although CDK1 encoding the 
associated kinase was slightly down-regulated, some cells might have shown a 
premature entry into mitosis due to an overaccumulation of cyclin B1. As suggested 
by Ianzini et al.160, this could possibly lead to an abrogation of the G2/M checkpoint 
followed by mitotic catastrophe (MC), which often results in cell death. The latter 
finding correlates with the growing population of apoptotic cells induced by multiple 
irradiations with 21.6 J/cm2 each on consecutive days (Figure 26), which in turn might 
also explain lower DNA synthesis rates and cell counts (Figure 27, Figure 28). 
  
Due to uncontrolled temperature rises during continuous operation, irradiations with 
the MEDILIGHT system had to be performed in cycled mode (Figure 46, Figure 47). 
Compared to cell metabolism studies with the BioLight LED Lamp, a similar biphasic 
dose-response curve was obtained, although higher doses were required to induce 
comparable changes (Figure 49). A literature review revealed that the use of thermal 
cycling is quite known for heat management issues, whereas especially laser light 
treatments are rather performed in pulsed mode (light pulses of < 1 second, DIN EN 
60079-28) avoiding tissue heating161. However, on the one hand, dose fractionation 
might have increased the threshold to induce stimulation, while on the other hand, 
less cytotoxic effects might have been induced by recurrent lower doses. Therefore, 
the stimulatory window was not only shifted to higher doses, but also broadened.  
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Consequently, with a sufficient light distribution through the wound dressing E2723, 
the MEDILIGHT prototype showed a comparable efficacy to the BioLight LED Lamp 
validating its use for subsequent in vivo tests. Nevertheless, in order to analyze the 
discrepancy of biological effects induced by different irradiation modes, further 
studies are needed to elucidate the underlying mechanisms of action.  
 
In conclusion, it was shown that varying blue light doses, 5.4 J/cm2 and 21.6 J/cm2, 
differentially impacted the metabolic activity, proliferation rates and the mitochondrial 
function of NHDF cells. Moreover, gene expression profiles suggested different levels 
of oxidative stress to occur after single treatments with both irradiation doses. In 
addition to antioxidant defense mechanisms, the balance between pro-survival and 
pro-apoptotic forces was affected, finally leading to contrary cell fates. Thereby, the 
lower blue light dose of 5.4 J/cm2 seemed to allow a faster cell adaptation to acute 
light stress via redox homeostasis and metabolic reprogramming, which was crucial 
for maximizing cell survival and resistance to cell death. All in all, several routes of 
cytoprotection were found to be activated shortly after irradiation, including growth 
arrest, antioxidant defense and DNA repair mechanisms promoting cell recovery and 
even an enhanced proliferation activity in the long run. In contrast, following blue light 
treatment with 21.6 J/cm2, cytoprotective responses were activated at a later time 
point showing an increasing stimulation of antioxidant defense strategies up to 
24 hours afterwards. Nonetheless, when exposing NHDF cells to consecutive blue 
light treatments with 21.6 J/cm2 each, they probably failed to maintain redox balance 
leading to a sustained mitochondrial dysfunction and finally cell death, either induced 
by an accumulation of cell damage over time or MC.  
 
However, it has to be noted that the study was performed with artificially cultured 
cells lacking physiological conditions of mammalian tissue, which involves the 
interaction of several cell types in the local milieu as well as other response factors 
induced by irradiation. Although suitable irradiation parameters were found for NHDF 
cells cultured under optimized conditions, further investigation needs to be performed 
using in vitro disease and animal models. Thereby, effective PBM regimens could be 
established, particularly with respect to the light treatment of non-healing chronic 
wounds characterized by an impaired activity of dividing cells, but also hypertrophic 
scars and keloids.  
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5 SUMMARY 
Phototherapy, basically heliotherapy, has already been used for the last 3,000 years. 
However, major breakthroughs in modern clinical phototherapy were achieved since 
the beginning of the 20th century, including for instance the invention of lasers. From 
then on, the use of light as a therapeutic tool grew constantly, demonstrated by the 
development of new artificial light sources and an increasing number of published 
studies on a variety of medical, mostly cutaneous, disorders. But although the last 
decade has witnessed a rapid expansion of PBM, its scientific acceptance is still 
debated: first, due to inconsistent experimental outcomes, caused by highly variable 
study designs and irradiation parameters, and second, due to a lack of mechanistic 
insights into light-triggered signaling. The latter especially applies for blue light, which 
is, in comparison to red and N(IR) light, rather used for a limited range of medical 
cutaneous ailments, primarily necessitating inhibitory or even cytotoxic effects, like 
fibrotic skin diseases. However, also stimulatory effects of blue light have rarely been 
reported in wound healing studies. Hence, the biomodulatory potential of different 
blue light doses on cellular activity was examined using primary normal human 
dermal fibroblasts, NHDF cells, in particular with respect to metabolic processes, cell 
proliferation and transcriptome changes.  
 
PBM using blue light revealed dose-dependent effects on the metabolism of NHDF 
cells, with low doses resulting in an increased activity, whereas higher irradiation 
doses induced a decreased and therefore inhibited cell metabolism. Based on the 
biphasic response, two irradiation doses, each leading to the maximum effect in the 
respective phase, were selected: 5.4 J/cm2 and 21.6 J/cm2. Cell metabolism assays 
performed at different time points after irradiation with either 5.4 J/cm2 or 21.6 J/cm2, 
revealed a fast response following the lower dose, while the higher one led to a 
delayed onset of metabolic inhibition. Nevertheless, both, stimulation and inhibition of 
cellular metabolism were long-lasting until 24 hours after light treatment. Subsequent 
studies with repeated irradiations on consecutive days, imitating a ‘chronic’ exposure 
model, showed an enhanced inhibition following multiple treatments using 21.6 J/cm2 
of blue light, whereas two daily treatments over several days were required for an 
increased stimulation by 5.4 J/cm2 of blue light.  
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The contrary effects on cell metabolism observed for both irradiation doses, were 
translated into similar, but less pronounced effects in proliferation, which was studied 
with various assays testing cell cycle distribution, DNA synthesis and cell counts. 
Also gene expression profiles revealed contrary trends in DNA replication and cell 
cycle regulation affecting cyclins, CDKs as well as repair checkpoints. Mitochondrial 
function was assessed by measuring H2O2 concentrations and ΔΨm at different time 
points following irradiation. Both blue light doses revealed a rapid increase of H2O2 
levels, accompanied by fast decreases in ΔΨm indicating metabolic stress; however, 
both effects returned towards control levels within 24 hours. Thus, to some extent, 
light effects were identified to rely on retrograde mitochondrial signaling altering the 
expression of several transcription factors like NF-κB or Nrf2 via changes in ΔΨm 
and the Janus-face mediator ROS. Moreover, PRKAA1 and AKT1 coding for primary 
effectors of metabolic stress, respectively AMPK and AKT, were found significantly 
expressed exerting antagonistic regulations of FOXO1 and MTOR, which modulate 
oxidative stress resistance, cell survival and growth. In addition, genes involved in 
antioxidant defense mechanisms, inter alia transcribed by Nrf2 and AhR, were found 
up-regulated, showing a higher activation for 21.6 J/cm2. Cytoprotection was further 
promoted by affecting the interplay between pro- and anti-apoptotic genes inducing 
stress resistance and even a higher proliferative capacity following 5.4 J/cm2 of blue 
light. Prevention of apoptotic signaling was verified by cell viability studies negating 
cytotoxicity up to a single light dose of 172.8 J/cm2. Though, reduced proliferation 
rates observed after consecutive irradiations with 21.6 J/cm2 each were accompanied 
by a higher occurrence of apoptotic cells, possibly indicating mitotic catastrophe.  
 
In conclusion, blue light seemed to be pro-oxidant in the short term, but anti-oxidant 
in the long term likely to induce stress resistance, at least following low and controlled 
amounts of oxidative stress. Driven by metabolic and redox homeostasis, various 
downstream processes were activated modifying antioxidant defense, survival and 
proliferation. Moreover, the results indicated that an optimal choice of irradiation 
parameters, particularly the dose, is important for the effectiveness of the treatment, 
since doses lower or higher than the optimum can lead to ineffective or even negative 
outcomes. Using cycled irradiation, the differential effect of blue light doses on NHDF 
cells might be exploited for novel concepts in advanced wound care, particularly for 
chronic wounds showing impaired activity of dividing cells and fibrotic skin diseases.  
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Table 17: Statistics for Figure 20. Using the Wilcoxon method, nonparametric comparisons were performed for each pair. Statistically significant differences from the untreated 
control are indicated by a nominal p-value < 0.05.  
- Level 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Level 1.8 3.6 5.4 7.2 9.0 10.8 12.6 14.4 16.2 18 21.6 32.4 43.2 64.8 86.4 
p-Value 0.5094 <.0001 <.0001 <.0001 0.0003 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 
 
Table 18: Statistics for Figure 21. Using the Wilcoxon method, nonparametric comparisons were performed for each pair. Statistically significant differences from the untreated 
control are indicated by a nominal p-value < 0.05.  
Dose [J/cm
2
] 5.4 21.6 
- Level 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Level 1 3 6 12 24 48 72 1 3 6 12 24 48 72 
p-Value <.0001 <.0001 0.5560 0.2366 <.0001 <.0001 0.4001 0.3525 0.0611 <.0001 <.0001 <.0001 0.2172 <.0001 
 
Table 19: Statistics for Figure 22. Using the Student’s t-test (Wilcoxon method), (nonparametric) comparisons were performed for each pair. Statistically significant differences for 
each pair are indicated by a nominal p-value < 0.05.  
Dose [J/cm
2
] 5.4 (Wilcoxon method) 21.6 (Student‘s t-test) 
- Level 0 0 0 5.4 5.4 10.8 0 0 0 21.6 21.6 43.2 
Level 5.4 10.8 16.2 10.8 16.2 16.2 21.6 43.2 64.8 43.2 64.8 64.8 
p-Value <.0001 <.0001 <.0001 0.5359 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 0.9727 
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Table 20: Statistics for Figure 23. Using the Student’s t-test (Wilcoxon method), (nonparametric) comparisons were performed for each pair. Statistically significant differences 
from the untreated control are indicated by a nominal p-value < 0.05.  
Irradiation No. 
per Day 
1x (Wilcoxon method) 2x (Student‘s t-test) 3x (Student‘s t-test) 
- Level 0 0 0 0 0 0 0 0 0 
Level 5.4/10.8/16.2 10.8/21.6/32.4 16.2/32.4/48.6 5.4/10.8/16.2 10.8/21.6/32.4 16.2/32.4/48.6 5.4/10.8/16.2 10.8/21.6/32.4 16.2/32.4/48.6 
p-Value <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 
 
Table 21: Statistics for Figure 24. Using the Wilcoxon method, nonparametric comparisons were performed for each pair. Statistically significant differences from the untreated 
control are indicated by a nominal p-value < 0.05.  
Dose [J/cm
2
] 5.4  21.6  
- Level 0 0 0 0 0 0 0 0 0 0 
Level 0.5 1 3 6 24 0.5 1 3 6 24 
p-Value 0.0169 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 
 
Table 22: Statistics for Figure 26. Using the Student’s t-test, comparisons were performed for each pair of respective cell cycle phases. Statistically significant differences from 
the untreated control are indicated by a nominal p-value < 0.05.  
Dose [J/cm
2
] 5.4 21.6 
- Level 0 0 0 0 0 0 
Level 5.4 10.8 16.2 21.6 43.2 64.8 
p-Value (Sub-G0/G1) 0.3848 0.5733 <.0001 0.4519 0.0124 <.0001 
p-Value (G0/G1) <.0001 <.0001 <.0001 <.0001 0.0002 0.0246 
p-Value (S) 0.0017 <.0001 0.0076 0.0002 <.0001 <.0001 
p-Value (G2/M) 0.0468 0.0003 <.0001 0.0510 <.0001 <.0001 
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Table 23: Statistics for Figure 27. Using the Student’s t-test, comparisons were performed for each pair. Statistically significant differences for each pair are indicated by a 
nominal p-value < 0.05.  
Dose [J/cm
2
] 5.4  21.6  
- Level 0 0 0 5.4 5.4 10.8 0 0 0 21.6 21.6 43.2 
Level 5.4 10.8 16.2 10.8 16.2 16.2 21.6 43.2 64.8 43.2 64.8 64.8 
p-Value 0.0007 <.0001 0.0073 0.0992 <.0001 <.0001 <.0001 <.0001 <.0001 0.0197 <.0001 <.0001 
 
Table 24: Statistics for Figure 28. Using the Student’s t-test, comparisons were performed for each pair. Statistically significant differences for each pair are indicated by a 
nominal p-value < 0.05.  
Dose [J/cm
2
] 5.4  21.6  
- Level 0 0 0 5.4 5.4 10.8 0 0 0 21.6 21.6 43.2 
Level 5.4 10.8 16.2 10.8 16.2 16.2 21.6 43.2 64.8 43.2 64.8 64.8 
p-Value <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 
 
Table 25: Statistics for Figure 29. Using the Student’s t-test, comparisons were performed for each pair. Statistically significant differences for each pair are indicated by a 
nominal p-value < 0.05.  
Dose [J/cm
2
] 5.4  21.6  
- Level 0 0 0 5.4 5.4 10.8 0 0 0 21.6 21.6 43.2 
Level 5.4 10.8 16.2 10.8 16.2 16.2 21.6 43.2 64.8 43.2 64.8 64.8 
p-Value 0.6240 0.0005 0.0047 0.0128 0.0067 <.0001 <.0001 <.0001 <.0001 0.0520 <.0001 <.0001 
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Table 26: Statistics for Figure 30. Using the Student’s t-test, comparisons were performed for each pair. Statistically significant differences from the untreated control are 
indicated by a nominal p-value < 0.05.  
Dose [J/cm
2
] 5.4  21.6  
- Level 0 0 0 0 0 0 0 0 0 0 
Level 0.5 1 3 6 24 0.5 1 3 6 24 
p-Value <.0001 <.0001 0.0005 0.1302 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 
 
Table 27: Statistics for Figure 31. Using the Wilcoxon method, nonparametric comparisons were performed for each pair. Statistically significant differences from the untreated 
control are indicated by a nominal p-value < 0.05.  
Dose [J/cm
2
] 5.4  21.6  
- Level 0 0 0 0 0 0 0 0 0 0 
Level 0.5 1 3 6 24 0.5 1 3 6 24 
p-Value <.0001 0.2283 0.1715 0.6994 0.1211 <.0001 <.0001 <.0001 0.3604 0.1222 
 
Table 28: Statistics for Figure 39. Using the Student’s t-test, comparisons were performed for each pair. Statistically significant differences for each pair are indicated by a 
nominal p-value < 0.05.  
Quadrants Living cells Dead cells 
- Level Untreated Untreated Treated Untreated Untreated Treated 
Level Treated Positive control Positive control Treated Positive control Positive control 
p-Value (5.4 J/cm
2
) 0.7869 0.0003 0.0003 0.7869 0.0003 0.0003 
p-Value (21.6 J/cm
2
) 0.6255 <.0001 <.0001 0.6255 <.0001 <.0001 
p-Value (43.2 J/cm
2
) 0.2729 0.0001 0.0002 0.2729 0.0001 0.0002 
p-Value (86.4 J/cm
2
) 0.2318 <.0001 <.0001 0.2318 <.0001 <.0001 
p-Value (172.8 J/cm
2
) 0.0160 <.0001 <.0001 0.0160 <.0001 <.0001 
Appendix  
114 
Table 29: Statistics for Figure 48. Using the Student’s t-test (Wilcoxon method), (nonparametric) comparisons were performed for each pair. Statistically significant differences 
from the untreated control are indicated by a nominal p-value < 0.05.  
Condition + Diffusor (Wilcoxon method) + Wound dressing E2723 (Student‘s t-test) 
- Level 0 0 0 0 0 0 0 0 
Level 5.4 10.8 21.6 43.2 5.4 10.8 21.6 43.2 
p-Value <.0001 0.0049 <.0001 <.0001 0.0032 0.3755 0.0001 <.0001 
 
Table 30: Statistics for Figure 49. Using the Wilcoxon method, nonparametric comparisons were performed for each pair. Statistically significant differences from the untreated 
control are indicated by a nominal p-value < 0.05. 
Light source 
- Level 0 0 0 0 0 0 0 0 0 0 0 0 0 
Level 1.8 3.6 5.4 7.2 9.0 10.8 12.6 14.4 16.2 18 21.6 32.4 43.2 
BioLight  
LED Lamp 
p-Value 0.5094 <.0001 <.0001 <.0001 0.0003 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 
MEDILIGHT 
Prototype 
p-Value  0.4076 0.0005 <.0001 <.0001 <.0001 <.0001 <.0001 0.5254 0.1207 <.0001 <.0001 <.0001 <.0001 
 
 
Curriculum Vitae and Publications  
115 
8 CURRICULUM VITAE AND PUBLICATIONS 
 
PERSONALIEN 
 
Name und Vorname: Anna Sophie Klapczynski  
Geburtsdatum: 12.12.1990 
Geburtsort: 67346 Speyer, Deutschland  
Familienstand: Ledig 
Vater: Henry Stefan Klapczynski  
Mutter: Dorothee Emma Klapczynski  
 
SCHULISCHER WERDEGANG 
 
2001 – 2010 Werner-Heisenberg-Gymnasium, Bad Dürkheim  
20.03.2010 Hochschulreife, Abschlussnote: 2,0 
 
UNIVERSITÄRER WERDEGANG 
 
09/2010 – 02/2014 Bachelor of Science 
Studienfach: Biologische Chemie (Biotechnologie) 
Hochschule Mannheim, Deutschland  
Abschlussnote: 1,8 (08.04.2014) 
 
09/2012 – 02/2013   Praktisches Studiensemester  
Titel: „Innovative Methoden in der Strukturaufklärung“ 
Agrarzentrum der BASF SE, Limburgerhof, Deutschland  
Global Product Safety & Registration  
Betreuer: Dr. Reinhard Dötzer, Dr. Markus Radzom  
 
10/2013  Praktische Studienarbeit  
Titel: „Entwicklung von Immunoassays zur Bestimmung von 
humanem Albumin in Urin“ 
Hochschule Mannheim, Deutschland  
Institut für Biochemie  
Betreuerin: Prof. Roswitha Stenzel  
 
11/2013 – 04/2014  Bachelorarbeit  
Titel: „Entwicklung und Validierung einer pH-Gradienten 
Plattform Ionenaustauschchromatographie-Methode zur 
Trennung der Ladungsvarianten monoklonaler Antikörper” 
AbbVie Deutschland GmbH&Co.KG, Ludwigshafen am Rhein 
NBE Analytical R&D 
Betreuer: Alexander Feick 
Note: 1,0 
Curriculum Vitae and Publications  
116 
03/2014 – 08/2015 Master of Science  
Studienfach: Biomedical Science and Technology 
(Biotechnology) 
Hochschule Mannheim, Deutschland  
Abschlussnote: 1,3 (17.08.2015) 
 
02/2015 – 08/2015  Masterarbeit 
Titel: “Effects of blue light irradiation on human dermal 
fibroblasts” 
Zentrum für Medizinische Forschung (ZMF) 
Medizinische Fakultät Mannheim  
Ruprecht-Karls-Universität Heidelberg, Deutschland 
Betreuer: Prof. Norbert Gretz 
Note: 1,0  
 
10/2015 – Jetzt Promotion, Dr. sc. hum. (scientiarum humanarum) 
Titel: “Influence of photobiomodulation with blue light on the 
metabolism, proliferation and gene expression of human 
fibroblasts”  
Zentrum für Medizinische Forschung (ZMF)  
Medizinische Fakultät Mannheim  
Ruprecht-Karls-Universität Heidelberg, Deutschland  
Doktorvater: Prof. Norbert Gretz  
 
PUBLICATIONS 
 
 Becker, A, Distler, E, Klapczynski, A, Arpino, F, Kuch, N, Simon-Keller, K, Sticht, 
C, van Abeelen, FA, Gretz, N, Oversluizen, G: Blue light inhibits proliferation of 
melanoma cells. In: SPIE (Ed.) SPIE BiOS, San Francisco, International Society 
for Optics and Photonics, 2016, pp 969503-969513. 
 
 Becker, A, Klapczynski, A, Kuch, N, Arpino, F, Simon-Keller, K, De La Torre, C, 
Sticht, C, van Abeelen, FA, Oversluizen, G, Gretz, N: Gene expression profiling 
reveals aryl hydrocarbon receptor as a possible target for photobiomodulation 
when using blue light. Sci Rep, 6: 33847, 2016. 
 
PATENTS  
 
 Patent in collaboration with URGO RID on the proliferative effect of 7.5 min blue 
light found in human keratinocytes and human fibroblasts: “Flexible device for the 
irradiation of chronic wounds inducing wound healing by accelerated proliferation 
of fibroblasts and keratinocytes (LEDs (wavelength 450-490 nm))”; EP16181721.8 
(EU), PCT/EP2017/068951 (USA) 
 
 Patent in collaboration with URGO RID and the University of Heidelberg on the 
antibacterial effect of blue light: “Flexible photobiomodulation device that is able to 
emit blue light at 450 nm and is suitable at least to be bacteriostatic and 
preferably to reduce proliferative effect of bacteria”; EP18305067 (EU) 
Acknowledgements 
117 
9 ACKNOWLEDGEMENTS  
First of all, I sincerely thank my supervisor Prof. Norbert Gretz for giving me the 
opportunity to work on this interesting and future-based project. I am very thankful for 
all his valuable advices, suggestions as well as comments and moreover his constant 
support throughout the whole period of research and writing.  
 
Furthermore, I am very grateful for all the experiences I gained as a member of the 
European MEDILIGHT consortium introducing me to the challenges of international 
project work. It was a pleasure to work with all the partners involved, but a special 
thanks goes to URGO RID, providing the financial support for the last period of my 
PhD. I would like to take this opportunity to thank Dr. Marielle Bouschbacher for 
always thriving new ideas. Besides MEDILIGHT, I would like to thank Prof. Gretz for 
my participation in the Doctoral Program ‘Cooperative Research Training Group – 
Tissue Analytics for Stem Cell based Diagnostics and Therapy (TASCDT)‘. I am very 
thankful for all the helpful courses I could attend throughout this program.  
 
Moreover, I thank Cathleen Fichtner for her excellent assistance in the lab and all the 
countless hours of help in upcoming questions and problems. I also thank Elisabeth 
Seelinger, Jasmin Baumgartl and Maria Muciek for their technical support. A special 
thanks goes to Dr. Carolina De La Torre and Dr. Carsten Sticht for helping me in 
gene expression analyses and statistics. In addition, I deeply thank Dr. Katja Simon-
Keller for supporting me in new experimental set-ups. Thanks to all my ZMF 
colleagues for sharing knowledge, frustrations and success. A special thanks goes to 
Natalia Kuch, Fabiola Arpino and my former colleague Anja Becker, who had 
introduced me to the cell culture lab. Moreover, I would like to thank Sina Schwalm 
and Edda Eustachi for their support in administrative concerns as well as all the 
encouraging conversations.  
 
My greatest and deepest thanks goes to my dearest parents, sisters and my beloved 
boyfriend, for always believing in me and being at my side during this long journey of 
ups and downs. This work would not have been possible without your efforts, support 
and patience. You are part of who I am today. All my successes are also yours.  
